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ABSTRACT 
Background: Chronotype, social jetlag, poor sleep, proinflammatory diet, and low 
physical activity have been associated with increased risk of chronic diseases: obesity, 
diabetes, cardiovascular disease, depression and cancer. Yet the relationships between 
these factors have not been extensively investigated in prospective studies.  
Methods: Two studies were conducted. The first study followed 390 healthy men and 
women ages 21-35 for two years. Social jetlag [SJL] and sleep measures (total sleep time 
[TST], sleep onset latency [SOL], wake after sleep onset [WASO]), sleep efficiency 
[SE]), were derived from physical activity personal (armband) monitoring. The 
participants wore the armband for 4-10 days at 6-month intervals (1,431 observations). 
Temporal consistency of repeated  sleep measures was analyzed using generalized linear 
mixed models (GLMM). Repeated measures latent class analyses (RMLCA) identified 
subgroups among participants with adequate or inadequate sleep characteristics over 
time. Relationships between chronotype, absolute SJL, sleep measures and 
anthropometric measures (Body Mass Index [BMI], Percent Body Fat [%BF], Waist-to-
Hip Ratio [WHR], Waist-to-Height Ratio [WHtR], Systolic Blood Pressure [SBP] and 
Diastolic Blood Pressure [DBP], Total Mood Disturbance score [TMD], and Perceived 
Stress Score [PSS]) were analyzed using GLMM for repeated measures. Stratification by 
latent chronotype group was used to study effect modification.  
The second study examined association between energy-density Dietary Inflammatory 
Index (e-DII) and incident PrCA among 40,161 men ages 45-69 at recruitment
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(2002-2003) and followed for a mean of 9.7 years. The e-DII was calculated from a food 
frequency questionnaire (FFQ) at baseline and categorized into quartiles. Incident PrCA 
cases were ascertained via linkage with cancer registry and categorized into three groups: 
high-risk, intermediate and low-risk. Accelerated failure time models were fit to model 
time-to-development of incident PrCA. Cox proportional hazards models were used to 
calculate hazard ratios (HR) and 95% confidence intervals (95% CI) of high- and 
intermediate risk PrCA. In all analyses, the lowest quartile of e-DII representing a more 
anti-inflammatory diet was used as the referent group. 
Results: Minor temporary changes were observed only for SJL, chronotype and TST. 
The RMLCA identified two groups of absolute SJL: low (mean±SE: 0.8±0.6 h, 58%) and 
high (1.4±0.8, 42%); the latter were employed and had an evening chronotype. 
Subgroups with disrupted sleep tended to be male, African American, have a lower 
income, and an evening chronotype relative to those with normal sleep. Chronotype and 
absolute SJL were not associated with anthropometric characteristics. TST <6 h, SE 
<85% or WASO ≥60 min increased odds of high %BF, WHR or WHtR in participants 
with early chronotypes. Those with early chronotypes and sleep latency ≥12 min had 1.9 
times increased odds of high SBP (95%CI: 1.15-3.16, pinteraction=0.02). Among late 
chronotypes, TST <6 hours was associated with 2.6 times increased odds of high SBP 
(95%CI: 1.08-6.40, pinteraction=0.74).  
 Time-to-development of incident total PrCA did not differ by quartile of e-DII; 
although, among Whites, it was shorter relative to other races (AFQ4 vs.Q1=1.16; 
95%CI:1.01-1.34). The hazard Ratio (HR) for high-risk PrCA was increased by 36% in 
the third quartile of the e-DII (95%CI:1.04-1.76); no increased risk was observed in the 
vi 
 
fourth quartile. The HR for high-risk PrCA was the highest among Blacks (HRQ3 
vs.Q1=3.77; 95%CI:1.29-11.06). The e-DII was not associated with intermediate- or low-
risk PrCA incidence. 
Conclusions: Sleep disruption among young adults remained persistent during two years. 
Chronotype modified the association between disrupted sleep, obesity and elevated blood 
pressure. Pro-inflammatory diet increased risk of high-risk PrCA especially among 
Blacks. 
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CHAPTER 1 
Introduction 
Background & Significance 
 Most physiological and behavioral processes in humans follow approximately 24-
hour cycles generated by self-sustaining internal circadian clocks (1). These free-running 
cycles are synchronized by environmental stimuli called zeitgebers, and the most 
important zeitgeber is light (2). Due to the difference in circadian entrainment 
characteristics, differing in their preferences for timing of daily activities people may be 
categorized into morning, neutral and evening chronotypes (3, 4). People with early 
chronotypes, the so-called "larks", wake up and go to bed at night early while those with 
late chronotypes ("owls"), prefer to wake up and go to bed late (3). For instance, on free 
days, people with morning chronotypes go to bed on average between 10 p.m. and 
midnight while those with evening chronotypes retire between 1 and 3 a.m. (3). Morning 
and evening chronotypes differ in daily rhythms of many physiological processes such as 
body temperature, melatonin and cortisol secretion, behavioral patterns and mood (5-7). 
Due to variation in circadian clock genes and environmental factors, chronotypes in 
populations are characterized by an approximately normal distribution from extremely 
early to extremely late with the majority in the middle (3, 6). In addition, chronotypes are 
influenced by age, sex, photoperiod of birth, genetic factors, employment status and work
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schedule, race, altitude and latitude of residence, exposure to light, season, and social 
factors (7-11).  
 Hectic modern life in industrialized countries imposes on individuals multiple 
work and social life related demands, and, through which, a schedule that often comes 
into conflict with the individual's chronotype. This discrepancy (misalignment) between 
biological preference and social clock is called "social jetlag" (SJL) (6). Individuals with 
evening chronotypes tend to accumulate sleep debt during the week for which they try to 
compensate during the weekend. Morning chronotypes, on the contrary, tend to develop 
sleep debt during the weekend (6). Social jetlag can start in teenage years and continue 
throughout working years until retirement and, thus, may affect millions of people in 
industrialized countries (12).  
 The extreme form of circadian misalignment is caused by shift work when an 
individual has to work at night and sleep during the day. People with different 
chronotypes have different abilities to adjust to shift work (13, 14). For instance, people 
with morning chronotypes have decreased tolerance to shift work, particularly to night 
shifts (13, 14). They accumulate larger sleep debt, have poorer quality of daytime sleep 
and are more likely to withdraw from shift work as compared to people with evening 
chronotypes (13, 14). Chronic jetlag in humans, for instance, in flight attendants working 
in long-distance transmeridian flights, is associated with impaired cognitive function 
(15), menstrual disturbances (16, 17), mood disorders (18) and cancer (19). Chronic 
jetlag was associated with increased mortality in aged mice (20). Since the circadian 
clock regulates metabolism and homeostasis in many tissues, circadian disruption may 
predispose millions of people to chronic diseases such as obesity, metabolic syndrome, 
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type 2 diabetes, depression, mood disorders, cardiovascular disease and cancer, similar to 
what has been described among shift workers (21-29). Thus, it is important to investigate 
complex relationships between individual circadian preference, circadian misalignment 
and disease risk taking into consideration various other factors that may be involved 
(genetic, demographic, behavioral, environmental). 
 The relationships between chronotype, mood and stress have recently received a 
lot of attention although the underlying mechanisms are not clear (7). There is evidence 
of higher incidence of evening chronotype (“eveningness”) among patients with 
psychiatric conditions such as major depression and bipolar disorder (30-33), and that 
eveningness is associated with depressive symptoms and elevated stress in healthy 
individuals (34-44). Some studies, however, argue that morning chronotype 
(“morningness”) also may be associated with altered health (22, 45-47). In some studies, 
people with morning chronotypes reported difficulties staying asleep in early morning 
hours and had elevated morbidity assessed with Nottingham Health Profile (45). 
Morningness has been associated with elevated blood pressure, altered metabolic 
parameters (46, 48) and decreased adaptability to shift work (13, 14). It is plausible that 
both morningness and eveningness can be associated with mood changes; these 
relationships are complex and the role of other influential factors needs to be explored. 
Although chronotype is strongly correlated with SJL (6, 12, 37, 49), only a few studies 
explored the relationships between SJL, alterations in mood, and depression (6, 36, 37). 
Results of two studies suggested that the relationships between SJL and depression may 
be modified by chronotype (37, 50); however, these studies disagreed with regard to 
whether it is a morning or evening chronotype that predispose to depression. Thus, 
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studies are needed to explore the relationships between chronotype, SJL and mood or 
stress using a longitudinal study design (to explore the temporality) that includes 
mediation analysis. 
 There is evidence that chronotype is associated with obesity (12, 33, 51-55), and 
in most studies those with an evening chronotype had a higher risk (12, 33, 51, 53-56). 
However, some other studies either refute any association between chronotype and 
obesity (57) or show that morning chronotypes also have an elevated risk of obesity and 
even cancer (12, 22, 47). Social jetlag has been associated with increased body mass 
index (BMI), body fat, waist circumference, metabolic syndrome, and markers of 
systemic inflammation independently from sleep duration (12, 49, 58). Chronotype in 
combination with inappropriate social schedule causes social jetlag (6, 12); thus, it is 
reasonable to hypothesize that social jetlag may mediate the relationship between 
chronotype and obesity. The only study that explored this potential mediating role of 
social jetlag using mediation analysis produced conflicting results (56). Thus, 
interrelationship between chronotype, SJL, BMI and other adverse metabolic or 
psychological outcomes remains unresolved. 
 Recently, relationships between sleep characteristics and various health outcomes 
such as obesity, type 2 diabetes, hypertension, cardiovascular disease and cancer have 
been examined in prospective studies (59-65). Yet, in most of these studies chronotype 
and other sleep measures were defined based only on self-report at baseline under the 
assumption that they were accurately reported and did not change during the study 
period. To date, only a few studies have investigated the variability of sleep 
characteristics over prolong periods of time using objective measures such as 
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polysomnography or actigraphy (66-68). Thus, longitudinal studies of sleep 
characteristics utilizing objective measurements are needed to investigate sleep 
variability, especially in young adults.  
 Recent research suggests that if insufficient or disrupted sleep along with 
proinflammatory diet and low physical activity persist for many years they may be 
associated with increased risk of cancer, possibly via oxidative stress, inflammation, and 
altered immune response (28, 69, 70). The complex relationships of previously 
mentioned life style factors in pathogenesis of prostate cancer, especially in longitudinal 
studies, have not yet been studied and, thus, require further investigation. According to 
Global Burden of Cancer Study (GLOBOCAN) data, prostate cancer is the second most 
frequently diagnosed cancer in men worldwide, and its incidence rates are the highest in 
Australia/New Zealand, Eastern and Western Europe, and North America (71). In the 
United States, incidence and mortality from prostate cancer differs by race/ethnicity and 
socioeconomic status (72, 73). In addition, in immigrants, prostate cancer incidence 
increases to the levels characteristic of the destination population (74, 75). This suggests 
that in addition to differences in screening practices, differences in lifestyle factors may 
play a role. 
 Diet is an important lifestyle risk factor for prostate cancer and yet summary 
measures of the diet used in previous investigations of these relationships had some 
limitations. For instance, an estimation of single nutrient intakes did not account for the 
complex relationships between multiple nutrients in the individual's complete diet (76). 
Dietary patterns are difficult to standardize, and some dietary indices only assessed 
adherence to dietary recommendations that changed over time (77-79). Developed by the 
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researchers at the University of South Carolina, the Dietary Inflammatory Index (DII) 
allows calculations of an inflammatory potential of the individual's diet and, thus, is a 
biologically-based summary measure for studies of the relationships between diet and 
health outcomes that are strongly based on inflammatory mechanisms (80, 81). The DII 
was based on an extensive published literature, standardized against actual food intakes 
in 11 populations around the world (USA, Mexico, England, Denmark, India, Australia, 
New Zealand, Bahrain, Scotland, South Korea and Japan) (82), and validated in 
epidemiological studies against inflammation biomarkers (83). Due to its unique ability 
to assess the inflammatory potential of the diet, the DII would be a useful measure to 
investigate the pathogenesis of prostate cancer, both alone and in combination with other 
key lifestyle factors, namely sleep and physical activity. The latter two factors also may 
increase predisposition to prostate cancer via oxidative stress and inflammation (28, 84, 
85). 
 
Objectives & Specific Aims 
 The proposed study has the following objectives: 1) evaluate the stability of 
chronotype, SJL, and sleep disruption during two years; 2) examine the relationships 
between chronotype, SJL or disrupted sleep and obesity, blood pressure, mood states, 
stress and poor sleep; and 3) explore the role of inflammatory potential of diet and 
lifestyle factors, such as sleep and physical activity in pathogenesis of prostate cancer.  
 The project has the following specific aims:  
Specific Aim 1: Determine whether chronotype, social jetlag and disrupted sleep change 
within two years. Disrupted sleep is defined by the following measures: total sleep time 
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(TST), sleep onset latency (SOL), wake after sleep onset (WASO), and sleep efficiency 
(SE). 
Hypothesis: Chronotype, social jetlag and disrupted sleep remain stable within two years. 
Specific Aim 2: Examine relationships between chronotype, SJL, objective sleep 
characteristics (TST, SOL, WASO, SE) and various health indicators including: BMI, 
percent body fat (%BF), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), systolic 
blood pressure (SBP), diastolic blood pressure (DBP), mood, stress, and poor sleep. 
Hypothesis 1: People with extreme chronotype (morning or evening) are more likely to 
have: elevated BMI, %BF, WHR, WHtR, SBP, DBP, altered mood states (depressive 
symptoms), stress or disrupted sleep than those with intermediate chronotype. 
Hypothesis 2: People with higher SJL are more likely to have: elevated BMI, %BF, 
WHR, WHtR, SBP, DBP or altered mood states (depressive symptoms), stress, disrupted 
sleep than those with lower SJL. 
Hypothesis 3:People with disrupted sleep are more likely to have elevated BMI, %BF, 
WHR, WHtR, SBP, DBP, altered mood states (depressive symptoms) or stress than those 
whose sleep is not disrupted. 
Specific Aim 3 
Specific Aim 3, sub-aim 1: Determine whether the e-DII is associated with prostate 
cancer incidence and investigate potential effect modification by race.  
Hypothesis 1: Men with higher (pro-inflammatory) e-DII scores will have an elevated 
risk of prostate cancer. 
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Hypothesis 2: Prostate cancer incidence among men with higher e-DII is further elevated 
among African-Americans as compared to other races.  
Specific Aim 3, sub-aim 2: Study relationships between the e-DII and high-risk prostate 
cancer and the role of effect modification by race.  
Hypothesis 1: A pro-inflammatory diet (as measured by the DII) predisposes individuals 
to an elevated risk of advanced or aggressive prostate cancer. 
Hypothesis 2: The incidence of advanced or high-aggressive prostate cancer in men with 
higher DII is further elevated in African-Americans, with low total physical activity, 
short sleep duration, elevated BMI or decreased in those who use NSAID.  
 
Study outline 
 Chapter 2 first introduces concepts of individual circadian preference 
(chronotype) and SJL followed by a review of studies of the relationships between 
chronotype or SJL and disrupted sleep, mood disorders, stress, obesity and basic vital 
signs (blood pressure, heart rate). Further, a summary of current literature on temporal 
patterns of sleep characteristics and insomnia is presented. Chapter 2 concludes with the 
review of the current knowledge about the relationships between individual's diet, 
physical activity and sleep and prostate cancer risk. Chapter 3 describes research methods 
used for each specific aim, including description of data sources and analytical methods. 
Chapter 4  is a manuscript for Specific Aim 1: Temporal pattern of chronotype, social 
jetlag and disrupted sleep within two-year time frame. Chapter 5 is a manuscript 
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addressing Specific Aim 2: Relationships between chronotype, SJL or sleep 
characteristics and anthropometric indices of obesity, blood pressure, mood and stress. 
Chapter 6 is a manuscript on Specific Aim 3: Relationships between diet, physical 
activity and sleep and prostate cancer risk. Chapter 7 includes overall summary and 
suggestions for the future research. 
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CHAPTER 2 
Literature review 
Introduction to chronotypes 
 Most physiological and behavioral processes in humans have a diurnal rhythm 
(1). This daily rhythm is generated by a self-sustaining internal circadian clock located in 
the suprachiasmatic nuclei of the brain (2). The central circadian clock generates rhythms 
that are slightly longer than 24 hours; thus they have to be synchronized (or entrained) by 
environmental stimuli to be more closely aligned with the 24-hour light dark cycle (2). 
The most important synchronization stimulus (zeitgeber) is light (2, 86). Due to 
differences in genetic predisposition and circadian entrainment stimuli, individuals differ 
in their preferences for timing of daily activities and are typically categorized into 
morning, neutral and evening chronotypes (3, 4). People with early chronotypes, the so-
called "larks", wake up early and go to bed early, between 10 and 11 p.m., while those 
with late chronotypes ("owls"), prefer to wake up later and go to bed later, between 11 
p.m. and 1 a.m. (3). Chronotype is an individual trait influenced by genetic predisposition 
(9, 87), possibly photoperiod of birth (7), and modulated by environmental (geographic 
location of residence and light exposure) (7), and social factors (36). Due to variation in 
circadian clock genes and environmental factors, chronotypes in populations have an 
approximately normal distribution from extremely early to extremely late with the 
majority in the middle (3, 6). Chronotype may vary by age and sex. For instance, children 
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tend to have early chronotypes that gradually progress to late chronotypes reaching the 
peak of "lateness" in early adulthood (20 years) and then gradually become earlier and 
earlier for the rest of their life (88). Women reach the peak of their chronotype 
eveningness slightly earlier than men, and then, on average, have earlier chronotypes than 
men until the age of 60 years when chronotypes become very similar for both sexes and 
earlier than they were in childhood (88). 
Social jetlag 
 Due to the differences between biologically preferred and social schedules (e.g. 
school, work), individuals with evening chronotypes accumulate sleep debt during the 
week for which they compensate during the weekend. Morning chronotypes, on the 
contrary, develop sleep debt during the weekend (6). They delay their bed time due to 
social interactions with later chronotypes but cannot sleep longer the next morning 
because of their circadian rhythm determined earlier wake-up time. This discrepancy 
between biological preference and social clock is called "social jetlag" (6). Originally, the 
term "jetlag" was described in relation to transmeridian travel as a complex of 
characteristic symptoms: difficulties falling asleep or staying asleep at night followed by 
daytime fatigue, loss of concentration, irritability, altered appetite and bowel irregularity 
due to the phase shift that occurs between the body’s internal clock and the ambient light-
dark cycle in the new location (89, 90). The major difference between aforementioned 
two types of jetlag is that while travel-associated jetlag is transient, social jetlag is 
chronic and may adversely affect mood and behavior, and contribute to development of 
chronic health conditions such as obesity (6, 12, 49). Some suggest that in industrialized 
countries, over two-thirds of healthy adults are at risk of chronic social jetlag, although 
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few studies have addressed its potential health impacts (12, 49). An evening chronotype 
positively correlates with amount of sleep debt accumulated during the week (6) and thus 
with social jetlag (37). 
Chronotype, social jetlag, and obesity 
 Circadian clock regulates metabolism and obesity; thus, circadian misalignment 
may lead to obesity and metabolic syndrome via altered metabolic processes, lack of 
physical activity and poor eating habits (49, 52, 91-94). Circadian misalignment may lead 
to lipid disregulation, decreased insulin sensitivity, impaired glucose tolerance and 
altered cortisol secretion (49, 52, 91). Short sleep duration has been associated with 
disregulation of metabolic hormones leptin and ghrelin, which increase appetite and 
cravings for energy dense foods (95).  
 In a cross-sectional study among patients with bipolar disorder, chronotype 
explained 19% of the variation in total body fat (after adjustment for age, sex, mood and 
sleep disruption), and “eveningness” was associated with increased total body fat (51). In 
another study, chronotype was a significant predictor of BMI in people with normal 
weight (BMI 18.5-<25 kg/m
2
), and morningness was associated with increases in BMI 
(12). Social jetlag did not predict BMI in people with normal weight; however, in 
overweight and obese, SJL rather than chronotype was positively associated with BMI 
(12). Recent experimental studies show that chronotype and circadian misalignment 
affect glucose tolerance via different mechanisms and independently from behavior (52). 
 Several studies found that evening circadian preference is associated with 
increased body weight in different age groups (33, 53-55). Depressed peri- and post-
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menopausal women with evening chronotype and delayed mid-sleep time had higher 
BMI and were prone to weight gain compared to those with morning chronotypes and 
less delayed mid-sleep phase (33). Delayed mid-sleep time was associated with increased 
risk of obesity in elderly men and women in two cohort studies of Osteoporotic Fractures 
(96). In a follow-up study of healthy college freshmen, evening chronotype was 
associated with increase of BMI while there was no change among morning and neutral 
chronotypes combined in one group (53). A recent cross-sectional study supports this 
observation that evening chronotypes are more likely to have higher BMI than 
intermediate and morning chronotypes combined in a representative sample of US adults 
18-71 years old (55). In another cross-sectional study in adolescent girls, however, 
evening chronotype was not associated with increased BMI (57). The mechanism 
underlying the relationship between chronotype and obesity has not yet been established. 
It is possible that some other factors such as short sleep duration, sleep/wake 
disturbances, stress-behavioral patterns (changes in diet or physical activity), or mood 
may play a mediating role. Some studies suggest that persons with late chronotype, 
especially those who are depressed, have increased appetite and carbohydrate cravings 
(33) and consume unhealthy foods (93, 94) that predispose them to obesity. In a cross-
sectional study of US adults aged 18-71 years, relationships between chronotype and 
BMI were mediated by self-control (55). Chronotype and social jetlag are moderately 
correlated, especially on work days, and people with evening chronotypes tend to have 
more social jetlag (6, 12, 37, 49, 58). Social jetlag has been associated with increased 
BMI, body fat, waist circumference, metabolic syndrome, and markers of systemic 
inflammation (12, 49, 58). Chronotype in combination with social schedule can elicit 
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increase in social jetlag (6, 12); thus, it is reasonable to hypothesize that social jetlag may 
mediate the relationships between chronotype and obesity. The only study that explored 
this potential mediating role of social jetlag using mediation analysis produced 
conflicting results (56). One hundred thirty seven college freshmen attending an urban 
US university were enrolled in the study during the second week of the fall semester, and 
fifty-four of them were followed up eight weeks later (53, 56). Upon enrollment and at 
the follow-up, the students completed several self-administered questionnaires including 
the 5-item reduced version of Morningness-Eveningness Questionnaire used to define 
chronotype (97). Their chronotype did not change significantly during the study period, 
and a sensitivity analysis showed that completion status and chronotypes were not related 
(53). Those who completed the study did not differ from noncompleters by weight, BMI, 
sleep quality and physical activity at the baseline. The authors used linear regressions to 
model changes of BMI and mood during the study period based on chronotype (53). In 
the mediation analyses, the direct effect of chronotype on BMI could not be evaluated 
because of the violation of the two key assumptions, normality (for BMI) and statistical 
significance of the association between exposure (chronotype) and outcome (BMI); 
therefore, only the indirect effect was studied using a nonparametric bootstrap approach 
(56). Chronotype was modeled as a dichotomous variable; evening chronotypes were 
compared to morning and neutral chronotypes combined in one group due to the very 
small number of participants with morning chronotypes (56). The bootstrap analysis 
showed that evening chronotypes had higher SJL and the latter was associated with 
increase in BMI. This suggests that chronotype has indirect effect on BMI through the 
SJL; however, the final test for mediation (Sobel test) was not statistically significant 
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(56). Post hoc analyses showed that when chronotype was modeled as a continuous 
variable, later chronotype increased BMI via increase in SJL, and this conclusion was 
supported by a statistically significant Sobel test (56).  
 Some researchers evaluated relationships between chronotype, social jetlag and 
measures of obesity by incorporating both chronotype and social jetlag into their 
statistical models at the same time (12, 58). This approach may introduce 
multicollinearity which can increase the potential for Type 2 error (false negative). We 
propose to start with an evaluation of the correlation between chronotype and social 
jetlag and then conduct mediation analyses between chronotype and SJL as they relate to 
the metabolic and psychometric outcomes included in this study. The results of the 
mediation analysis will help develop an unbiased understanding of the roles of these 
factors in physical and psychological health. 
 Few studies have investigated relationships between chronotype/social jetlag and 
overweight/obesity. Circadian disruption is highly prevalent in industrialized countries 
and may contribute to obesity or other adverse metabolic outcomes. The Energy Balance 
data will allow for an examination of these questions in a longitudinal study with 2-years 
of follow-up; the planned analyses will use BMI, BF%, WHR, and WHtR. While BMI is 
more convenient and widely used, it is only a surrogate measure and has been shown to 
underestimate obesity (98-100) since it doesn't distinguish between fat and muscle tissue 
(101). BF% measured by dual X-ray absorptiometry is considerably more precise than 
BMI; it measures bone, muscle and fat tissues simultaneously (98). In addition, waist 
circumference and waist-to-hip ratio seem to require ethnic-specific cut-off points that 
makes their use for screening complicated (102). Another anthropometric index, waist-to-
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height ratio (WHtR) is a better predictor of central obesity-related outcomes as compared 
to BMI and waist circumference (103). Thus, it has been suggested for use as a global 
screening index with cut-off point 0.5. 
Chronotype, social jetlag, and basic vital signs 
 Blood pressure (BP) has wide circadian variation determined by internal and 
external factors. In healthy normotensive individuals blood pressure rises abruptly upon 
waking up and is the highest in the morning, slightly decreases after meals and is the 
lowest during night sleep (104). Blood pressure varies by sex; men usually have higher 
BP and lower resting heart rate (HR) than women (104, 105). During the day, there are 2 
BP peaks, at 9 a.m. and 7 p.m., and a slight nadir at 3 p.m. The internal or circadian 
regulation of BP and HR occurs via hormones, peptides and neurotransmitters which all 
have their own circadian rhythms (104). External factors affecting blood pressure include 
physical activity, diet and sleep (106). Evening chronotypes tend to have higher systolic 
blood pressure and heart rate and lower heart rate variability than people with morning 
chronotypes, whereas no significant difference was observed for diastolic blood pressure 
(44, 105). In two studies, evening chronotypes had higher SBP and HR after being 
exposed to stress (44, 105). Social jetlag may affect the cardiovascular system. For 
instance, in a recent pilot study among rotating shift workers, social jetlag positively 
correlated with resting HR (107). Larger longitudinal studies are needed to confirm those 
relationships. Since chronotype and SJL have been associated with cardiovascular 
pathology and type 2 diabetes (46, 49, 107), more research is needed to explore 
relationships between chronotype/social jetlag with basic physiologic characteristics such 
as BP and HR. This information may be useful in the future to develop lifestyle 
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recommendations to prevent cardiovascular complications and type 2 diabetes in people 
with different chronotypes. 
Chronotype, mood and perceived stress 
 Little is known about relationships between chronotype and mental health. 
Individuals with evening chronotype tend to have psychiatric conditions, such as major 
depressive disorder, bipolar disorder, anxiety or addiction disorder, or insomnia, and their 
depression symptoms are more severe (30-33, 108). It is difficult to make a conclusion 
whether mental condition affects chronotype or vise versa due to the cross-sectional 
nature of these studies (30, 31, 33, 57, 109). Studies in healthy individuals also revealed 
that people with evening chronotypes were more likely to have depressive symptoms (34-
42, 110), experience higher level of stress (34, 43, 44, 111) and complain about poor 
health (10, 34, 110). Healthy individuals with evening chronotypes were more likely to 
have seasonal variation of mood and behavior and experience burnout, consume 
stimulants, coffee, caffeinated soft drinks and alcohol, to smoke and to consume ‘fast 
food’ than those with morning and neutral chronotypes (41, 53, 93, 110, 112, 113), 
although not all studies support this observation (34). Some studies report that 
morningness also may be associated with altered health (22, 45-47). For instance, people 
with morning chronotypes have difficulty staying asleep in early morning hours and 
report elevated morbidity elicited by Nottingham Health Profile questionnaire (45). In 
one study, young people with morning chronotype had a higher lifetime risk of any of the 
DSA IV Axis one disorders (e.g. major depressive episode, schizophrenic episode, panic 
attack), although, people with evening preference had higher odds of having three and 
more of those disorders (110). Morningness has been associated with a higher cortisol 
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awakening response (48), and elevated systolic blood pressure, blood glucose, low 
density lipoprotein and total cholesterol levels compared with evening types (46). Total 
sleep deprivation for 24 hours in healthy people with a morning chronotype led to 
increases in depression-dejection symptoms, whereas depression-dejection symptoms 
decreased among evening chronotypes (50). This may help explain why people with 
morning chronotypes have decreased tolerance to shift work, particularly to night shifts 
(13, 14). They accumulate larger sleep debt, have lower quality of daytime sleep and 
more likely to withdraw from shift work as compared with evening chronotypes (13, 14). 
There is an evidence that the relationship between morningness-eveningness preference 
and stress can be mediated by perceived sleep disruption (111), and the relationships 
between chronotype and depression can be modified by BMI (57). Thus, the role of 
various other factors in the relationships between chronotype, perceived stress and altered 
mood also should be taken into consideration. 
Social jetlag and mood disorders 
 Studies of SJL and mood disorders indicate that SJL is associated with depression 
and smoking (6, 37). Rural Brazilian residents with more than two hours of SJL had 
higher depression scores compared to those with two hours or less (37). However, in 
another study SJL was not associated with depression (36). It is possible, that SJL, rather 
than chronotype, predisposes to depressive mood as it has been shown for smoking (6). 
Social jetlag strongly correlates with chronotype (6, 12, 37, 49), and there is some 
evidence suggesting that the relationships between SJL or sleep deprivation and 
depressive mood may be driven by chronotype (37, 50). For instance, rural Brazilian 
residents with up to two hours of SJL ranked by their mean depression scores from the 
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highest to lowest in the following order: intermediate, morning and evening chronotypes 
(37). The mean depression scores for two other groups of larger SJL (>2-4 and >4 hours) 
were not presented due to the small sample size, and SJL-depression relationship was 
statistically significant only among people with ≤ 2 hours of SJL (37). In agreement, in 
an experimental study among healthy people following 24 hours of sleep deprivation,  
depression-dejection symptoms increased among people with morning chronotypes and 
significantly decreased in those with evening chronotypes (50). After partial sleep 
deprivation (participants went to bed at their regular time and were awoken at 1:30 AM), 
depression-dejection scores in morning chronotypes did not significantly change while in 
evening chronotypes they decreased (50). 
Temporal patterns of sleep characteristics 
 There is a multitude of sleep disorders and the most common of them is insomnia 
(114); thus, it will be used as an example of “disrupted” or “bad sleep”. The proposed 
study, however, will not be limited to insomnia. Insomnia is can be defined as difficulty 
falling asleep, staying asleep, or decreased sleep quality despite having opportunities for 
sleep with the following day time impairment (115). Because different epidemiological 
studies define insomnia different ways, the prevalence of insomnia symptoms and 
insomnia diagnosis varies between studies and populations (116). The prevalence of 
insomnia symptoms in adults is 33-50% and the prevalence of general insomnia disorder 
(insomnia symptoms associated with associated functional impairment) is 10-15% (115). 
Studies show that insomnia may be associated with increased risk of many chronic 
diseases such as cardiovascular disease (117), hypertension (118), obesity (54, 119), 
diabetes (120), and  cancer (28, 121, 122). Taking into account high prevalence of 
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insomnia in general population, investigation of its role in development of chronic 
diseases is very important. Recently, relationships between sleep characteristics and 
previously mentioned highly prevalent chronic diseases have been examined in many 
prospective studies (59-65). In most of these studies, information about sleep was 
obtained from questionnaires completed by study participants who were asked to provide 
average estimates for previous time periods of different length. Thus, these studies 
assume that self-report accurately describes the individual's sleep and sleep 
characteristics do not change over time. On the contrary, it has been shown that sleep 
disruption assessed by self-report differs from sleep assessed using objective measures 
(123, 124). For instance, healthy young individuals in one study overestimated their sleep 
onset latency and underestimated frequency of awakening (124). In another study, 
participants with chronic insomnia underestimated their total sleep time and number of 
awakenings but overestimated sleep onset latency (125).  Only a few studies have 
investigated the variability of sleep characteristics over prolong periods of time using 
objective measures such as polysomnography or actigraphy (66-68). In middle-aged 
people, sleep measures, such as sleep duration, efficiency, latency and time in bed 
showed considerable day-to-day variability, however, they were stable during the 1-3 
year follow-up (66-68). In college students aged 18-40 years, longitudinal studies 
assessed sleep based only on self-report and yielded contradictory results; both studies 
were conducted during the spring semester (126, 127). Among undergraduate students, 
for instance, sleep duration decreased and the number of awakenings increased as the 
semester progressed (126). In another study, however, the sleep duration and quality 
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increased within a 3-month long semester (127). Thus, a prospective study design is 
proposed to study the consistency of actigraphic sleep measures over time. 
 
Diet, sleep, physical activity, and prostate cancer 
 Chronic inflammation predisposes individuals to many chronic diseases, 
including cancer, and may contribute to development of more aggressive form of the 
disease (128, 129). Among agents predisposing to chronic inflammation are infections, 
poor diet, disrupted or insufficient sleep, obesity, smoking and immunosenescence, or 
age-related diminution of immune response (130-133). Continuous exposure to antigenic 
stimulation and stress compromises the ability of the aging immune system to cope with 
such stimuli, which in turn leads to chronic inflammation, the so-called “inflamm-aging” 
(134). 
 The role of inflammation in carcinogenesis has been described for several 
cancers, such as colorectal, lung, liver, bladder, cervical and pancreatic (135). 
Additionally, a relationship with inflammation has been suggested for prostate cancer 
(136, 137). Inflammation is frequently detected in different prostatic conditions, such as 
prostatitis, benign prostatic hypertrophy, and prostatic intraepithelial atrophy (138-140). 
On average, 11-16% of men in the United States are diagnosed with prostatitis in their 
lifetime (141). About 20% of men with inflammation detected during prostate biopsies 
developed prostate cancer within 5 years, and additional 6% were diagnosed with high-
grade prostatic epithelial neoplasia, which is considered a precursor of prostatic 
adenocarcinoma (136).  
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 There is evidence that inflammation within the prostate is strongly associated with 
oxidative stress, which has been shown by multiple experimental, epidemiological and 
clinical studies to play an important role in the pathogenesis of prostate cancer (142).  
Inflammatory cells present at the sites of chronic prostate inflammation produce 
increased amounts of reactive oxygen species (ROS) (143) that, over time, cause DNA 
mutations, promote genetic instability and cellular senescence and, therefore, can 
contribute to the initiation of  carcinogenesis (144).  In addition, prostate cancer cells 
themselves produce high quantities of ROS, which can play important role in tumor 
growth and development of a malignant phenotype (145). Increased levels of ROS 
combined with inability of antioxidant systems to neutralize them lead to chronic state of 
oxidative stress (146). Oxidative stress that occurs via tissue damage and the 
corresponding recruitment of more inflammatory cells lead to the perpetuation of chronic 
inflammation, which completes the vicious cycle (147). 
 Recent research identified a few modifiable risk factors - diet, physical activity 
and sleep duration and disruption that have been shown to affect inflammation, immune 
response and oxidative stress (28, 69, 70); however, further research is needed to 
elucidate the role of these factors in pathogenesis of prostate cancer. Taking into account 
the high incidence of prostate cancer in Western countries, developing strategies that 
target these potentially modifiable risk factors is a high priority for public health. In the 
United States, prostate cancer incidence and mortality rates vary by race and are the 
highest among African-Americans (72, 73). According to age-adjusted estimates for 
2013, prostate cancer incidence in African Americans is 70% and mortality is 2.4 times 
higher than in European Americans (72, 73). African Americans tend to be diagnosed at a 
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younger age and with more aggressive disease than their European-American 
counterparts. Prostate cancer incidence and mortality in Hispanics/Latino and Asian-
Americans are lower than in African- and European Americans (73). Migrant studies 
show that prostate cancer incidence and mortality in immigrants to the United States are 
higher than in their countries of origin which suggests the involvement of environmental, 
behavioral and lifestyle factors (74, 75). 
  It has been proposed that racial/ethnic disparities in health status may be due to 
differences in access to healthcare, socioeconomic status, cultural factors (e.g. diet, 
utilization of health care, religious beliefs) and genetic predisposition (73, 148); thus, it is 
important to explore complex relationships between multiple modifiable risk factors and 
prostate cancer risk/aggressiveness by race/ethnicity. It has been shown, that racial/ethnic 
minorities are more likely to have a sedentary life style and a bad diet with low 
consumption of fruit and vegetables as compared to non-Hispanic Whites, and this 
lifestyle pattern is associated with high levels of systemic inflammation, as expressed by 
increased levels of C-reactive protein (CRP) (149-151).  
 Among the dietary factors that have been proposed to decrease prostate cancer 
risk are tomatoes and lycopene, cruciferous vegetables, green tea, soy, vitamin E, and 
selenium (152-154). The protective effects of selenium and vitamin E intakes, however, 
were not confirmed in a recent double-blind placebo-controlled Selenium and Vitamin E 
Cancer Prevention Trial (SELECT study) (155). The potential mechanism of anticancer 
effect of plants mentioned above and vitamin E works through protection of cells and 
DNA from oxidative stress (156). Phytochemicals contained in cruciferous vegetables, 
kale, cauliflower and Brussels sprouts, in addition to antioxidative, also have pro-
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apoptotic (157), anti-proliferative and anti-metastatic effects in prostate cancer cells in 
vitro, and in animal models (158). Excessive intake of total dietary energy, meat, dairy 
products, calcium, total and animal fat, and beta-carotene, on the contrary, may 
predispose to increased prostate cancer risk (152-154). According to some theories, 
excessive intake of fat and red meat can promote carcinogenesis within the prostate via 
increased insulin growth factor (IGF) and damage by ROS (156). Caloric restriction 
reduces oxidative stress and related damage in vitro and in animal models (159).  
 Although analyses of single nutrients and foods are a common practice, they are 
inherently flawed because they do not account for possible interactions between nutrients 
and fail to evaluate joint effects of diet on health outcome (76). More recent approaches 
use diet quality scores and dietary patterns to evaluate a combined effect of food usually 
consumed on disease (77). For instance, higher Healthy Eating Index and Alternate 
Healthy Eating Index-2010 values were associated with decreased risk of total prostate 
cancer, while no association was detected for the alternate Mediterranean Diet score (78). 
A few studies examined relationships between dietary patterns and prostate cancer and 
yielded inconsistent results (76, 79). The use of diet quality scores and dietary patterns 
has inherent shortcomings. For instance, the diet quality scores only measure adherence 
to the recommended diet and fail to account for ethnic variability within and between 
populations (77). Dietary pattern analysis lacks standardization, which impairs 
generalization, complicates comparisons between studies and is more suitable for 
hypothesis generation rather than testing (77).  
 Developed by researchers at the University of South Carolina’s Cancer Prevention 
and Control Program, the dietary inflammatory index (DII) is a unique approach which 
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allows for calculation of the overall inflammatory score of the individual’s diet from 
maximally anti- to maximally pro-inflammatory. More negative scores are associated 
with anti-inflammatory potential, whereas more positive scores are indicative of more 
pro-inflammatory potential (80, 160). The major advantage of DII over other dietary 
indices is that it measures the inflammatory potential of the individual’s diet based on 
actual intakes. The individual’s DII scores are standardized against range of actual food 
intakes observed in 11 different populations around the world, which facilitates 
comparability between existing and future studies (160). Another important advantage of 
the DII is that it gives comparable results if calculated using different methods of dietary 
assessment, which facilitates its use by epidemiological studies of different design and 
different dietary assessment methods (161).  DII scores have been shown to predict levels 
of inflammatory markers and risk of chronic disease in several studies (80, 82, 161-180). 
Several of these studies investigated the relationships between DII and breast, 
esophageal, pancreatic, and colorectal cancers (164-166, 174, 180). One case-control 
study has investigated the relationships between DII and prostate cancer risk among 
Jamaican men (181). Men in the highest quartile of DII score had 2.4 times increased risk 
of prostate cancer as compared to those in the lowest quartile (aOR=2.39; 95% CI:1.14-
5.04). This suggests that a diet with the higher proinflammatory potential may increase 
individual’s risk of prostate cancer; however, this finding needs to be confirmed in 
longitudinal studies with larger sample sizes that include participants of different 
race/ethnicity.
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CHAPTER 3 
Methods 
Specific Aims 1 & 2 
1. Study population 
 For Aims 1-2 was used previously collected data from the Energy Balance Study 
(EBS) conducted by researchers from the University of South Carolina, Columbia, SC 
(182). The EBS is an ongoing three-year longitudinal study investigating effects of 
energy intake and expenditure on changes in body weight, body composition and health 
indices in healthy young adults. In 2011, the EBS recruited 430 healthy men and women 
who were 21-35 years of age and had a BMI of 20-35 kg/m
2
. This population group was 
studied since they may be at risk for weight gain and an increase in body fat as they 
approach middle age (183). The prospective participants were eligible for the study if 
they were 21-35 years of age, did not have any major health conditions, did not change 
their health behavior within preceding 6 months, and did not plan to relocate within the 
next 15 months (182). The participants were excluded if they had history of major 
depression, anxiety or panic disorder, took serotonin reuptake inhibitors, used 
medications to lose weight or stop smoking within previous 6 months. Women were 
excluded if they gave birth within previous 12 months, changed their birth control 
regimen within the 3 previous months, were pregnant, or if they planned to start or stop 
birth control medication within the following 3 months (182). All otherwise eligible 
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prospective participants were excluded if they had systolic blood pressure ≥150 mmHg 
and/or diastolic blood pressure ≥90 mmHg or a blood glucose level >145 mg/dl as 
diagnostic criteria for hypertension and diabetes, respectively. The EBS was approved by 
the Institutional Review Board at the University of South Carolina, and all study 
participants signed informed consent. 
2. Energy Balance Study data collection procedures 
 The participants were initially screened for demographic and health-related 
inclusion/exclusion criteria via email and then additionally screened over the phone. All 
eligible study participants attended an orientation session where they were provided the 
information about the study and had their height and weight measured to verify their 
BMI. Within three weeks following the orientation, the participants had three baseline 
measurement sessions. During the first baseline session the participants provided detailed 
demographic information and a medical history and completed psychometric and activity 
questionnaires. Resting blood pressure, weight, height, hip and waist circumferences, and 
body composition were measured during the second baseline session. For the third 
baseline session, the participants had to fast for 12 hours and to abstain from physical 
activity for 24 hours. During this session weight, height, hip and waist circumferences 
were measured again, and the participants received a SenseWear
®
 Mini Armband (SWA) 
(BodyMedia Inc., Pittsburgh, PA) to monitor their physical activity and sleep over 10 
days (182). During these 10 days, licensed dietitians conducted three 24-hour dietary 
recalls by phone; two on randomly selected week days and one on a weekend. These 
dietary recalls elicited information about all the food participants consumed during the 
previous 24 hours. The follow-up assessments were conducted quarterly up to 24 months. 
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Upon completion of all follow-up sessions the study participants were given incentives: 
$500 and a report containing the information on their energy intake and expenditure, 
body weight and composition, resting metabolic rate, and cardio-respiratory fitness 
levels. 
 3. Sleep measures 
 The sleep measures were derived from the Armband data. The SenseWear
®
 Mini 
Armband  is a portable device 8.8×5.6×2.1 cm in size, 82 g weight, worn over the triceps 
muscle of the right arm and has micro-electro-mechanical sensor detecting and measuring 
limb movements (184). The sensor is monitored 32 times per second and data were 
recorded at 1 minute intervals. The SWA data by minute are analyzed using SenseWear 
Professional
®
 Research Software (Version 7.0, Body Media
®
 Inc.). The demographic 
information (i.e. age, sex, height, weight and smoking status) was used to customize 
proprietary algorithms. The SWA data yields several average night-time sleep measures: 
sleep onset and wake-up times, TST, SOL, WASO, and SE (185). The sleep onset time 
was determined by the first out of three minutes asleep that coincided with ≥10 minutes 
lying down (185). Morning wake-up time was defined by the first out of 90 consecutive 
minutes awake (185). Sleep duration is the sum of all minutes asleep during one sleep 
bout (185). The ability of the SWA to measure sleep was validated against 
polysomnography and found to be adequate (184). For each study participant all 
measures were averaged across the entire period of wearing of the SWA (4-10 days). 
Day-to-day variability in sleep characteristics exceeded the long term variability (68). 
Previous studies showed that five to seven nights of actigraphy are sufficient to obtain 
reliable estimates of sleep duration (68, 123, 186). The study participants were instructed 
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to take the Armband off only when it could get wet (showering or bathing) and to keep a 
log of their activities during all times when the Armband was not worn (182). Activities 
from the log were matched to activities in the 2011 Compendium of Physical Activity 
(187), and corresponding metabolic equivalent was multiplied by individual’s resting 
metabolic rate which allowed to calculate energy expenditure and sleep characteristics 
during non-wear periods (182). Total physical activity minutes were calculated for 
activities equal to or exceeding 1.5 metabolic equivalents (185). Physical activity was 
used as a continuous measure. Only observations with actigraphy data on 4 or more 
nights were considered complete and used in this study. 
3.1. Chronotype 
 Chronotype was defined as the time of mid-sleep on work days corrected for 
“make-up sleep” on free days (12). For detailed chronotype calculations see Appendix A. 
3.2. Social jetlag  
 SJL was defined as a difference between midpoints of sleep on a weekend 
(unadjusted) and on week days (12). An absolute value of the social jetlag was used for 
all analyses where SJL was an independent variable.  
3.3. Total Sleep Time 
 TST was categorized as <6, 6-7, and ≥7 h (185). Two sleep duration measures 
were used for all analyses: average for all days of actigraphy (week days and weekend 
days) and average on week days only. The upper cut-off point 7 h was selected due to the 
insufficient sample size that we would have if we selected cut-off point ≥8 h, which is 
frequently used in other studies (96, 119, 188). Moreover, several studies showed that 
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individuals tend to overestimate their average sleep duration by 1 hour and more as 
compared with objective measures (e.g. actigraphy) (189, 190).  
3.4. Sleep onset latency  
 SOL is a time that a person spends in bed before he/she falls asleep. In EB study, 
sleep onset latency was calculated using SWA data as time between lying down and sleep 
onset (185). According with clinical guidelines, sleep onset latency of >30 min is 
considered one of the symptoms of insomnia (115). However, in the EBS population, less 
than 5% of participants had sleep onset latency >30 min at any one of five time points. 
Thus, the more relaxed cut-off point of 12 min ( ≥12 vs. <12 min) was used (191). 
3.5. Wake After Sleep Onset 
 WASO was calculated from SWA data as a sum of wake periods of ≥2 min each 
after sleep onset and until the final wake-up time (185).  To be consistent with the 
previous studies that used wrist actigraphy, WASO was dichotomized (<60 min, ≥60 
min) (119, 188). 
3.6. Sleep efficiency  
 SE was calculated as a proportion of TST from the length of the night sleep bout 
(185). Naps were excluded. SE was used as a continuous and a categorical variable; the 
latter was dichotomized according with clinical guidelines for insomnia (≥85% vs. <85%) 
(115).  
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3.7. Naps  
 Naps were defined as sleep bouts <4 hours that ended between noon and 10 p.m. 
or bouts <45 minutes (185). Variable nap was dichotomous (Yes/No); those with >0 min 
of nap were consider having a nap. 
3.8. Sleep quality 
 Sleep quality was defined using Pittsburgh Sleep Quality Index (PSQI) obtained 
using PSQI questionnaire (see section "Questionnaires"). The PSQI score was 
dichotomized using conventional definitions of poor sleep (PSQI >5) and a good sleep 
(PSQI ≤5) (192). TST, SOL, WASO or SE were used as indicators of sleep disruption. 
 Sleep measures in this study had potential limitations. The assumption that the 
study participants had free days only on weekends may introduce non-differential 
misclassification of the exposures: chronotype and social jetlag. To address this issue, 
distributions of chronotype and social jetlag in the study population were compared with 
the distributions among participants of the same age in other studies. 
4. Questionnaires  
4.1. Profile of Mood States (POMS)  
 POMS is a self-administered questionnaire that consists from 65 adjectives and 
short phrases with Likert-type scale with five answer choices for each question (193). 
Different groups of adjectives define six factors: Tension-Anxiety, Depression-Dejection, 
Anger-Hostility, Vigor-Activity, Fatigue-Inertia, Confusion-Bewilderment, and each of 
those factors has its own scale. The Total Mood Disturbance Score (TMD score) is 
calculated by summing 5 factors and then subtracting for the Vigor-Activity score. The 
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Total Mood Disturbance Score and its 6 components were used separately as continuous 
variables. The Energy Balance study participants completed the POMS questionnaire at 
baseline, 12 and 24 months follow-up (Table 2.1), and all 3 aforementioned time points 
were used in the analyses. 
4.2. Perceived Stress Scale  
 Perceived Stress Scale is a 10-item questionnaire where each item inquires how a 
subject feels or thinks and offers him/her 5 choices with increasing value from never to 
very often (194). The positive items are reverse scored. All scores are summed to yield 
the total score ranging from 0 to 40. A higher score indicates a higher stress level. The 
Perceived Stress Scale was validated in different populations, found to be a better 
measure of overall stress as compared to objective measures of stressful life events, and 
recommended for studies investigating relationships between stress and disease outcomes 
(194-196). The Perceived Stress Score (PSS) was used as a stress measure at 3 time 
points (baseline, 12 and 24 months follow-up) (Table 2.1). The Perceived Stress Scale is 
not a clinical test; therefore, there are no established cut-off points. To categorize PSS, 
some studies used a median split (194, 197) while others used quartiles (198). PSS in the 
EBS sample had approximately normal distribution and was modeled as continuous and 
categorical variables with the median as a cut-off point (<12 vs. ≥12). 
4.3. Pittsburgh Sleep Quality Index (PSQI)  
 PSQI ascertains information on seven areas of sleep during the previous month 
(192). The respondents self-score each of the seven components using a Likert scale from 
0 to 3, where 3 is assigned to the highest negative extreme. The sum of scores for all 
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individual components yields the total PSQI score (192). It was administered at baseline, 
12 and 24 months follow-up (Table 2.1). The PSQI was used as an indicator of sleep 
quality: poor sleep (PSQI >5), and a good sleep (PSQI ≤5) (192). 
5. Anthropometric measures 
 For the assessment of all anthropometric measurements the participants were 
dressed in scrubs and had bare feet. Their height and weight were measured using 
traditional stadiometer and electronic scales with a precision of 0.1 cm and 0.1 kg, 
respectively. The average of three measurements was used to calculate BMI (weight 
(kg)/height (m
2
) ). To measure waist and hip circumferences, a calibrated spring-loaded 
tape measure was used. The waist circumference was measured at mid-point between 
costal margin and iliac crest on the axillary line on both sides of the trunk and 2 cm above 
the umbilicus (182). The hip circumference was measured at the level of the greater 
trochanter, at the widest point. The average of three measurements rounded to 0.1 cm was 
recorded. Body composition was measured using dual x-ray absorptiometry full body 
Lunar fan-beam scanner (GE Healthcare model 8743, Waukesha, WI). 
 BMI was categorized into two groups: underweight and normal weight (<25 
kg/m
2
); overweight and obese (≥25 kg/m2) (199). BF% was dichotomized using the 
guidelines by the American Society of Bariatric Physicians (ASBP) and American 
Medical Association (AMA) specialty board (2009) that defined obesity as BF% ≥25% in 
men and ≥30% in women (98). A recent meta-analysis showed that cut-off points for 
BF% >25% in men in > 30% in women were the most sensitive for obesity (99). Waist-
to-hip ratio will be dichotomized: <0.95 vs. ≥0.95 in men and <0.80 vs. ≥0.80 in women 
(200). Waist-to-height ratio will be dichotomized as <0.5 vs. ≥0.5 (103). An average of 
34 
 
two resting blood pressure measurements were categorized into two groups: SBP ≥120 
vs. <120 mmHg, and DBP ≥ 80 vs.<80 mmHg. 
6. Covariates  
 Estimates of total daily physical activity time were obtained from armband data. 
Information for the periods of non-wear was supplemented with values for matching 
activity from the 2011 Compendium of Physical Activity (184). Total daily hours of 
physical activity were defined as any activity of at least 5 metabolic equivalents. Time 
napping was obtained from armband data. Dietary information was collected using three 
24-hour dietary recalls conducted by phone; two on randomly selected weekdays and one 
on a weekend. The Nutrient Data System for Research (version 2012: Nutrition 
Coordinating Center, University of Minnesota, Minneapolis, Minnesota) was used to 
estimate nutrient and individual food intakes from the dietary recalls. Forty three food 
parameters and nutrients were further used to calculate a dietary inflammatory index (e-
DII) that expresses an inflammatory potential of individual's diet (81). Lower DII scores 
are anti-inflammatory while the higher scores are more proinflammatory, and the 
maximum theoretical range is −8.87 to 7.98. To account for individual differences in 
energy intake, the DII scores were calculated per 1,000 kilocalories (4,184 KJ) (e-DII) as 
previously described (185). 
7. Exclusion criteria 
 All 430 participants of the EBS were eligible for the proposed study. Individuals 
were excluded from statistical analyses if their armband data had the following 
deficiencies: missing bed time or wake time, <4 days of actigraphy in any given 
assessment period, missing sleep data on the weekend, extreme or implausible TST 
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values (<4 hours either on week days, free days, or on average, TST >11 hours on work 
days or on average), and when mid-sleep on free days occurred in the afternoon (12). In 
addition, participants were excluded from all analyses if they regularly used (≥3 times per 
week) sleep promoting medications (over the counter or prescription), worked night 
shifts, or traveled across meridians during periods of armband wear. The final analytical 
dataset consisted of 390 participants (1,431 repeated observations). 
7. Statistical analyses plan 
Specific Aim 1 
 The first specific aim was to determine whether chronotype, social jetlag, and 
sleep disruption change within two years. For these analyses was used SWA data at five 
time points (baseline, 6, 12, 18, and 24 months). The analytical dataset consisted of 390 
participants (1,431 repeated observations).  
Regression approach 
 First, descriptive statistics, distributions for continuous data and frequencies for 
categorical variables were analyzed. Further, the bivariate relationships between time, 
chronotype, SJL, objective sleep measures (TST, SOL, WASO, SE), and potential 
covariates were explored using simple subject-specific Generalized Liner Mixed Models 
(GLMM) with GLIMMIX procedure in SAS® (version 9.4, Cary, NC). This method 
accounts for correlations between repeated measurements through the inclusion of an 
additional variance component (201). Each subject in this study was considered a cluster 
of observations. The following covariates were considered: sex (male, female), race 
(European American [EA], African American [AA], Other [Hispanic, Asian, Native 
American or mixed race]), education (high school graduate/GED some college, college ≥ 
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4 y.), income (<$20,000, 20,000 to <40,000, 40,000 to <60,000, 60,000 to <80,000, 
≥80,000), employment (student/other, employed and self employed), marital status 
(married, single), having children (yes/no), physical activity (h), caffeine intake (g/d), e-
DII, napping (yes/no), and season (winter [November-January], spring [February-April], 
summer [May-July], autumn [August-October]), and current dieting (yes/no). Potential 
covariates with p-value <0.2 in bivariate analyses were selected for inclusion in full 
statistical models. Time was the main independent variable for all analyses. Separate 
multivariable statistical models were built for chronotype, SJL and objective sleep 
measures (TST, SOL, WASO, SE) as continuous dependent variables. Manual backwards 
elimination was used to identify covariates for inclusion in the final model that changed 
the effect estimate of the main exposure variable by ±10%. Variables that were 
statistically significant (p≤0.05) also were included in the final model. 
Latent class analyses  
 RMLCA was performed using PROC TRAJ in SAS® to identify latent groups for 
each continuous variable (absolute SJL, chronotype, TST, SOL, SE, WASO) (202, 203). 
This procedure uses a mixture model approach to define the trajectories of unique 
subgroups within a population that don't change their group membership over time (204, 
205). The best fitting crude model was selected using Bayesian Information Criterion and 
comparing differences between simple and more complex models (205). The final 
selection of the number of latent groups was based on the best model fit and minimum 
group sizes containing ≥10% of the study population. Analyses for chronotype, TST and 
SE were adjusted for race (EA vs. AA or Other) and sex, which were assumed not to 
change over time. WASO was adjusted for race only. Absolute SJL and SOL were not 
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adjusted for race or sex because latent groups were not influenced by these variables. 
Since the group trajectories for each measure were linear, potential covariates that change 
over time were not examined. Only participants with at least three assessments during the 
study period were included into these analyses (n=312, 1,297 observations).  
 Finally, bivariate GLMM were used to identify demographic and other 
characteristics that differed among the latent classes for absolute SJL and each of the 
sleep outcomes. 
Specific aim 2 
 The second specific aim was to examine the relationships between chronotype, 
absolute SJL, objective sleep characteristics and various outcomes: BMI, %BF, WHR, 
WHtR, blood pressure, mood, perceived stress, and poor sleep (defined with PSQI). For 
the analyses involving anthropometric outcomes was used dataset with five time points 
(n=390, 1,431 repeated observations). Since data on mood, stress and poor sleep was 
available only for three time points (baseline, 12, and 24 months) a smaller subset of data 
was used (n=390, 813 observations) for these analyses. 
 Descriptive analyses were conducted first. They included analyses of distributions 
for continuous and frequencies for categorical variables. Bivariate associations between 
chronotype, SJL, objective sleep measures, mood, perceived stress, poor sleep, and 
potential covariates (see specific aim 1 above) were explored next using GLMM with 
repeated measures. Potential covariates with p-value <0.2 in bivariate analyses were 
selected for inclusion in full statistical models. Manual backwards elimination was used 
to identify covariates for inclusion in the final model that changed the effect estimate of 
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the main exposure variable by ±10%. Variables that were statistically significant (p≤0.05) 
also were included in the final model. When examining relationships between SJL or 
sleep measures and the anthropometric outcomes, mood and stress, chronotype 
(continuous) was considered as a potential confounder along with other covariates. 
 RMLCA analyses using PROC TRAJ in SAS® were used to identify three latent 
groups for chronotype as was described above. Any time points with complete SWA data 
were included into these analyses. Since the group trajectories for all three latent 
chronotype groups (morning, intermediate and evening) were linear, other potential 
covariates that change over time were not used to adjust trajectories. Adjusted means of 
SJL and all objective sleep characteristics by latent chronotype group were compared 
using F-test with PROC GLIMMIX. The intermediate chronotype was used as a 
reference group. This categorical chronotype variable was used as a main independent 
variable in the GLMM evaluating the relationships between chronotype and 
anthropometric measures. To explore a possibility that the relationship between SJL, 
other sleep characteristics and anthropometric measures were modified by chronotype, 
two approaches were used. First, an interaction term between a sleep measure and 
chronotype group were added to the final statistical model. The second approach 
involved stratification by chronotype group. This approach was also applied in the 
analyses of the relationships between absolute SJL, mood and stress. 
Specific Aim 3 
1. Study population 
 For the proposed study was used data from the California Men’s Health Study 
(CMHS), a large multiethnic cohort of U.S. men members of Kaiser Permanente (KP), a 
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health insurance provider that covers a large number of residents of Northern and 
Southern California. The primary goal of CMHS cohort was to study the etiology of 
prostate cancer in populations with diverse ethnicity (206). In 2002-2003 the CMHS 
recruited 84,170 men of ages 45-69 years; 40% of them were from minority populations. 
Men were eligible for the CMHS if they had membership at KP for at least one year prior 
to the recruitment and were 45-69 years of age. Information about the CMHS recruitment 
and data collection procedures was described in detail elsewhere (206). Briefly, the study 
enrolled minority populations including Chinese, Latino and African Americans. The 
potentially eligible participants were first selected based on their last names obtained 
from insurance records, and a preference was given to men with Chinese and Spanish last 
names (206). The recruitment was conducted in three waves. First, the participants were 
mailed a recruitment letter and a short questionnaire inquiring about their ethnicity, 
anthropometrics, and a personal history of prostate specific antigen (PSA) screening, 
benign prostatic hyperplasia (BP), and prostate cancer. The letters and questionnaires 
mailed to men with Chinese last names were in Cantonese/English and in 
Spanish/English for all others. Also, the participants were selected from areas covered by 
KP plan where a high proportion of residents were African American (206). Further, men 
who responded to the short questionnaire and were eligible for the study were mailed a 
longer questionnaire. Some participants completed both short and long questionnaires on-
line (206). The CHMS collected comprehensive information on participants' health 
status, comorbidities, family history of prostate cancer, medication and supplementation 
use, and potential prostate cancer risk factors such as diet, physical activity and sleep. 
The CMHS cohort has broad range of education and income (206). The important 
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advantage of enrolling study participants from among the members of the health 
insurance plan allows linking self-reported data with medical records and information 
from cancer registries. The latter provides high quality ascertainment of prostate cancer 
cases.  
 For the proposed study was used data on 43,202 participants of the CMHS 
followed from the time of the completion of the long CMHS questionnaire in 2002-2003. 
Time of the follow-up was censored at: diagnosis of incident prostate cancer, death, gap 
in KP membership exceeding 90 days, or the end of the study on December 31, 2014, 
whichever comes first. For the description of the available study population see Table 7. 
Participants who reported personal history of prostate and any other cancer except non-
melanoma skin cancer in the baseline questionnaire were excluded (100/1,286). 
Participants who  had caloric intake of less than 500 kcal or greater than 6,000 kcal per 
day were excluded from the analyses (53 with prostate cancer and 905 without prostate 
cancer). Indicator variables with consequent sensitivity analyses were used to preserve 
observations with missing data on significant confounders. For the analysis of the 
relationships between DII and the incidence of advanced prostate cancer, all participants 
with  missing data on prostate cancer stage based on SEER classification were excluded 
(n=38, 1.36%). 
2. Questionnaires used to collect the data in CMHS 
2.1. Short questionnaire, as was previously mentioned, elicited information about 
anthropometrics, and a personal history of PSA screening, BPH, and prostate cancer. 
2.2. Long questionnaire was 24 pages long, completed upon enrollment and elicited 
information on demographics, family history of cancer, an individual's health conditions 
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including those involving prostate, medication use, lifestyle factors including physical 
activity and smoking, diet and supplement use, marital status, education and family 
income during the preceding year. 
2.3. Semi-quantitative food frequency questionnaire (FFQ) was the version of 
Women's Health Initiative FFQ modified for use in men and validated in several studies 
(207-209). This FFQ allowed collecting the information about habitual diet and alcohol 
consumption within the previous year. E-DII was calculated for all participants of this 
study. 
2.4. Physical activity questionnaire used questions adopted from the CARDIA Physical 
Activity History (210). It elicited information on frequency, duration and intensity of 
recreational, household and occupational activities (206). Total physical activity was 
measured in MET-hours per week and used as a continuous variable for all analyses. 
3. Prostate cancer ascertainment 
 The information about all prostate cancer cases diagnosed during the 
follow-up was obtained via linkage of CMHS members to the Kaiser Permanente 
Northern California Cancer Registry (206, 211). California state law requires reporting of 
all incident cancer cases and the KPNCCR ascertains and reports all cases according to 
the standards established by the National Cancer Institute’s Surveillance, Epidemiology, 
and End Result Program (SEER). In this study, PrCA was categorized into three groups 
using the updated (2010) version of the standard PrCA staging system endorsed by the 
American Joint Committee on Cancer (AJCC)/International Union Against Cancer 
(UICC) (212).  
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4. Measures 
Exposures 
 The DII was calculated per 1,000 kcal (e-DII) using derived values for 27 food 
parameters including whole foods, micro- and macronutrients, and other food 
constituents (e.g. flavonoids). The information on habitual food intake used for derivation 
of the food parameters was elicited using previously mentioned semi-quantitative FFQ. 
The choice of food parameters for the DII calculation is based on previous research that 
entailed reading and scoring nearly 2,000 articles (160). Derived from the literature 
individual effects of individual DII components were standardized to global database 
comprised from 11 diverse populations: USA, Australia, Bahrain, Denmark, India, Japan, 
Mexico, New Zealand, South Korea, Taiwan, and UK (81). This approach to calculation 
of DII both “anchors” the individual’s exposure to a robust range of dietary patterns in a 
variety of cultural traditions and obviates completely the problem of units because the z-
scores and percentiles are independent of the units of measurement (i.e., the percentile is 
the same whether the parameter is expressed in ug or mg) (160). Ideally, the DII 
calculations are based on the total 45 food parameters, although it also can be calculated 
when fewer food parameters are available. For instance, the DII was previously used in 
the SEASONS study with the 7DDR (which yielded 28 food parameters) and in the 
Asclepios Study using semi-quantitative FFQ (which yielded 17 food parameters) and 
had observed findings consistent with those obtained from 24-hour recall interviews 
(which ideally yield all 45 parameters) (83, 169). From the research conducted this far, 
the DII is typically within the range of -5 to +5 (maximum and minimum ~-8 and +8). In 
the sample available for this study, the DII in all participants ranges from -6.3 to 4.7 
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(Table 7). The reason for the adjustment for energy is previously detected strong negative 
correlation of the DII with total energy intake (164). An absolute intake of each food 
parameter in the study population was individually modeled using a regression model 
with total caloric intake in the study population as an independent variable as previously 
described (164). The predicted energy-adjusted intake of each nutrient was calculated as 
a sum of the absolute nutrient intake of an individual with the mean caloric intake with 
the corresponding residual from the regression model. Further, energy-adjusted intakes of 
all individual food parameters were standardized to the world’s population using z-scores 
and percentile scores. The individual percentile scores were then multiplied by 
parameter-specific inflammatory values and summed yielding the final e-DII score. For 
all analyses, the e-DII will be used both as a continuous variable and as a categorical 
variable. Since the clinically meaningful cut-points for e-DII have not yet been 
established, we will use the cut-off points between quartiles of e-DII distribution among 
men without prostate cancer. 
Events of interest 
 For the analyses of the relationship between e-DII and PrCA risk (sub-aim 1), 
incident PrCA will be presented as a dichotomous variable (Yes/No). For the sub-aim 2,  
PrCA was categorized into three groups using the updated (2010) version of the standard 
PrCA staging system endorsed by the American Joint Committee on 
Cancer (AJCC)/International Union Against Cancer (UICC) (212). The high-risk PrCA 
group included men with clinically localized high-risk PrCA and advanced, very high-
risk PrCA (≥T3a or PSA>20 ng/ml, or a Gleason score of 8-10, or those who died from 
PrCA). The clinically localized, intermediate-risk group consisted of men with T2b-T2c, 
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or T1-T2a and PSA10-20, or T1-T2a and a Gleason score of 7. All other men with PrCA 
were in the clinically localized, low-risk PrCA group. 
Statistical analysis 
 The follow-up time was censored at: diagnosis of incident PrCA, death, gap in KP 
membership exceeding 90 days, or the end of the study (December 31, 2014), whichever 
came first. The analyses started with descriptive statistics. The e-DII was categorized into 
quartiles based on its distribution among all participants. Categorical variables with strata 
containing <10% of the total population were recoded using indicator variables that had 
missing values as a separate category. Bivariate relationships between prostate cancer 
status and e-DII, or potential covariates, including: race (White, Black, Asian, Hispanic, 
Other), age at baseline (5-year intervals for the overall PrCA risk estimates and 45-55, 
56-65, 65-70 years for subgroup analyses), body mass index (BMI) calculated from self-
reported weight in kilograms divided by square height in meters (< 25, 25-29.9, ≥30 
kg/m
2
), education (high school equivalent or less; vocational or technical school;  some 
college, associate or bachelor degree; graduate/professional school), smoking status 
(current or former smokers vs. non-smoker), income (<$40,000, $40,000-$59,000, $60-
$80,000, $80-100,000, >$100,000), regular use of non-steroidal anti inflammatory 
medicines (NSAID) (Yes/No), regular multivitamin use (Yes/No), sleep duration (≤6, 7, 
≥8 hrs), total physical activity (0-359, 360-1102, 1103-2201, > 2202 MET-min/week), 
history of diabetes (Yes/No; recorded diagnosis in the Northern California KP Diabetes 
Registry), family history of PrCA in a first-degree relative (Yes/No), and benign prostatic 
hyperplasia (BPH).Variables with a p-value of ≤0.20 will be selected for further 
evaluation in a multivariable model. A manual backwards selection procedure was used 
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to identify covariates for inclusion in multivariable models. Variables were retained in 
the final statistical models if their exclusion resulted in a change in the effect estimate for 
e-DII by ≥10%. Statistically significant covariates (α<0.05) also were retained in the final 
statistical models. The proportional hazards assumption was tested using graphical 
(Kaplan-Meyer survival plots) and regression approaches (cumulative Martingale 
residuals). Effect modification was tested using two approaches: Likelihood Ratio Test 
(LRT) for significance of the interaction term added to the final model, and stratification 
of the analysis based on differing levels of the effect modifier. Cox proportional hazards 
models were used to assess the relationships between the e-DII and either high- or 
intermediate-risk PrCA. The proportional hazards assumption was violated for sleep and 
age; therefore, these variables were placed in the STRATA statement in the PHREG 
procedure in SAS
®
. For linear trend tests, the median of each e-DII quartile was included 
in statistical models as a continuous variable with adjustment for the same confounders 
that were included in the previous analyses.  
 Sensitivity analyses were conducted to explore the possible effects of missing 
data on the results. Men diagnosed with PrCA during the first 3 years of follow-up were 
excluded in order to assess the possibility of reverse causality. In separate analyses, all 
participants with missing sleep duration were excluded, and analyses were then repeated 
after removal of the sleep duration variable from the statistical models.
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Table 3.1 Questionnaires and measurements used in the Energy Balance Study 
 
Questionnaire/ 
measure 
Time point 
Baseline 6 M 12 M 18 M 24 M 
Demographics         
Medical History       
Profile of Mood States
1         
Perceived Stress Scale         
PSQI         
Physical Activity           
Sleep measures           
Anthropometrics
2           
Basic vital signs
3           
PSQI: Pittsburgh Sleep Quality Index (PSQI).  
1 
Yields Total Mood Disturbance Score (TMD). 
2 
Height and weight, waist circumference, hip circumference, percent total fat mass, percent 
total lean mass. 
3 
Resting heart rate, systolic blood pressure, diastolic blood pressure. 
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CHAPTER 4 
Stability of Social Jetlag and Sleep Characteristics Over Time: A Prospective Study
1
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ABSTRACT 
Background: Insufficient sleep has been associated with increased risk of many chronic 
diseases that can take decades to develop. However, few studies have examined the 
persistence of sleep disruption over time. Armband actigraphy is an objective method of 
monitoring of an individual's limb movements that yields sleep timing on work and free 
days, and their difference defines ‘social jetlag’, a misalignment between internal and 
social clocks. This prospective investigation examined objectively measured individual 
sleep characteristics over a two-year period to test the hypothesis that SJL and poor sleep 
remain stable during this time period.  
Methods: Social jetlag [SJL] and sleep measures (total sleep time [TST], sleep onset 
latency [SOL], wake after sleep onset [WASO]), sleep efficiency [SE]), were derived 
from physical activity personal armband monitoring among 390 healthy men and women 
21-35 years old. Participants wore the armband for a 4-10 day period at 6-month intervals 
(N=1,431 person-weeks of sleep measurement). The consistency of sleep measures over 
time was analyzed using generalized linear mixed models (GLMM) for repeated 
measures. Repeated measures latent class analyses (RMLCA) were then used to identify 
subgroups among the study participants with adequate or inadequate sleep characteristics 
over time. These latent groups were then evaluated using GLMM to characterize 
demographic or other personal characteristics that differed among the subgroups.  
Results: Minor changes in mean SJL, chronotype, or TST were observed over time, and 
no changes in SOL, WASO, or SE were observed during the study period. The RMLCA 
identified two groups of absolute SJL: low (mean±SE: 0.8±0.6 h, 58%) and high 
(1.4±0.8, 42%); those with high SJL were employed and had an evening chronotype. 
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Similarly, two distinct subgroups were observed for SOL, WASO, and SE, with one 
group consistently exhibiting disrupted sleep over time, and another with a relatively 
normal sleep pattern; both remaining stable over time. TST had three latent groups with 
relatively short (5.6±1.0 h, 21%), intermediate (6.5±1.0, 44%) and long (7.3±1.0 h, 36%) 
durations, all with temporally stable linear trajectories. Subgroups with poor sleep tended 
to be male, African American, have a lower income, and an evening chronotype relative 
to those with more normal sleep characteristics.  
Conclusions: Objective sleep measures in young adults remained relatively stable over 
the two-year study period. Sleep disruption symptoms as measured by TST, SOL, WASO 
and SE, persisted throughout the study. The results suggest that poor sleep can be a 
chronic condition in certain subgroups, consistent with evidence that sleep disruption 
contributes to metabolic syndrome, cardiovascular disease, cancer, and other chronic 
disease risks. 
 
Introduction 
 Insufficient sleep has been associated with increased risk of major chronic 
diseases such as cardiovascular disease and hypertension (65, 118), obesity (213), 
diabetes (120, 214), and cancer (28, 47). The biological processes associated with these 
impacts may include immunologic, metabolic, and genetic factors (49, 52, 91, 95, 133, 
215-217). In order to elicit pathophysiological changes that can lead to chronic disease, 
sleep has to be disrupted over an extended period of time. However, the temporality of 
sleep disruption has not been extensively studied. In many longitudinal studies, 
information about sleep is only obtained at baseline by means of questionnaires, and it is 
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assumed that self-reported symptoms accurately describe an individual's sleep 
disturbances, and that they persist over time. However, sleep disruption assessed by self-
report can differ from sleep assessed using objective measures (123, 124). For instance, 
one study among healthy young individuals reported that sleep onset latency was 
overestimated and frequency of awakening was underestimated using self-reported data 
(124). In another study, participants with chronic insomnia underestimated their total 
sleep time and number of awakenings but overestimated sleep onset latency (125). 
Several longitudinal studies assessed consistency of insomnia and sleep disruption over 
various periods of time spanning from several months to 20 years (66, 67, 218-226). 
Presence of insomnia and its subtypes was variable within one year of follow-up (226, 
227). Studies with a follow-up of several years showed that insomnia is a fairly persistent 
condition (66, 67, 218-223, 225), although its patterns may change over time and clinical 
course of insomnia can exhibit remissions and recurrences (219, 224, 226). 
Characterizing factors that contribute to the persistence of sleep disruption is important 
for understanding its role as a chronic disease risk factor. 
 Only a few studies have investigated the variability of sleep characteristics over 
prolong periods of time used objective measures such as polysomnography or actigraphy 
(66-68, 225). In middle-aged people, objective sleep measures, such as sleep duration, 
efficiency, latency and time in bed showed considerable day-to-day variability, although 
they were stable during a 1-3 year follow-up (66-68, 225). No comparable studies 
utilizing objective sleep measures have been conducted among young adults. The 
importance of such investigations in young adults is based on a high prevalence of 
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insomnia in the general population and a common knowledge that many chronic diseases 
that manifest in middle age can take decades to develop. 
 Most human physiological processes and behaviors exhibit a circadian rhythm (1, 
2). Due to variations in intrinsic timing, individuals may be categorized into morning, 
neutral, or evening chronotypes (3, 4). People with morning chronotypes, the so-called 
"larks", wake up and go to bed relatively early (between 10 p.m. and midnight), whereas 
evening chronotypes ("owls"), prefer to wake up and go to bed late (between 1 and 3 a.m) 
(3). A conflict between this inherent sleep preference and social demands can result in a 
misalignment in sleep/wake timing, or "social jetlag" (SJL) (6). SJL is calculated as a 
difference between mid-sleep on free and work days (6); it reflects the potential 
magnitude and direction of time shift for daily activities as well as physiological and 
psychological processes (12, 58, 91). Evening chronotypes tend to accumulate a sleep 
debt during the week for which they try to compensate during the weekend by extending 
their sleep period. For example, if a person with evening chronotype on work days sleeps 
between midnight and 6 a.m., his mid-sleep is at 3 a.m. If, on free days, their sleep is 
extended from midnight until 9 a.m, the mid-sleep is 4:30 a.m, and their SJL is 1 h 30 
min. Morning chronotypes, on the contrary, tend to develop sleep debt during the 
weekend (6). Circadian misalignment resulting from altered sleep/wake timing may lead 
to metabolic alterations: lipid disregulation, decreased insulin sensitivity, impaired 
glucose tolerance, altered melatonin and cortisol secretion, and oxidative stress (49, 52, 
91). These impacts are commonly observed among shift workers, although some studies 
suggest that this relationship may extend to populations not involved in shift work, such 
as those with SJL (12, 25, 37, 47, 49, 58, 107, 228). Although clinically significant cut-
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points for SJL have not been established, those with ≥2 h of SJL had shorter sleep 
duration, higher 5-hour blood cortisol levels, and a higher resting heart rate relative to 
those with ≤1 h of SJL (49). In addition, those with >2 h of SJL had higher depression 
scores than those with ≤2 h (37). To date, no prospective studies have examined the 
persistence of SJL over time.  
 This study quantitatively assessed sleep and sleep/wake timing among young 
adults during two years of follow-up to test the hypothesis that SJL and poor sleep remain 
stable over time. Data were obtained from participants in the Energy Balance Study 
(EBS), a three-year follow-up study that investigated the effects of energy intake and 
expenditure on changes in body weight, body composition and health indices among 
healthy young adults ages 21-34 years (182). This age group is at risk for decreasing 
metabolic rate and increase in weight and percent of body fat (183, 229) which may lead 
to development of chronic disease at a later age. Actigraphy measures repeated at 6-
month intervals were used to characterize SJL and sleep disturbances at each time point. 
To assess the consistency of SJL and sleep disturbances over time, generalized linear 
mixed models were used to evaluate the temporal stability of SJL and each sleep 
measure, and RMLCA was used to identify subgroups (latent groups) with different sleep 
trajectories. Finally, the socio-demographic characteristics of each subgroup was 
described, including the extent to which they are influenced by chronotype. 
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Methods 
Study population 
 Eligible individuals were 21-35 years of age with no major health conditions or 
large changes in body composition during the previous six months, and had a BMI of 20-
35 kg/m
2 
(182). Participants were excluded at baseline if they had systolic blood pressure 
≥150 mmHg and/or diastolic blood pressure ≥90 mmHg or a blood glucose level >145 
mg/dl as diagnostic criteria for hypertension and diabetes, respectively (182). In 2011, 
430 participants residing in the Columbia, SC region were enrolled. After comprehensive 
baseline assessment, participants were re-examined every 6 months to assess their 
demographic and anthropometric characteristics, as well as their sleep/wake patterns via 
armband actigraphy, and to ascertain diet using three 24-hour dietary recalls (2 on 
random weekdays and one on the weekend). Each participant completed one to five 
assessments at six-month intervals over the two-year study period (2011-2013). All 
available repeated measures were used to evaluate the temporal characteristics of SJL and 
objective sleep measures. Only participants with ≥3 data time points were included in the 
RMLCA. The study was approved by the University of South Carolina Institutional 
Review Board, and all participants provided informed consent.  
Chronotype, social jetlag and other objective sleep measures 
 All objective sleep measures were derived from the data collected with a 
SenseWear
®
 Mini Armband worn by study participants over the triceps muscle of the left 
arm (184). A micro-electro-mechanical sensor in the armband recorded limb movements 
at a sampling frequency of 32 times per second averaged over 1-minute intervals. All 
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participants wore the armband for 7-10 days and kept a log of their activities during 
periods of non-wear. These activities were matched with the 2011 Compendium of 
Physical Activity (187) to fill gaps in information on energy expenditure and sleep for 
non-wear periods (185).  
 The 1-minute armband data were further summarized using SenseWear 
Professional
®
 Research Software (Version 7.0, Body Media
®
 Inc.). Demographic 
information (i.e. age, sex, height, weight and smoking status) was used with proprietary 
algorithms to calculate objective sleep measures. The armband yields several average 
night-time sleep measures: sleep onset and wake-up times, TST, SOL, SE and WASO 
(185). The sleep onset time was defined as the first of three minutes asleep that coincided 
with ≥10 minutes lying down (185). Wake-up time was defined as the first of 90 
consecutive minutes awake following sleep onset (185). TST was defined the sum of all 
minutes asleep from initiation of the sleep period until wake-up time (185). SE was 
calculated as a proportion of the total sleep time to the length of the night sleep bout. 
WASO was calculated as the sum of wake periods of at least two minutes duration 
between sleep onset and the final wake time (185). All measures were averaged across 
each data collection period using a minimum of 3 weekdays and one weekend day. 
 Chronotype was defined as the time of mid-sleep on work days corrected for 
“make-up sleep” on free days (12). SJL was defined as a difference between unadjusted 
midpoints of sleep on a weekend and on a week day (12) and modeled as two continuous 
variables: actual and absolute. It was assumed that free days occurred only on weekends, 
and rest/activity logs were examined to identify and exclude individuals who did not 
conform to this pattern (10). Individuals were also excluded from statistical analyses if 
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their armband data had any of the following characteristics: missing bed- or wake-time, 
<4 days of data in a given assessment period, missing sleep data on the weekend, extreme 
or implausible TST values (<4 hours either on weekdays, free days, or on average, TST 
>11 hours on work days or on average), and when mid-sleep on free days occurred in the 
afternoon (12). Participants also were excluded if they regularly used sleep promoting 
medications (≥3 times per week over the counter or prescription), worked night shifts, or 
traveled across meridians during periods of armband use (12, 230).  
Covariates  
 Estimates of total daily physical activity time were obtained from armband data. 
Information for the periods of non-wear was supplemented with values for matching 
activity from the 2011 Compendium of Physical Activity (184). Total daily hours of 
physical activity were defined as any activity of at least 5 metabolic equivalents. Time 
napping was obtained from armband data. Dietary information was collected using three 
24-hour dietary recalls conducted by phone; two on randomly selected weekdays and one 
on a weekend. The Nutrient Data System for Research (version 2012: Nutrition 
Coordinating Center, University of Minnesota, Minneapolis, Minnesota) was used to 
estimate nutrient and individual food intakes from the dietary recalls. Forty three food 
parameters and nutrients were further used to calculate a dietary inflammatory index (e-
DII) that expresses an inflammatory potential of individual's diet (81). Lower DII scores 
are anti-inflammatory while the higher scores are more proinflammatory, and the 
maximum theoretical range is −8.87 to 7.98. To account for individual differences in 
energy intake, the DII scores were calculated per 1,000 kilocalories (4,184 KJ) (e-DII) as 
previously described (185).  
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Statistical analyses 
 All statistical analyses were performed using SAS 9.4 (Cary, NC). Stability of 
SJL, absolute SJL, and objective sleep measures (TST, SOL, WASO, SE) over time were 
analyzed using generalized linear mixed models for repeated measures for which we 
estimated an unstructured covariance matrix. Time was treated as a main exposure 
variable (categorical) in crude and adjusted statistical models. The following covariates 
were considered: sex (male, female), race (European American [EA], African American 
[AA], Other [Hispanic, Asian, Native American or mixed race]), education (high school 
graduate/GED some college vs. college ≥ 4 y.), income (<$20,000, 20,000 to <40,000, 
40,000 to <60,000, 60,000 to <80,000, ≥80,000), employment (student/other, employed 
and self employed), marital status (married, single), having children (yes/no), physical 
activity (h), caffeine intake (g/d), e-DII, napping (yes/no), and season (winter 
[November-January], spring [February-April], summer [May-July], autumn [August-
October]), and current dieting (yes/no). To select potential covariates, bivariate 
relationships with objective sleep measures were summarized, and variables with p-value 
<0.2 were selected for inclusion in full statistical models. Manual backwards elimination 
was used to identify covariates for inclusion in the final model that changed the effect 
estimate of the main exposure variable by ±10%. Variables that were statistically 
significant (p≤0.05) were included in the final model. Each sleep characteristic was 
modeled separately as a continuous variable. These analyses included 390 participants 
with valid repeated measures data available (1431 observations). Least squares means of 
continuous sleep variables, SJL or chronotype at different time points were compared 
using the F-tests in PROC GLIMMIX. 
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 RMLCA was estimated using PROC TRAJ in SAS to identify latent groups for 
each continuous variable (absolute SJL, chronotype, TST, SOL, SE, WASO) (202, 203). 
This analysis assumes a mixture model to define the trajectories of unique subgroups 
within a population that don't change their group membership over time (204, 205). The 
best fitting crude model was selected using Bayesian Information Criterion (205). The 
final selection of the number of latent groups was based on the best model fit and 
minimum group sizes containing ≥10% of the study population. Analyses for chronotype, 
TST and SE were adjusted for race (EA vs. AA or Other) and sex, which were assumed 
not to change over time. WASO was adjusted for race only. Absolute SJL and SOL were 
not adjusted for race or sex because latent groups were not influenced by these variables. 
Since the group trajectories for each measure were linear, potential covariates that change 
over time were not examined. Only participants with at least three assessments during the 
study period were included into these analyses (n=312). Finally, generalized linear mixed 
models  was estimated to identify demographic and other characteristics that differed 
among the latent classes for absolute SJL and each of the sleep outcomes. 
 
Results 
 The final analytical dataset consisted of 390 participants (with a total of 1,431 
repeated observations). A majority of the participants had at least three (26%), four 
(15%), or five (39%) assessments, whereas 11% of participants had one and 10% had two 
assessments. The average age at baseline was 28±4 years and the sex distribution was 
approximately equal (51% women, Table 4.1). Most participants were EA (68%) and had 
at least 4 years of college education (84%). College students comprised 45% of 
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participants (19% undergraduate, 81% graduate), and another 55% were employed. A 
majority of participants' annual incomes were below $60,000 (71%). Thirty two percent 
were married, and 14% had children (Table 4.1). 
 At baseline, ~50% of participants had ≤1 hour of SJL and another 33% had more 
than 1 but less than 2 hours, and 17% had ≥2 hours of SJL. At baseline, SJL was 
moderately correlated with chronotype (Spearman r=0.42, p<0.001). Adjusted mean SJL 
values at 12 and 24 months exceeded the baseline average by 6 or 12 minutes, 
respectively; although the overall linear trend for SJL over two years was not statistically 
significant (Table 4.2). A 12 min increase was observed for absolute SJL (p=0.01, data 
not shown). TST, SOL, WASO and SE remained stable during the study period, although 
a minor difference in mean TST value was observed at 12 months relative to 6 months 
(Table 4.2). 
 Results from the RMLCA indicated that absolute SJL had 2 latent groups with 
low (mean±SE, 0.4±0.04 h, 42%) and high (1.4±0.03 h, 58%) values (Figure 1). Minor 
changes in absolute SJL were observed over time, although neither trajectory departed 
statistically from linearity. If the RMLCA sample was analyzed using the methods that 
generated results for Table 4.2, absolute SJL remained stable over the study period 
(p=0.1, data not shown). Three latent groups were apparent for chronotype: early 
(3.0±0.9 h, 33%), intermediate (4.4±0.9 h, 52%) and late (6.0±1.3 h, 14%). By the end of 
the study, a 23 minute phase advance was observed in the late chronotype group, 
although no changes were observed in the other two groups. TST had three latent groups 
with relatively short (5.6±1.0 h, 21%), intermediate (6.5±1.0, 44%) and long (7.3±1.0 h, 
36%) durations, all with temporally stable linear trajectories. SOL was generally low in 
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this population (<30 minutes for 98% of observations, median: 13 min); two latent 
groups were identified: low (9.7±1.0 min, 73%) and high (18.3±1.0 min, 27%). Two 
latent groups were observed for WASO: low (42.1±18.6 min, 77%) and high (90.4±31.0 
min, 23%), and for SE: low (74.6±1.0%, 27%) and high SE (85.3±1.0%, 73%). Latent 
groups for SJL and each sleep parameter all had linear trajectories that remained stable 
over time (Figure 1). 
 In bivariate analyses, those in high SJL group were employed and had later 
chronotypes relative to the low SJL group (Table 4.3). Participants in the short TST 
group were younger, male, of AA or Other race, had lower incomes, were married, 
consumed less caffeine, and tended to have a more proinflammatory diet (i.e., higher e-
DII scores) compared with those in the intermediate TST group (Table 4.3). Those in the 
long TST group tended to be female, EA, have higher incomes and no children relative to 
those with an intermediate TST (Table 4.3). The SOL latent groups differed only by 
employment status; students had a higher SOL relative to those who were employed 
(Table 4.4). The two WASO groups differed only by race (Table 4.4); a higher proportion 
of those with elevated WASO values were of AA or Other race. Among those with low 
SE, a higher proportion was male, AA or Other race, had lower incomes and consumed 
less caffeine (Table 4.4). Overall, participants with poor sleep (e.g., high SOL, high 
WASO, short TST, or low SE) tended to have an evening chronotype. 
 
Discussion 
 To our knowledge, this is the first study that used actigraphy measures to 
prospectively describe SJL along with chronotype, TST, SOL, WASO and SE in a non-
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clinical population of young adults. The prevalence of SJL in the current study was 
comparable with previous studies of SJL among adults (≥1 hour: 63-69%, ≥2 h: 26-33%) 
(12, 49). A majority of participants (58%) was in a latent class with SJL exceeding one 
hour (mean: 1.4 h at baseline) that increased slightly during the two-year study period 
(mean: 1.5 h at 24 months). SJL tended to remain stable during the study, whereas by the 
end of the two-year follow-up, chronotype shifted to an average of 23 minutes earlier. 
Because the heritability of chronotype may be up to 50% (9), one might not expect such a 
change within a two year span. However, the phase advance observed in the present study 
is consistent with results from a large cross-sectional study, which suggested that 
chronotype gradually becomes earlier after age 20 (88). In a series of large internet 
surveys, SJL gradually decreased over time between the ages 20 and 35 years and was 
higher among males than females (6, 12). However, it is unclear whether this represents 
age-related changes, some form of adaptation, or random variation, or unaccounted 
cohort effects. Temporal patterns of SJL within individuals have not been reported 
previously. In the present study, SJL was more common among those with an evening 
chronotype, and was higher among those who were employed compared to students or 
those not in the work force. These observations agree with the concept that SJL results 
from misalignment between an individual's social and biological timing (6). These 
findings also are consistent with previous observations that young adults with later 
chronotypes had greater SJL (12, 49, 58). SJL may be associated with increased risk of 
depression, metabolic syndrome, obesity and cardiovascular disease (12, 37, 49, 58, 92, 
107, 228) (12, 37, 49, 58, 92, 107, 228). Thus, understanding the temporal dynamics of 
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SJL and factors that contribute to increased SJL risk is important for development of 
disease preventive strategies targeting SJL and the disruption of sleep/wake timing. 
To our knowledge, this also is the first longitudinal study to examine objective 
sleep measures among young adults (21-35 years old) over an extended time period. Poor 
sleep, defined as a low TST or SE, and elevated SOL or WASO, persisted during the 
two-year follow-up; 21% of study participants had a short TST (mean: 5.6 h), 32% had 
elevated WASO (mean: 90 min), 27% had low SE (mean: 75%), and in 27% of 
participants, SOL was elevated (mean: 19 min). The mean values for sleep parameters in 
the above groups are consistent with cut-off values for TST, SOL, WASO, and SE that 
have been used to define disrupted sleep or insomnia in prior studies: <6 h for TST (231-
234), ≥12 min for SOL (185, 191), ≥50 min for WASO (185), and <78% (233) or <85% 
for SE (185). RMLCA was used in this study to define temporal trajectories of 
chronotype and SJL using objective measures of sleep and sleep/wake timing (34, 38, 
235). The characteristics of poor sleep in the latent groups identified by RMLCA were 
generally consistent with categorizations used previously. For example, mean TST values 
among latent groups coincided with categories used to define short (≤6 h), intermediate 
(6-7 h), or long sleep (≥7 h) (61, 65, 231). The mean values for low and high SOL among 
latent groups in this study (11 and 19 min, respectively) allowed for segregation based on 
some previously suggested cut-off points (12 min and 15 min) (191, 236), but were lower 
than the 30-minute value that has been used previously to characterize insomnia (115, 
237). Mean values in the low- and high- latent groups for WASO (means: 42 and 91 min, 
respectively) were both above the previously described cut-point of 30 min for insomnia 
(115, 237). Finally, the mean values among latent groups of SE (low mean: 75%; high 
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mean: 85%) identifies two groups that are above and below the previously used cut-point 
for insomnia of 80% (115, 237); however, they were both below the suggested cut-point 
from another study (92%) (191). 
Some limitations in this study are noteworthy. Information on work schedules was 
not available for all participants, thus it was assumed that participants worked on 
weekdays and had free days on weekends. Approximately 45% of participants were 
students (81% at a graduate level), who typically attend classes and work part-time 
during the day. A few students may have had evening jobs, although it is unlikely they 
regularly worked night shifts due to the potential interference with their education. 
Another potential limitation is that no information was available on alarm clock use on 
free days. To minimize these potential impacts, participants with extreme or implausible 
TST values were excluded from the analyses, consistent with prior studies (12, 37). In 
addition, the generalizability of these results is limited to healthy adults ages 21-35, half 
of whom were college students and had a relatively low income < $40,000.  
A major strength of this study is the use of objective measurements to 
characterize SJL, chronotype, and sleep, which avoids issues related to self-report of 
sleep or sleep/wake timing. Armband actigraphy is a valid, non-invasive method for 
obtaining ‘real-life’ sleep/wake measurements that are compatible with the "gold 
standard" method of polysomnography (184). Armband data were collected minute-by-
minute over several days, and information for non-wear periods was obtained using logs 
completed by participants. Thus, measurement error was expected to be lower than self 
report information. Participants did not have any major acute or chronic health conditions 
that could potentially affect objective sleep measures, and those who regularly used 
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sleep-promoting medications  were excluded. Therefore, confounding by somatic 
conditions or sleep disorders was unlikely to bias the results. 
Studies using multiple cross-sectional analyses suggest that sleep tends to 
deteriorate with age (total sleep time and SE decrease, WASO and SOL increase) (88, 
238). In middle-aged and elderly adults, prospective studies using repeated actigraphic 
measures of sleep reported that sleep characteristics remained generally stable within a 1 
to 2.5-year time frame, although insomnia subtypes changed over time (66, 67, 225, 226). 
Prospective studies among college students that used questionnaires to assess sleep 
produced conflicting results with respect to the temporal stability of sleep duration and 
the number of nocturnal awakenings during a one-semester time frame (126, 127). 
Among undergraduate college students, sleep duration decreased and the number of 
awakenings increased as the semester progressed (126). However, in another study, sleep 
duration and quality increased during a 15-week spring semester (127). In a cohort of 591 
young adults surveyed for over 20 years, 35% of those with incident one-month insomnia 
still had it at the next interview and the cumulative prevalence of one-month insomnia 
was 20% (220). Forty percent of those with incident insomnia subsequently developed 
chronic insomnia, and 17-50% of those with insomnia had a subsequent major depressive 
episode (220). Results of these studies suggest that sleep disruption tends to be persistent, 
although some inconsistencies have been observed in both younger and older age groups. 
Whether the observations in the present study correspond to more chronic sleep 
disruption that extends beyond two years remains to be determined. Given the persistent 
character of insomnia and other sleep disorders in terms of their reported association with 
chronic diseases such as depression (37, 220, 239), obesity (213, 240, 241), diabetes (62, 
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120), hypertension (63, 118, 242), CVD (65) and cancer (28), the identification of 
susceptible subgroups of young adults with persistent sleep disruption may provide a 
health benefit to those individuals in terms of chronic disease prevention. The 
demographic characteristics identified in this study that may contribute to persistent sleep 
disruption include: male sex, being a student, non-White race, low income, and evening 
chronotype. 
In summary, this study adds to knowledge concerning the temporal patterns of 
SJL, chronotype, and actigraphic sleep among healthy young adults. Absolute SJL, TST 
and objectively measured insomnia symptoms remained stable over a two-year span. The 
findings may contribute to the development of prevention strategies targeting sleep 
hygiene among young adults to prevent the chronic disease development.
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Table 4.1 Demographic characteristics of the Energy Balance Study sample at baseline
 
after 
basic exclusions 
 
Variable All Participants 
(n=390) 
Women 
(n=198) 
Men 
(n=192) 
Age (yrs) 27.6±3.8 27.7±3.7 27.4±3.9 
Race, n (%)    
   European American 264 (68) 131 (66) 133 (70) 
   African American   47 (12)   31 (16)   16  (8) 
   Hispanic/Latino   11  (3)    7   (3)    4   (2) 
   Asian   42 (11)   15   (8)   27 (14) 
   Native American   12  (3)    8   (4)    4   (2) 
   Other   14  (3)    6   (3)    8   (4) 
Education, n (%)    
   HS Graduate/GED 
   Some College 
  62 (16)   18  (9)   44 (23) 
   College (4+ years) 328 (84) 180 (91) 148 (77) 
Income ($), n (%)    
   < 20,000   65 (17)   34 (17)   31 (16) 
   20,000 to < 40,000 137 (35)   76 (39)   61 (32) 
   40,000 to < 60,000   74 (19)   37 (19)   37 (19) 
   60,000 to < 80,000   50 (13)   23 (12)   27 (14) 
   ≥ 80,000   62 (16)   26 (13)   36 (19) 
Employment, n (%)    
   Employed and self 
employed 
214 (55) 113 (57) 101 (53) 
   Student/Other
1
 176 (45)   85 (43)   91 (47) 
Marital status, n (%)    
   Married
2
 178 (46)   90 (45)   88 (46) 
   Single
3 
212 (54) 108 (55) 104 (54) 
Children, age    
   <18 years, n (%)    
   0 336 (86) 173 (88) 163 (85) 
   1   29  (7)   13  (7)   16  (8) 
   ≥ 2   24  (7)   11  (5)   13  (7) 
1 
Out of work (<1 year), homemaker, unable to work (n=4, 1 %). 
2 
Includes members of unmarried couples (n=55, 14 %).  
3 
Includes divorced and separated (n=7, 1.7 %). 
 
  
 
6
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Table 4.2 Stability of Objective Sleep Measures Over Time (n=390, 1,431 observations) 
 
Sleep measure 
Follow-up Time (Months)  
F-test, 
p-value 
Baseline  
(n=390) 
6  
(n=341) 
12  
(n=317)  
18  
(n=206) 
24  
(n=177) 
Mean±SE Mean±SE Mean±SE Mean±SE Mean±SE 
Social Jet Lag (h)       
     Crude 1.2±0.04 1.1±0.04 1.1±0.05 1.2±0.06 1.2±0.06 0.78 
     Adjusted
1 
0.9±0.05 0.9±0.05 1.0±0.05*   1.0±0.1  1.1±0.1* 0.09 
Chronotype (h)       
     Crude 4.4±0.1 4.2±0.1* 4.1±0.1* 4.1±0.1* 4.0±0.1* <0.01 
     Adjusted
2 
4.4±0.1 4.2±0.1* 4.1±0.1* 4.0±0.1* 4.0±0.1* <0.01 
Total Sleep Time (h)       
     Crude 6.6±0.04 6.6±0.04* 6.5±0.04* 6.6±0.05 6.6±0.05 0.10 
     Adjusted
3 
6.4±0.10 6.5±0.10*
 
 6.3±0.10* 6.4±0.1 6.4±0.10 0.40 
Sleep Onset Latency (min)       
     Crude 12.9±0.3 13.0±0.3 12.9±0.3 13.8±0.4 12.6±0.4 0.15 
     Adjusted
4 
12.9±0.3 12.8±0.4 12.7±0.4 13.6±0.4 12.4±0.5 0.16 
Wake After Sleep Onset (min)
 
      
     Crude 53.8±1.5 54.2±1.6 53.3±1.6 54.0±1.8 51.9±1.9  0.75 
    Adjusted
5 
61.3±2.2 61.6±2.3 60.7±2.3 61.4±2.4 59.3±2.5 0.77 
Sleep Efficiency (%)       
     Crude 82.3±0.3 82.4±0.3 82.4±0.4  82.1±0.4 82.6±0.4 0.76 
     Adjusted
6 
81.2±0.4  81.3±0.4 80.3±0.4 82.0±0.5  81.5±0.5 0.77 
Abbreviations: 95%CI - 95% Confidence Interval. Participants with any valid time points (1-5) were included. 
1 
Adjusted for
 
time, chronotype, race, employment status, and current dieting. 
2 
Adjusted for age and sex.  
3
Adjusted for 
 
time, chronotype, gender, race, having children (yes/no), caffeine intake (g/d), napping (yes/no), 
physical activity (MET-hours, continuous) and season. 
4
Adjusted for time, season, income, caffeine, nap, physical 
activity (MET-hours, continuous). 
5 
Adjusted for race. 
6 
Adjusted for race, sex, income, energy-adjusted Dietary 
Inflammatory Index (continuous), and physical activity (MET-hours, continuous).* p<0.05. For absolute SJL time 
points 12 and 24 months differed from baseline. For Chronotype, every time point was different from the baseline. 
For TST, time points 6 and 12 m were different from each other. 
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Table 4.3 Characteristics of Latent Groups within Social Jetlag, Chronotype, and Total Sleep Time 
 (n=312; 1,297 observations) 
 
Variable 
Social Jet Lag (h)  Total Sleep Time (min)  
p Low High p Short Intermed. Long 
Mean±SE Mean±SE Mean±SE Mean±SE Mean±SE 
0.8±0.6
 
1.4±0.8
 
5.6±0.04
 
6.5±0.02
 
7.3±0.03
 
 % %  % % %  
Sex
 
       
   Male 55 48 
0.20 
71* 54  35* 
<0.01    Female 45 52 29* 46  65* 
Race
 
       
   European American 64 68  27* 71 82  
   African American 12 10 0.50 30*  9  2 <0.01 
   Other
1 
24 22  43* 20 16  
Employment        
   Student/Other
2 
52 41 
0.05 
50 46 43 
0.70 
   Employed
 
48 59 50 54 57 
Income ($)
 
       
   < 20,000 19 16  24* 16  16*  
   20,000 to < 40,000 36 38  43* 38  30*  
   40,000 to < 60,000 19 19 0.80 23* 21  16* 0.02 
   60,000 to < 80,000 13 14  4* 16  16*  
   ≥ 80,000 13 13  6*  9  22*  
Marital status
 
       
   Married
3 
46 46 
0.96 
70* 50 50 
0.02 
   Single
4 
54 54 30* 50 50 
Children
 
       
   Yes 17 11 
0.10 
13 18  8* 
0.10 
   No 83 89 87 82 92* 
 Mean±SE Mean±SE  Mean±SE Mean±SE Mean±SE  
Chronotype (h) 3.8±0.1 4.3±0.05 0.01   4.6±0.1* 4.1±0.1 3.9±0.05 <0.01 
Age (yrs) 27.8±0.2 27.6±0.1 0.30 27.0±0.2* 28.0±0.2 27.7±0.2 <0.01 
Physical activity (h)     2.2±0.1     2.2±0.1 1.00  2.3±0.2 2.3±1.0   2.0±0.1*  0.04 
Caffeine (g/d) 109.0±8.6 117.4±6.8 0.50 79.3±11.7* 120.2±7.9 126.5±8.8 <0.01 
e-DII    0.4±0.2    0.6±0.1 0.40 1.1±0.2* 0.4±0.1     0.3±0.2   0.01 
Abbreviations: SE - standard error, e-DII - energy-adjusted Dietary Inflammatory Index; p - p-value F-test. 
1 
Hispanic/Latino, Asian, Native American, mixed race. 
2
 Out of work (<1 year), homemaker, unable to 
work. 
3 
Includes members of unmarried couples. 
4 
Includes divorced and separated. *p<0.05, reference 
group Intermediate Chronotype. 
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Table 4.4 Characteristics of latent groups within sleep variables (n=312, N=1,297 observations) 
 
Variable 
Sleep Onset Latency 
p 
Wake After Sleep Onset 
p 
Sleep Efficiency 
p 
Low High Low  High High Low 
Mean±SE Mean±SE Mean±SE Mean±SE Mean±SE Mean±SE 
10.8±0.2 19.2±0.3 42.1±0.9 90.7±1.7 85.4±0.1 74.8±0.3 
 % %  % %  % %  
Sex
 
         
   Male 49 54 
0.50 
51 50 
0.99 
47 60 0.04 
   Female 51 46 49 50 53 40 
Race
 
         
   European American 68 61 
0.50 
75 36 
<0.01 
76 40 
<0.01    African American 11 11  7 24   7 20 
   Other
1 
21 28 18 40 17 40 
Employment          
   Student/other
2 
41 58 
0.01 
43 54 
0.10 
43 51 
0.20 
   Employed
 
59 42 57 46 57 49 
Income ($)
 
         
   < 20,000 8 17 
0.20 
16 26 
 
0.10 
16 20 
0.04 
   20,000 to < 40,000 33 46 34 45 32 48 
   40,000 to < 60,000 22 12 19 19 21 15 
   60,000 to < 80,000 14 13 16  5 14 11 
   ≥ 80,000 13 12 15  5 16 6 
Marital status
 
         
   Married
3 
47 42 
0.30 
47 41 
0.40 
48 40 
0.20 
   Single
4 
53 58 53 59 52 60 
Children
 
         
   Yes 12 18 
0.30 
14 12 
0.60 
14 11 
0.40    No 88 82 86 88 86 89 
 Mean±SE Mean±SE  Mean±SE Mean±SE  Mean±SE Mean±SE  
Chronotype (h)    4.0±0.04     4.3±0.01 <0.01     4.0±0.04   4.4±0.1 0.01   4.0±0.1   4.4±0.1 <0.01 
Age 27.6±0.1 27.8±0.2 0.40 27.7±3.6 27.6±4.2 0.30
 
27.9±0.1 27.1±0.2 <0.01 
  
 
6
9 
Physical activity (h)   2.3±0.1    2.0±0.1 0.10   2.2±0.1   2.1±0.1 0.60   2.2±0.1   2.1±0.1 0.60 
Caffeine (g/d) 114.3±3.8 114.2±6.4 0.80 119.9±6.1 94.6±11.2 0.05 124.2±6.2    87.2±10.1 0.01 
e-DII      0.5±0.1     0.5±0.2 0.90    0.4±0.1 0.6±0.2 0.40     0.4±0.1 0.6±0.2 0.40 
Abbreviations: WASO stands for Wake After Sleep Onset, SE - Standard Error, e-DII - energy-adjusted Dietary Inflammatory Index,  
p - p-value F-test.
  
1 
Hispaic/Latino, Asian, Native American, mixed race. 
2
 Out of work (<1 year), homemaker, unable to work. 
3 
Includes members of unmarried couples. 
4 
Includes divorced and separated 
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Figure 4.1. Latent group trajectories for Social Jetlag, Chronotype and Objective Sleep 
Measures at five time points (baseline, 6 m, 12 m, 18 m, and 24 m) obtained with RMLCA 
analyses (n=312, 1,297 obs.). Only participants with ≥3 time points were included. 
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CHAPTER 5 
Relationships between Social Jetlag, Chronotype and Objective Sleep 
Characteristics with Anthropometric Indices of Obesity and High Blood Pressure
1
                                                          
1
 McMahon, D.M., Burch, J., Wirth, M.D., Youngstedt, S.D., Hardin, J.W., Hurley, T.G., 
Blair, S.N., Hand, G.A., Shook, R.P., Drenowatz, C., Hebert, J.R. To be submitted to 
Chronobiology International. 
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ABSTRACT 
Background: Chronotype, social jetlag and poor sleep have been associated with 
increased risk of chronic diseases such as obesity, metabolic syndrome, cardiovascular 
disease and cancer. Yet, the relationships between these factors have not been extensively 
investigated in prospective studies.  
Methods: Social jetlag [SJL] and objective sleep measures (total sleep time [TST], sleep 
onset latency [SOL], wake after sleep onset [WASO] and sleep efficiency [SE]) were 
derived from physical activity personal (armband) monitoring data among 390 healthy 
men and women 21-35 years of age. Participants wore the armband for 7-10 days at 6-
month intervals (1,431 repeated measurements). Generalized linear mixed models with 
repeated measures (PROC GLIMMIX) were used to analyze relationships between 
chronotype, absolute SJL, TST, SOL, WASO, SE and anthropometric measures: body 
mass index [BMI], percent body fat [%BF], waist-to-hip ratio [WHR], waist-to-height 
ratio [WHtR], systolic blood pressure [SBP] and diastolic blood pressure [DBP]. The 
relationships between sleep disruption or SJL and indicators of obesity and high blood 
pressure were evaluated for potential effect modification by chronotype. 
Results: Sleep latency ≥12 min was associated with 1.4 times increased odds of high 
WHtR (odds ratio [OR]=1.4; 95% confidence interval [95%CI]: 1.03-1.84). The odds of 
high WHtR decreased 0.97 times (95%CI:0.95-0.99) per 1% increase in SE. SJL was 
correlated with eveningness (Spearman ρ=0.49, p<0.001), and evening chronotypes had 
shorter TST, lower SE and higher WASO compared to those with intermediate 
chronotypes. Chronotype and absolute SJL were not associated with anthropometric 
measures. However, chronotype modified relationships between objective sleep measures 
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and anthropometric measures. Morning chronotypes with short TST (<6 h), low SE 
(<85%) and large WASO (≥60 min) had increased odds of high %BF, WHR and WHtR, 
whereas morning chronotypes with longer sleep latencies (≥12 min) had increased odds 
of high SBP. Among evening chronotypes, shorter sleep (<6 hours) was associated with 
increased odds of high SBP. 
Conclusions: Chronotype and sleep disturbances may work in combination to increase 
an individual's risk of obesity or elevated blood pressure. 
 
Introduction 
 In 2013-2014, almost 38% of adults in the United States were obese (243). 
Obesity is associated with many serious complications such as metabolic syndrome, type 
2 diabetes mellitus, arterial hypertension, cardiovascular disease, and cancer (244), some 
of which develop already in a childhood (183). One modifiable risk factor for obesity is 
sleep (213, 245). Poor sleep has been associated with has been associated with increased 
risk of major chronic diseases such as cardiovascular disease and hypertension (65, 118), 
obesity (213), diabetes (120, 214), and cancer (28, 47). 
 Sleep timing is related to individual circadian preference and is more efficient 
when it occurs during preferred times (246). Most physiological and behavioral processes 
in humans follow ~24-hour internally generated cycles that are synchronized (or 
entrained) by environmental stimuli, the most important of which is light (1, 2). Due to 
inherent differences in sleep/wake timing, people tend to be categorized into morning 
("larks"), neutral, or evening ("owls") chronotypes (3, 4). For example, people with a 
morning chronotype go to bed between 10 p.m. and midnight, on average, while evening 
 74 
 
chronotypes retire between 1 and 3 a.m on their free days. Individuals with evening 
chronotypes tend to accumulate sleep debt during the week, for which they try to 
compensate with a longer sleep during the weekend. Morning chronotypes, on the 
contrary, tend to develop sleep debt during the weekend (6). Modern life in industrialized 
countries imposes on individuals multiple work-related and social demands that can come 
into conflict with the individual's chronotype. This discrepancy (misalignment) between 
biological preference and social clock is called "social jetlag" (SJL) (6). SJL is calculated 
as the difference between mid-sleep time on free and work days (6). For instance, if on a 
work day, a person sleeps from 1 a.m. to 7 a.m. and on free days from 1 a.m. to 9 a.m., 
his SJL is 1 hour. In experimental studies, circadian misalignment has been implicated in 
disruption of important physiological processes (92). Social jetlag starts in teenage years 
and continues throughout working years until retirement and, thus, may affect millions of 
people in industrialized countries (12). In some reports, SJL has been associated with 
increased anthropometric indices of obesity, metabolic syndrome, markers of systemic 
inflammation and mood disorders (12, 37, 49, 58); however, its relationships with other 
factors, such as sleep disruption and chronotype, that also predispose to chronic disease 
have not been thoroughly examined.  
 In several studies, individuals with evening chronotype were more likely to be 
overweight or obese than those with morning or intermediate chronotypes (33, 53-55); 
however, not all studies confirmed this association (12, 57). In one study, morning 
chronotype was associated with increased risk of weight gain (12). Chronotype 
moderately correlates with social jetlag, especially on work days, and people with 
evening chronotypes tend to have more social jetlag (6, 12, 37, 49, 58, 236). Chronotype, 
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in combination with social schedule, can elicit an increase in social jetlag (6, 12). Thus, it 
is reasonable to hypothesize that social jetlag may mediate the relationship between 
chronotype and obesity. A study that tested this hypothesis produced conflicting results 
(56), and most other studies inferred that chronotype, SJL and sleep duration confound 
each other's associations with anthropometric indexes of obesity and metabolic syndrome 
(12, 58). 
 Sleep duration is generally independent from chronotype (88); however, circadian 
misalignment, a discrepancy between preferred and actual sleep/wake times, is associated 
with sleep loss (6, 88). Shortened, fragmented or inefficient sleep is associated with 
increased risk of weight gain and obesity in young adults (54, 213, 232, 234, 236, 240, 
247). Poor sleep is prevalent in young adults and tends to be persistent (116, 234, 236, 
240, 248, 249). For instance, a recent study showed that in 53% of young adults 19-23 
years old, sleep problems persisted over 3 years (249). Our previous research also 
demonstrated that SJL and poor sleep (low TST, high SOL, high WASO and low SE) 
derived from armband actigraphy in young adults 21-35 years old remained stable within 
two year period (submitted). Findings that sleep disruption is associated with chronic 
diseases warrants further investigation into the interplay between sleep quality, quantity 
and timing.  
 The objective of this study was to prospectively examine relationships between 
SJL, objective sleep measures (TST, SOL, WASO and SE) and anthropometric measures 
of obesity and high blood pressure (BMI, %BF, WHR, WHtR, SBP, and DBP) among 
young adults 21-35 years old using a serial cross-sectional study design. This age group 
is at risk for developing metabolic disturbances that predispose to increased risk for 
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chronic disease later in life (183, 229). During the last decade, prevalence of obesity in 
this age group in the United States remained high (30%) (183), a known risk factor for 
morbidity and premature mortality (250). Adults in this age range also may experience 
SJL and have persistent poor sleep (116, 234, 236, 240, 248, 249). We hypothesized that 
young adults with SJL or poor sleep were more likely to be obese, have elevated blood 
pressure, mood disturbances or elevated stress relative to those without SJL and good 
sleep, and that such impacts may be modified by chronotype. 
 
Methods 
Study population 
 Eligible individuals were 21-35 years of age, with BMI of 20-35 kg/m
2 
, and no 
major health conditions or large changes in body composition during previous six months 
(182). In 2011, 430 healthy men and women 21-35 years of age residing in the Columbia, 
SC region were enrolled. Those who met diagnostic criteria for hypertension and 
diabetes: systolic blood pressure ≥150 mmHg and/or diastolic blood pressure ≥90 mmHg 
or a blood glucose level >145 mg/dl, were excluded (182). In 2011, 430 participants 
residing in the Columbia, SC region were enrolled. After comprehensive baseline 
assessment, participants were re-examined every 6 months for: socio-demographic and 
anthropometric characteristics, sleep/wake patterns via armband actigraphy, and diet. 
During the two-year study period, each participant completed one to five assessments at 
six-month intervals. The study was approved by the Institutional Review Board at the 
University of South Carolina, and all study participants provided informed consent.  
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Chronotype, Social Jetlag and Sleep measures 
 Objective sleep measures were derived from the data collected using a 
SenseWear
®
 Mini Armband which participants wore over the triceps muscle of the left 
arm (184). A micro-electro-mechanical sensor in the armband detects and measures limb 
movements at a frequency of 32 times per second and data are averaged at 1 minute 
intervals. The armband data by minute were analyzed using SenseWear Professional
®
 
Research Software (Version 7.0, Body Media
®
 Inc.). Demographic information (i.e. age, 
sex, height, weight and smoking status) was used to customize proprietary algorithms for 
calculations of objective sleep measures. The participants wore the armband for 7-10 
days and kept a log of their activities during periods of non-wear. These activities were 
matched with the 2011 Compendium of Physical Activity (187) to fill gaps in 
information on energy expenditure and sleep for non-wear periods (185).  
 The armband data yields several night-time sleep measures: sleep onset and wake-
up times, TST, SOL, WASO and SE (185). The sleep onset time was determined by the 
first out of three minutes asleep that coincided with ≥ 10 minutes lying down (185). 
Morning wake-up time was defined by the first out of 90 consecutive minutes awake 
(185). TST is the sum of all minutes asleep from initiation of the sleep period until wake-
up  (185). Sleep efficiency was calculated as a proportion of the total sleep time to the 
length of the night sleep bout. WASO was calculated as the sum of wake periods of at 
least two minutes long between sleep onset and the final wake time (185). All sleep 
measures were averaged for each semiannual data collection period for a minimum of 3 
weekdays and one weekend day. 
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 Chronotype was measured as the time of mid-sleep on free days corrected for 
“make-up sleep” on free days (12). Information on work schedule was not collected in 
this study; it was assumed that free days occurred only on weekends. The sleep logs were 
examined to find and exclude individuals whose schedules deviated from this pattern 
(10). Social jetlag (SJL) was calculated as a difference between midpoints of sleep on a 
weekend and on a week day (unadjusted) (12). The absolute value of SJL was used for all 
analyses and, referred to as SJL throughout this paper. 
 Individuals were excluded from statistical analyses if their armband data had the 
following deficiencies: missing bed time or wake time, <4 days of actigraphy in any 
given assessment period, missing sleep data on the weekend, extreme or implausible TST 
values (<4 hours either on week days, free days, or on average, TST >11 hours on work 
days or on average), and when mid-sleep on free days occurred in the afternoon (12). In 
addition, participants were excluded from all analyses if they regularly used (≥3 times per 
week) sleep promoting medications (over the counter or prescription), worked night 
shifts, or traveled across meridians during periods of armband wear (12, 230).  
 
Anthropometric Outcomes 
 Height and weight were measured using traditional stadiometer and electronic 
scales with a precision of 0.1 cm and 0.1 kg, respectively (182). The average of three 
measurements was used to establish BMI (weight (kg)/height (m
2
). Waist and hip 
circumferences were measured with a calibrated, spring-loaded tape measure. The waist 
circumference was measured at mid-point between costal margin and iliac crest on the 
axillary line on both sides of the trunk and 2 cm above the umbilicus (182). Hip 
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circumference was measured at the level of the greater trochanter, at the widest point. 
The average of three measurements rounded to 0.1 cm was recorded. Body composition 
was measured using dual x-ray absorptiometry full body Lunar fan-beam scanner (GE 
Healthcare model 8743, Waukesha, WI). 
 
Covariates  
 Total daily physical activity time was obtained from armband data. Information 
for the periods of non-wear was supplemented with values for matching activity from the 
2011 Compendium of Physical Activity (184). Total daily hours of physical activity were 
defined as any activity of at least 5 metabolic equivalents. Dietary information was 
collected using three 24-hour dietary recalls conducted by phone; two on randomly 
selected week days and one on a weekend. To estimate energy, nutrient and individual 
food intakes from these recalls was used the Nutrient Data System for Research (version 
2012: Nutrition Coordinating Center, University of Minnesota, Minneapolis, Minnesota). 
Forty three food parameters and nutrients were further used to calculate a dietary 
inflammatory index (DII) that expresses an inflammatory potential of individual's diet 
(81). Lower DII scores are anti-inflammatory while the higher scores are more 
proinflammatory, and the maximum theoretical range is −8.87 to 7.98. To account for 
individual differences in energy intake, the DII scores were calculated per 1,000 
kilocalories (4184 KJ) (e-DII) (185).  
 
Statistical Analyses 
 All statistical analyses were performed using SAS 9.4® (Cary, NC). Continuous 
actigraphy variables were categorized using previously established cut-points: TST (<6, 
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6-<7, ≥7 h) (61, 65), SOL (≥12 vs. <12 min) (191), WASO (≥60 vs. <60 min) (119, 188), 
and SE (<85 vs. ≥85%) (119, 185). Relationships between SJL, chronotype, objective 
sleep measures (TST, SOL, WASO, SE) and anthropometric measures were analyzed 
using generalized linear mixed models for repeated measures for which we estimated an 
unstructured covariance matrix. Odds ratios (OR) and 95% confidence intervals (95%CI) 
were used to evaluate the relationship between disrupted sleep, individual chronotype, or 
SJL and measures of obesity, body composition, or blood pressure. BMI was categorized 
into 2 groups: underweight/normal weight (<25) and overweight/obesity (≥25 B kg/m2). 
Sex-specific cut-off points were used to categorize BF% and WHR. Obesity was defined 
as BF% ≥25% in men and ≥30% in women (98). WHR was dichotomized: <0.95 vs. 
≥0.95 in men and <0.80 vs. ≥0.80 in women (200). Waist-to-height ratio was 
dichotomized as <0.5 vs. ≥0.5 (103). Potential covariates included: age, sex (male, 
female), race (European American [EA], African American [AA], Other [Hispanic, 
Asian, Native American and mixed race]), education (high school graduate/GED some 
college vs. college ≥ 4 y.), income (<$20,000, 20,000 to <40,000, 40,000 to <60,000, 
60,000 to <80,000, ≥80,000), employment (student/other vs. employed/self-employed), 
marital status (married, single), having children (yes/no), physical activity (MET-hours), 
caffeine intake (g/d), e-DII (≤-1.18, -1.19-≤0.72, 0.73-≤2.10, >2.10), napping (yes/no), 
and season (winter [November-January], spring [February-April], summer [May-July], 
autumn [August-October]). The assessment time (one to five at 6-month intervals) was 
treated as a categorical variable and included in crude and adjusted statistical models. To 
select potential covariates, bivariate relationships between each sleep measure and the 
anthropometric outcomes were summarized, and variables with p-value <0.2 were 
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selected for inclusion in multivariable statistical models. Manual backwards elimination 
was used to identify covariates that changed an estimate of the main exposure by ±10%. 
The final model included only confounders detected with 10% rule, or if they were 
statistically significant (p≤0.05). Only observations with complete data were included. 
 Repeated Measures Latent Class Analysis (RMLCA) was estimated using PROC 
TRAJ in SAS® to identify latent groups for chronotype (morning, intermediate, and 
evening) over time (202, 203). This analysis assumes a mixture model to define the 
trajectories of unique subgroups within a population that don't change their group 
membership over time (204, 205). Assignment to a latent group was based on the highest 
posterior probability. The best fitting model was selected using Bayesian Information 
Criterion (BIC) (205) and a priori minimum group sizes ≥10% of the study population. 
RMLCA were adjusted for race (EA vs. AA/Other) and sex, which were assumed not to 
change over time. Because the group trajectories for all three latent chronotype groups 
were linear, other potential covariates that change over time were not used to adjust 
group trajectories. Participants with complete armband data for any available time point 
were included in these analyses (n=390, 1,431 observations). Generalized linear mixed 
models were estimated to compare means of SJL, chronotype and each continuous sleep 
measure between chronotypes using the F-tests in PROC GLIMMIX. The intermediate 
chronotype was a referent group.  
 Because chronotype may have several possible roles in how it influences 
anthropometric outcomes, it was analyzed in several different ways. Chronotype was 
used as either a continuous or a categorical (RMLCA) independent variable; in the latter 
analysis, the intermediate chronotype was used as the referent. When examining 
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relationships between SJL or sleep measures and the anthropometric outcomes, 
chronotype (continuous) was considered as a potential confounder along with other 
covariates. The potential role of chronotype as effect modifier was tested using two 
approaches. In the first approach, an interaction term between chronotype and a main 
independent variable was added to the multivariable statistical model and assessed using 
the Wald test. The continuous or categorical version of chronotype that was used for the 
interaction term was chosen to match the form of the other independent variable. The 
second approach used stratification of the relationship between absolute SJL, sleep 
measures and anthropometric outcomes by latent chronotype group. 
 
Results 
 The final analytical dataset consisted of 390 participants (with a total of 1,431 
repeated observations). A majority of the participants had at least three (79%), four 
(15%) or five (39%) repeated assessments, whereas 10% of participants had two, and 
11% had only one assessment. The average age at baseline was 28±4 years, and the sex 
distribution was approximately equal (51% women) (Table 4.1). Most participants were 
EA (68%) and had at least 4 years of college (84%). Fifty five percent of participants 
were employed, and 45% were college students (19% undergraduate, 81% graduate). A 
majority of participants (71%) had an annual income below $60,000. Thirty two percent 
of participants were currently married, and 14% had children (Table 4.1). With regard to 
anthropometric characteristics, 45% of participants were overweight (BMI 25-24.9 
kg/m
2, 31%) or obese (BMI≥30, 14%). Among males, 37% had %BF ≥25% and 3% had 
high WHR (≥0.95). Among females, 71% had %BF ≥30% and 15% had high WHR 
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(≥0.80). Twenty two percent of participants of both sexes had high WHtR (≥0.5). 
Systolic blood pressure was elevated (≥120 mmHg) among 59% of participants, 
including those who met a criterion for hypertension (≥140 mmHg, 11%). Only 23% had 
elevated DBP (≥80 mmHg), including those with hypertension (≥90 mmHg, 4%). 
 Chronotype was not associated with any of the anthropometric measures when 
analyzed as a continuous variable (Table 5.1). The RMLCA identified three latent 
chronotype groups: morning (mean±SE: 3.0±0.04 h, 32.5% of participants), intermediate 
(4.4±0.03 h, 53%) and evening (6.1±0.1 h, 14.5%). Chronotype defined by latent group 
membership was not associated with any anthropometric measures (Table 5.1). At 
baseline, chronotype was moderately correlated with SJL (Spearman ρ=0.42, p<0.001). 
Compared to participants with an intermediate chronotype (1.2±0.03 h), morning types 
had significantly less SJL (0.9±0.04, p<0.001), whereas those with evening chronotypes 
had significantly more of SJL (1.5±0.1 h, p<0.001) (Table 5.2). The evening types also 
had significantly shorter TST, lower SE and larger WASO relative to intermediate types 
(Table 5.2).  
 Approximately 50% of participants at baseline had more than one hour of SJL (>1 
hour and <2 hours: 33%; ≥2 hours: 17%). SJL was not associated with any of the 
anthropometric measures either before or after stratification by chronotype group (Table 
5.3).  
 Among the sleep measures, SOL, SE, and TST were associated with 
anthropometric measures. Sleep latency ≥12 min (Ref. <12 min) was associated with an 
increased odds of elevated WHtR (OR: 1.4, 95%CI: 1.03-1.84, Table 5.4). The odds of 
high WHtR decreased 0.97 times (95%CI:0.95-0.99) per 1% increase in SE (Table 5.4). 
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The odds of elevated SBP decreased 0.8 times (95%CI: 0.66-0.97) per 1 hour increase in 
TST; although it was not confirmed in adjusted analysis (Table 5.4). Chronotype 
continuous) was not included into the final models due to the negative tests for 
confounding (10% rule). 
 Stratification by latent chronotype group indicated that morning types who also 
had short TST (<6 h), elevated WASO (≥60 min) or low SE (<85%) were more likely to 
have increased %BF, WHR and WHtR (Table 5.5). Participants with sleep latency ≥12 
min who also had a morning chronotype were 1.9 times more likely to have elevated SBP 
(95%CI: 1.15-3.16, pinteraction=0.02, Table 5.5). Among the late chronotypes, the odds of 
high SBP were 2.6 times greater among those who also had short TST (<6 h, 95%CI: 
1.08-6.40, pinteraction=0.74, Table 5.5). Elevated WASO (≥60 min) was associated with an 
increased odds of high DBP only among those with an intermediate chronotype (OR: 1.7, 
95%CI: 1.05-2.71, pinteraction=0.10, Table 5.5). Results obtained when the data were 
analyzed using sleep measures as continuous variables were generally consistent with 
those obtained using categorical sleep variables. For example, among morning types, the 
odds of an elevated WHR or WHtR decreased with each 1% increase in SE (OR=0.91; 
95%CI: 0.85-0.98, pinteraction=0.004 and OR=0.95; 95%CI: 0.91-0.98, pinteraction=0.14, 
Table 3). Measures of chronotype, SJL or sleep were not associated with BMI. 
 
Discussion 
 To the author’s knowledge, this is the first study to use repeated actigraphy 
measures to examine relationships between chronotype, SJL, and objective sleep 
measures to characterize longitudinal associations with anthropometric indices of obesity 
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or hypertension. This study revealed that among healthy adults ages 20-35 years, 
disrupted sleep was associated with %BF and WHtR, whereas SJL and chronotype had 
no direct association with the anthropometric outcomes. These observations are 
consistent with previous studies that found an association between sleep disruption and 
risk of weight gain or obesity in young adults (213, 231, 232, 234, 236, 240, 241). In the 
current study, measures of body composition and abdominal adiposity (%BF, WHR, 
WHtR) tended to be most strongly associated with sleep measures, whereas the results for 
BMI and sleep measures did not indicate an association. In this study, those with larger 
SOL were predisposed to elevated WHtR, whereas increases in SE and sleep duration 
were protective. Short TST was associated with increased WHR, although only among 
morning types. Others have reported that short sleep duration was associated with 
increased waist circumference among women, although the participants' chronotypes 
were not evaluated (233, 241). Disrupted sleep in the current study, defined as short TST, 
high SOL, high WASO, or low SE, was not associated with BMI, whereas relationships 
with indices of %BF, WHR and WHtR were observed. The reasons for these 
discrepancies are uncertain but may be due to minor differences in the accuracy of the 
indicator. For example, BMI likely underestimates obesity among those with BMI <30 
kg/m
2 
(251), or overestimates among college athletes (252) relative to percent body fat. 
Most studies found that evening types were more likely to be obese compared to morning 
types (33, 51, 53-55). However, one large cross-sectional study reported that morning 
circadian preference was associated with increased BMI (12). In the present study, the 
lack of association between chronotype and BMI is in agreement with findings reported 
in another study (58). 
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 Although chronotype had no direct associations with outcomes in the present 
study, relationships between sleep disturbances and the anthropometric measures were 
modified by chronotype. Morning types with disrupted sleep, characterized as either short 
TST, elevated WASO, or low SE, had increased odds of increased %BF, WHR and 
WHtR. This finding is relatively novel since most previous studies investigated the 
effects of chronotype or sleep on obesity independently (33, 51, 53-55, 213, 231-234, 
236, 240, 241). Some studies adjusted for the effects of chronotype and sleep duration 
while examining the relationship between absolute SJL and BMI, percent fat mass, waist 
circumference, and obesity (12, 58). Increase in SJL or morningness, or decrease in sleep 
duration were independently associated with increased odds of being overweight or obese 
while adjusted for the other two variables (12). In the same study, among people with 
normal weight, chronotype and sleep duration were associated with BMI while SJL was 
not. Among overweight or obese people, SJL and decrease in sleep duration were 
associated with increase in BMI, and chronotype was not a significant predictor. In 
another study, SJL was associated with increase in BMI, fat mass, waist circumference 
and obesity while chronotype and sleep duration in the same statistical model were not 
associated with those measures (58). It is not clear why measures of disrupted sleep were 
associated with increases in anthropometric indexes of obesity predominantly among 
morning types. It suggests that a morning circadian preference increases vulnerability to 
the detrimental effects of sleep disturbance, and that the effect is linked to physiological 
processes controlling fat deposition. In another study, morning chronotypes had higher 
baseline and postprandial total cholesterol, lower low density lipoprotein and a higher 
adiponectin compared to intermediate or evening chronotypes (46). In the same study, 
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participants with morning chronotypes had higher baseline glucose levels and the greatest 
increases in postprandial blood glucose levels compared to other chronotypes (46). 
Others have observed that morning chronotypes had a higher cortisol awakening response 
relative to evening types (48, 253) and a stronger homeostatic response to sleep 
fragmentation than evening types (254). Morningness has been associated with decreased 
quality of sleep, problems maintaining sleep, and early awakenings relative to 
eveningness (45), which may be related to the tendency towards shift work intolerance 
that has been observed in this group (13, 14). 
In the current study, an interaction between sleep disturbances and chronotype 
also was observed in relation to arterial hypertension. Among evening chronotypes, those 
with TST <6 hours were 2.6 times more likely to have elevated SBP compared to those 
who slept 6 to less than 7 hours. In another study that examined blood pressure, there was 
no statistically significant interaction between sleep duration and chronotype; although 
TST ≤ 6 hours and evening chronotype were independently associated with increased risk 
of arterial hypertension (46). Evening chronotypes tend to have shorter sleep duration on 
work days relative to other chronotypes (88, 255). Poor sleep also is common among 
evening types (255, 256), consistent with results from the present study (236). Short or 
fragmented sleep may initiate a neuroendocrine stress response, leading to increased 
activity of the sympathoadrenal and hypothalamo-pituitary axis, which in turn can 
increase heart rate, blood pressure, increase evening cortisol, impair glucose metabolism,  
and lead to abdominal adiposity (257-259).  
 Absolute SJL was not associated with any of the anthropometric indices of 
obesity in this study. In prior cross-sectional studies, SJL was associated with increased 
 88 
 
BMI, fat mass, and waist circumference (12, 58, 228). In one study, SJL predicted 
increases in BMI only among those who were already overweight or obese (12). It is not 
clear why results from the present study were inconsistent with those of others. This 
present study used quantitative actigraphic armband data to characterize SJL, whereas 
others typically used self-report information to ascertain sleep/wake timing. The current 
study had fewer individuals with elevated absolute SJL relative to other studies (>1h 51% 
vs. 63-69%, ≥2h 16% vs. 26-30%, respectively) where the majority of participants were 
Caucasians in the age range 15-65 y. (12, 49, 58). Other studies asserted that SJL, 
chronotype, and sleep duration confound relationships of one another with obesity 
measures (12, 58, 228). It is plausible that the relationships between these variables are 
more complex. For instance, it has been proposed that SJL may mediate rather than 
confound the relationship between chronotype and anthropometric measures (49, 56). If 
this is the case, adjustment for mediator may introduce bias. Since in this study, neither 
chronotype nor SJL were associated with anthropometric outcomes, it was not possible to 
conduct a mediation analyses to test this hypothesis. Participants of this study did not 
have any major acute or chronic health conditions that could potentially affect sleep, and 
those who regularly used sleep promoting medications, both over the counter and 
prescription, were excluded. Therefore, confounding by somatic conditions or sleep 
disorders was unlikely to bias the results. Alternatively, the study population was 
relatively young and healthy, thus they may have been more resilient to the potential 
effects of sleep disturbances or changes in sleep/wake timing on measures of total and 
central obesity and blood pressure. 
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 This study also has a few noteworthy limitations. Since work schedules were not 
available for all participants, it was assumed that they only worked on weekdays and 
were free on weekends. Approximately 45% of study participants were graduate students 
who typically attend classes and work part-time during the day. Regular night work may 
be less likely in this population since it would potentially interfere with coursework. In 
any case, to diminish the possible influence of shift work on the study results, participants 
with extreme or implausible sleep schedules (TST values <4 hours either on week days, 
free days, or on average, or mid-sleep time in the afternoon) were excluded (12, 37, 230, 
255). Also, no information was available on alarm clock use on free days. Finally, the 
generalizability of these results is limited to healthy adults ages 21-35, half of whom 
were college students with relatively low incomes (<$40,000).  
 The main strength of this study was the use of actigraphic measurements to define 
SJL, chronotype, and sleep disruption, which avoids issues inherent to self-report data. 
Armband actigraphy is a convenient, non-invasive and relatively inexpensive method for 
quantifying sleep that is comparable with the "gold standard" method of 
polysomnography (184). The armbands provided minute-by-minute measurements over 
several days, and information for non-wear periods was obtained by inspecting the data 
and using logs completed by participants. Other study strengths included: the use of a 
repeated measures design to increase statistical power, the use of gender-specific cut-
points for obesity measures, which decreases potential misclassification of outcomes (98, 
99, 103, 200), and a statistical modeling strategy that accounted for possible temporal 
changes and correlated data within individuals. The RMLCA was used to categorize 
participants into latent chronotype groups based on individual trajectories over time. This 
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‘data-driven’ approach provided clear contrasts among those with different chronotypes 
and served as a robust method for defining chronotype groups (3, 37, 235). The 
prevalence of early (32.5%), intermediate (53%) and late (14.5%) chronotype groups 
using RMLCA in this study was comparable with chronotype distributions in the same 
age range (23-35 y.) from larger cross-sectional surveys (255, 256). 
 In summary, this study found that disrupted sleep (SOL, SE, TST) had a modest 
association with central obesity and high SBP, whereas crude associations between short 
TST and SBP were not statistically significant after adjustment for confounding. A 
somewhat unexpected finding was that neither chronotype nor SJL were independently 
associated with the anthropometric outcomes measured. However, chronotype tended to 
modify the relationship between disrupted sleep and the anthropometric measures. Those 
with poor sleep and a morning chronotype were more likely to have excess body fat and 
central obesity. Evening chronotypes who slept <6 hours had increased odds of elevated 
SBP. The complex relationships between sleep, chronotype, SJL and anthropometric 
indices of obesity and hypertension deserve careful examination in the future studies. 
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Table 5.1 Relationships between Chronotype and Anthropometric Characteristics 
 
Anthropometric 
characteristic 
Model Chronotype (continuous) Chronotype group (ref. Intermediate) 
OR (95% CI)
 
p-value Early 
OR (95% CI)
 
Late 
OR (95% CI) 
p-value 
Body Mass Index (kg/m
2
) Crude 0.91 (0.79-1.06) 0.24 1.56 (0.81-2.98) 0.95 (0.39-2.28) 0.36 
 Adjusted
1 
0.86 (0.76-1.03) 0.12  1.49 (0.80-2.78)
3
    1.22 (0.50-2.97)
3 
0.45 
 
      
Percent body fat
 
Crude 1.01 (0.86-1.17) 0.94 0.67 (0.35-1.30) 0.45 (0.18-1.12) 0.17 
 Adjusted
1 
1.11 (0.94-1.31) 0.22  0.77 (0.40-1.50)
4 
 1.41 (0.54-3.69)
4 
0.48 
 
      
Waist-to-hip ratio Crude 0.83 (0.68-1.01) 0.07 1.24 (0.64-2.44) 0.58 (0.20-1.66) 0.38 
 Adjusted
2 
0.86 (0.69-1.07) 0.17  1.18 (0.56-2.48)
5 
 1.66 (0.46-6.06)
5 
0.71 
       
Waist-to-height ratio
 
Crude 0.96 (0.82-1.13) 0.64 1.30 (0.67-2.52) 0.70 (0.30-1.98) 0.55 
 Adjusted
2 
0.98 (0.83-1.17) 0.86  1.38 (0.70-2.73)
2 
 1.36 (0.50-3.72)
2 
0.60 
       
Systolic BP (mmHg) Crude 1.00 (0.90-1.11) 0.90 1.21 (0.81-1.81) 1.81 (1.04-3.13) 0.10 
 Adjusted
1 
0.96 (0.87-1.07) 0.47  1.16 (0.79-1.72)
1 
 1.10 (0.63-1.90)
1 
0.74 
       
Diastolic BP (mmHg)
 
Crude 1.07 (0.96-1.20) 0.22  0.95 (0.62-1.44)
1 
 1.83 (1.06-3.16)
1 
0.06 
       Adjusted
1 
1.04 (0.93-1.16) 0.49 0.89 (0.59-1.34) 1.19 (0.68-2.07) 0.61 
Abbreviations: BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval. 
Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), percent body fat (males ≥25 vs. <25 %, 
females ≥30 vs. <30 %), waist-to-hip ratio (males ≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), 
systolic BP (≥120 vs. <120 mmHg), diastolic BP (≥ 80 vs.<80 mmHg). 
1 
Adjusted for time, sex, physical activity (MET-hours, continuous).
 2 
Adjusted for time, age, sex, physical activity (MET-hours, 
continuous).
 3 
Adjusted for time, sex, physical activity (MET-hours, continuous) and income.
4 
Adjusted for time, sex, race and 
physical activity (MET-hours, continuous).
5 
Adjusted for time, age, sex, race, physical activity (MET-hours, continuous) and 
employment status.
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Table 5.2 Objective Sleep Characteristics by Latent Chronotype Group (n=390, 1,431 
observations) 
 
Variable  Early  
32.5% 
Mean±SE 
Intermediate 
53% 
Mean±SE 
Late  
14.5% 
Mean±SE 
F-test,  
p-value 
Chronotype (h)      3.0±0.04* 4.4±0.03    6.1±0.1* <0.01 
Total Sleep Time (h)
1 
 6.4±0.1 6.4±0.1    6.1±0.1*   0.01 
Total Sleep Time on 
work days (h)
2
 
 6.3±0.1 6.3±0.1    6.1±0.1*   0.06 
Sleep latency (min)
2 
 11.1±0.04 11.6±0.03 10.6±0.1   0.35 
Sleep efficiency (%)
3 
81.4±0.5 81.3±0.5  78.8±0.8*   0.01 
WASO (min)
4
 58.5±2.4 58.4±2.0  66.1±3.4*   0.11 
Absolute SJL (h)
5 
     0.9±0.04*    1.2±0.03    1.5±0.1* <0.01 
Abbreviations: WASO - Wake After Sleep Onset, SJL - Social Jetlag, 95%CI - 95% confidence 
interval. Partial F-test in GLIMMIX with repeated measures and unstructured covariance matrix.  
*p<0.05 (Reference group - Intermediate chronotype). 
1 
Adjusted for time, sex, race, having children, employment status, physical activity and caffeine 
intake. 
2 
Adjusted for time, sex, race, employment status, physical activity (MET-hours, 
continuous). 
3 
Adjusted for
 
time, sex, race, employment status and caffeine intake. 
4 
Adjusted for 
time, sex and having children. 
5 
Adjusted for time and employment status. 
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Table 5.3 Relationships between Absolute Social Jetlag (continuous) and 
Anthropometric Characteristics 
 
Anthropometric 
characteristic 
Chronotype 
group 
OR (95% CI) F-test p 
 interaction 
Body Mass Index
1
 (kg/m
2
) All 0.93 (0.73-1.16) 0.71 
0.82 
 Early 0.96 (0.61-1.51) 0.85 
 Intermediate 0.98 (0.72-1.34) 0.90 
 Late 0.98 (0.57-1.69) 0.95 
Percent body fat
1 
All 0.90 (0.70-1.15) 0.41 
0.91 
 Early 0.82 (0.51-1.32) 0.41 
 Intermediate 0.96 (0.67-1.36) 0.81 
 
Late 0.77 (0.40-1.50) 0.44 
Waist-to-hip ratio
1 
All 0.81 (0.59-1.12) 0.20 
0.29 
 Early 0.78 (0.43-1.42) 0.41 
 Intermediate 0.73 (0.46-1.14) 0.17 
 Late 1.58 (0.64-3.90) 0.31 
Waist-to-height ratio
2 
All 1.00 (0.77-1.29) 0.98 
0.89 
 Early 1.04 (0.57-1.91) 0.90 
 Intermediate 1.01 (0.71-1.43) 0.96 
 Late 0.99 (0.53-1.85) 0.98 
Systolic BP
1
 (mmHg) All 1.12 (0.95-1.31) 0.19 
0.37 
 Early 0.92 (0.67-1.25) 0.59 
 Intermediate 1.31 (1.03-1.67) 0.03 
 Late 0.99 (0.69-1.42) 0.95 
Diastolic BP
1
 (mmHg)
 
All 1.02 (0.86-1.21) 0.83 
0.38 
 Early 0.89 (0.62-1.27) 0.51 
 Intermediate 1.04 (0.81-1.33) 0.78 
 Late 1.08 (0.74-1.57) 0.69 
Abbreviations: BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval 
Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), 
percent body fat (males ≥25 vs. <25 %, females ≥30 vs. <30 %), waist-to-hip ratio (males 
≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), systolic BP 
(≥120 vs. <120 mmHg), diastolic BP (≥80 vs. <80 mmHg). 
1 
Adjusted for
 
time, sex and physical activity (MET-hours, continuous).
 2 
Adjusted for time, 
age, sex and  physical activity (MET-hours, continuous). 
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Table 5.4. Relationships between Sleep Measures and Anthropometric Measures 
 
Anthropometric 
characteristic 
Model Total Sleep Time (ref. 6-<7 h) Sleep Efficiency  Sleep Latency Wake After 
Sleep Onset 
OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
  <6 h ≥7 h <85 vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
 Crude 1.28 (0.77-2.10) 1.01 (0.65-1.57) 1.03 (0.68-1.54) 1.06 (0.72-1.55) 1.04 (0.67-1.60) 
Body Mass Index (kg/m
2
) Adjusted  1.30 (0.77-2.19)
1 
0.87 (0.55-1.37)
1 
 0.96 (0.64-1.48)
1 
 0.99 (0.67-1.45)
2 
 0.97 (0.63-1.51)
1 
 
 continuous continuous continuous continuous 
 
Crude 0.88 (0.67-1.14) 1.00 (0.97-1.03) 1.01 (0.98-1.05) 1.00 (0.99-1.01) 
 
Adjusted 0.81 (0.62-1.06)
1 
1.01 (0.97-1.04)
1 
1.00 (0.97-1.04)
2 
1.00 (0.99-1.01)
1 
  <6 h ≥7 h <85 vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
 Crude 0.88 (0.53-1.49) 1.02 (0.64-1.64) 0.98 (0.65-1.48) 1.41 (0.94-2.10) 1.35 (0.86-2.14) 
Percent body fat Adjusted  1.00 (0.57-1.77)
3 
 0.75 (0.45-1.24)
3 
 0.95 (0.60-1.51)
4 
 1.41 (0.91-2.16)
3
  1.31 (0.80-2.14)
3 
 
 continuous continuous continuous continuous 
 
Crude 1.07 (0.81-1.41) 0.97 (0.94-1.00) 1.04 (1.00-1.07) 1.01 (1.00-1.02) 
 
Adjusted 0.83 (0.62-1.12)
3 
1.02 (0.93-1.01)
4 
1.03 (1.00-1.07)
3 
1.01 (1.00-1.02)
3 
  <6 h ≥7 h <85 vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
 Crude 1.16 (0.62-2.18) 1.17 (0.66-2.09) 1.22 (0.72-2.08) 1.25 (0.76-2.06) 1.31 (0.76-2.24) 
Waist-to-hip ratio Adjusted  1.34 (0.68-2.63)
5 
 0.98 (0.53-1.80)
5 
 1.20 (0.68-2.12)
5 
 1.23 (0.73-2.08)
5 
 1.23 (0.69-2.18)
3 
 
 continuous continuous continuous continuous 
 
Crude 1.09 (0.79-1.52) 0.98 (0.94-1.02) 1.00 (0.96-1.04) 1.00 (1.00-1.01) 
 
Adjusted 0.93 (0.63-1.31)
5
 0.98 (0.94-1.03)
5 
0.97 (0.94-1.03)
5 
1.00 (0.99-1.01)
3 
  <6 h ≥7 h <85 vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
 Crude 1.16 (0.62-2.18) 1.17 (0.66-2.09) 1.14 (0.89-1.47) 1.29 (1.01-1.65) 1.15 (0.71-1.87) 
Waist-to-height ratio Adjusted  1.58 (0.88-2.83)
5 
 0.76 (0.45-1.30)
5 
 1.16 (0.86-1.55)
5 
 1.37 (1.03-1.84)
6 
 1.30 (0.96-1.75)
5 
 
 continuous continuous continuous continuous 
 
Crude 0.83 (0.62-1.12) 0.98 (0.06-1.00) 1.03 (1.01-1.04) 1.00 (1.00-1.01) 
 
Adjusted 0.76 (0.56-1.04)
5 
0.97 (0.95-0.99)
5 
1.02 (1.00-1.04)
6 
1.00 (1.00-1.01)
5 
  <6 h ≥7 h <85 vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
 Crude 1.36 (0.95-1.96) 0.90 (0.64-1.25) 0.98 (0.96-1.01) 1.13 (0.85-1.50) 1.32 (0.96-1.82) 
Systolic BP (mmHg) Adjusted  1.26 (0.87-1.81)
3 
 0.95 (0.68-1.33)
3 
 1.15 (0.85-1.55)
3 
 1.05 (0.79-1.40)
3 
 1.31 (0.95-1.79)
5 
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 continuous continuous continuous continuous 
 
Crude 0.80 (0.66-0.97) 0.98 (0.95-1.00) 1.02 (0.99-1.04) 1.00 (1.00-1.01) 
 
Adjusted 0.86 (0.71-1.04)
3 
0.98 (0.96-1.01)
3 
1.01 (0.98-1.03)
3 
1.00 (1.00-1.01)
5 
  <6 h ≥7 h <85 vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
Diastolic BP (mmHg) Crude 1.26 (0.85-1.86) 1.18 (0.83-1.70) 1.12 (0.81-1.54) 1.16 (0.86-1.58) 1.24 (0.89-1.73) 
 Adjusted  1.18 (0.80-1.75)
3 
 1.28 (0.89-1.84)
3 
 1.04 (0.75-1.43)
3 
 1.08 (0.79-1.46)
3 
 1.23 (0.88-1.73)
5 
  continuous continuous continuous continuous 
 Crude 0.86 (0.70-1.05) 0.97 (0.95-1.00) 1.02 (0.99-1.04) 1.00 (1.00-1.01) 
 Adjusted 0.92 (0.75-1.12)
3 
0.98 (0.96-1.01)
3 
1.01 (0.98-1.03)
3 
1.00 (1.00-1.01)
5 
Abbreviations: WASO - Wake After Sleep Onset, BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval. 
Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), percent body fat (males ≥25 vs. <25 %, females ≥30 
vs. <30 %), waist-to-hip ratio (males ≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), systolic BP (≥120 vs. 
<120 mmHg), diastolic BP (≥80 vs. <80 mmHg). 
1 
Adjusted for time, sex, income and physical activity. 
2 
Adjusted for time, sex, employment status and physical activity. 
3
Adjusted for time, 
sex, physical activity. 
4 
Adjusted for time, sex, physical activity and sleep latency.
5 
Adjusted for time, age, sex and physical activity. 
6 
Adjusted for time, age, sex, race and physical activity. 
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Table 5.5 Relationships between Sleep Measures and Anthropometrics stratified by Latent Chronotype Group 
 
Anthropometric 
characteristic 
Chronotype 
group 
Total Sleep Time (ref. 6-<7 h) Sleep Efficiency Sleep Latency WASO 
<6 h ≥7 h <85% vs. ≥85% ≥12 vs. <12 min ≥60 vs. <60 min 
  OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) OR (95%CI) 
Body Mass Index  Early 0.98 (0.34-2.82)
1 
1.01 (0.42-2.44)
2 
1.12 (0.52-2.43)
2 
1.17 (0.55-2.51)
3 
0.88 (0.37-2.10)
1 
(kg/m
2
) Intermediate 1.63 (0.79-3.37)
1 
0.81 (0.45-1.47)
1 
0.99 (0.57-1.71)
2
 1.04 (0.62-1.75)
3 
1.26 (0.69-2.29)
1 
 Late 1.31 (0.33-5.27)
1 
1.77 (0.28-11.18)
1 
0.60 (0.17-2.11)
2 
1.26 (0.43-3.74)
3 
1.38 (0.39-4.86)
1 
pinteraction  0.99 0.69 0.97 0.32 
Percent body fat
 
Early 0.88 (0.30-2.57)
2 
0.69 (0.27-1.73)
2 
1.22 (0.53-2.84)
4 
1.73 (0.81-3.72)
2 
3.43 (1.35-8.72)
2 
 Intermediate 0.83 (0.37-1.86)
2 
0.79 (0.40-1.56)
2 
0.80 (0.43-1.50)
4 
1.33 (0.73-2.41)
2 
0.71 (0.37-1.38)
2 
 Late 1.23 (0.28-5.48)
2 
0.59 (0.09-3.79)
2 
0.68 (0.14-3.30)
4 
1.18 (0.29-4.82)
2 
1.38 (0.30-6.26)
2 
pinteraction  0.92 0.64 0.84 0.03 
Waist-to-hip 
 
Early 3.91 (1.19-12.84)
5 
1.39 (0.42-4.54)
5 
3.38 (1.07-10.69)
5 
2.13 (0.83-5.47)
2 
3.72 (1.38-10.07)
2 
ratio Intermediate 0.66 (0.25-1.78)
5 
0.82 (0.37-1.80)
5 
0.95 (0.46-1.95)
5 
1.06 (0.54-2.10)
2 
0.67 (0.30-1.51)
2 
 Late 2.01 (0.19-21.28)
5 
1.36 (0.16-11.59)
5 
0.20 (0.03-1.30)
5 
0.19 (0.03-1.20)
2 
0.42 (0.06-2.90)
2 
pinteraction  0.15 0.03 0.27 0.01 
Waist-to-height 
 
Early 1.59 (0.47-5.39)
5 
0.60 (0.21-1.72)
5 
1.89 (1.10-3.25)
5 
1.63 (0.94-2.84)
6 
2.21 (1.27-3.84)
5 
ratio Intermediate 1.76 (0.79-3.84)
5 
0.85 (0.42-1.70)
5 
0.87 (0.58-1.30)
5 
1.44 (0.96-2.18)
6 
0.81 (0.53-1.24)
5 
 Late 1.05 (0.22-5.09)
5 
1.65 (0.26-10.31)
5 
0.95 (0.39-2.32)
5 
0.87 (0.37-2.09)
6 
1.28 (0.55-2.94)
5 
pinteraction  0.74 0.05 0.13 0.007 
Systolic BP, 
 
Early 0.70 (0.36-1.38)
5 
0.65 (0.37-1.16)
5 
1.05 (0.63-1.75)
2 
1.90 (1.15-3.16)
2 
1.19 (0.67-2.09)
5 
mmHg Intermediate 1.45 (0.85-2.46)
5 
1.09 (0.68-1.75)
5 
1.24 (0.81-1.89)
2 
0.90 (0.59-1.35)
2 
1.38 (0.87-2.18)
5 
 Late 2.63 (1.08-6.40)
5 
2.31 (0.74-7.27)
5 
0.96 (0.41-2.22)
2 
0.63 (0.29-1.35)
2 
1.21 (0.55-2.66)
5 
pinteraction  0.74 0.95 0.02 0.93 
Diastolic BP, 
mmHg
 
Early 0.83 (0.38-1.81)
2 
1.51 (0.79-2.90)
2 
0.67 (0.38-1.20)
2 
0.83 (0.47-1.45)
2 
0.94 (0.50-1.78)
5 
 Intermediate 1.44 (0.81-2.54)
2 
1.46 (0.88-2.40)
2 
1.41 (0.90-2.22)
2 
1.40 (0.90-2.16)
2 
1.68 (1.05-2.71)
5 
 Late 1.15 (0.49-2.72)
2 
0.63 (0.20-2.01)
2 
0.72 (0.30-1.74)
2 
0.79 (0.36-1.73)
2 
0.73 (0.32-1.64)
5 
pinteraction  0.50 0.13 0.33 0.10 
Abbreviations: WASO - Wake After Sleep Onset, BP - blood pressure, OR - odds ratio, 95%CI - 95% confidence interval. 
pinteraction: p-value for the interaction term between a sleep variable and chronotype group in adjusted statistical model.  
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Cutoff points for anthropometric characteristics: Body Mass Index (≥25 vs. <25 kg/m2), percent body fat (males ≥25 vs. <25%, females 
≥30 vs. <30%), waist-to-hip ratio (males ≥0.95 vs. <0.95, females ≥0.8 vs. <0.8), waist-to-height ratio (≥0.5 vs. <0.5), systolic BP (≥120 
vs. <120 mmHg), diastolic BP (≥ 80 vs.<80 mmHg). 
1 
Adjusted for time, sex, income and physical activity. 
2
Adjusted for time, sex, physical activity (MET-hours, continuous). 
3 
Adjusted for 
time, sex, employment status and physical activity (MET-hours, continuous). 
4
Adjusted for time, sex, physical activity (MET-hours, 
continuous) and sleep latency. 
5
Adjusted for time, age, sex and physical activity (MET-hours, continuous).
6 
Adjusted for time, age, sex, 
race and physical activity (MET-hours, continuous). 
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CHAPTER 6 
Diet-Related Inflammatory Index and Prostate Cancer Risk in the  
California Men's Health Study
1
 
 
 
                                                          
1
 McMahon, D.M., Burch, J., Hebert, J.R., et al. To be submitted to Urology. 
 99 
 
ABSTRACT 
Background: Recent studies suggest that the inflammatory potential of individuals' diets 
may be associated with increased risk of Prostate Cancer (PrCA) whose incidence and 
mortality vary by race and socioeconomic status.  
Methods: The association between energy-density Dietary Inflammatory Index (e-DII) 
and incident PrCA was examined among participants in the California Men's Health 
Study (CMHS) (N=40,161). The men were 45-69 years old at recruitment (2002-2003) 
and followed for a mean of 9.7 years (SD=3.83). 
The e-DII was calculated based on a food frequency questionnaire (FFQ) at 
baseline and categorized into quartiles with lower e-DII scores representing a more anti-
inflammatory diet. Incident PrCA cases were ascertained via linkage with the Kaiser 
Permanente Northern California Cancer Registry (KPNCCR)  and were categorized into 
three groups: high-risk intermediate-high and low-risk. Accelerated failure time models 
with log-logistic distribution were fit to model time-to-development of incident PrCA. 
Cox proportional hazards models were used to calculate hazard ratios (HR) and 95% 
confidence intervals (95% CI) of high- and intermediate- risk PrCA. In all analyses, the 
lowest quartile of e-DII was used as the referent group. 
Results: Time-to-development of incident total PrCA did not differ by quartile of e-DII, 
although there was a suggestion of a shorter time to diagnosis for those in the highest 
quartile (Acceleration Factor (AF)Q4 vs.Q1=1.07; 95%CI:0.95-1.20). In race-stratified 
analyses, the time to diagnosis was significantly shortened only among Whites (AFQ4 
vs.Q1=1.16; 95%CI:1.01-1.34). The HR for high-risk PrCA was increased by 36% in the 
third quartile of the e-DII (HRQ3 vs.Q1=1.36; 95%CI:1.04-1.76); however, there was no 
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increased risk in the fourth quartile (HRQ4 vs.Q1=0.99; 95%CI:0.74-1.32, ptrend=0.74). The 
HR for high-risk PrCA was the highest among Blacks (HRQ3 vs.Q1=3.77; 95%CI:1.29-
11.06) and Other (HRcontinuous=1.23; 95%CI:1.03-1.48). The e-DII was not associated 
with intermediate- and low-risk PrCA incidence.  
Conclusions: Pro-inflammatory diet may contribute to increased risk of high-risk PrCA, 
especially, among Blacks. 
 
Introduction 
 In the United States, prostate cancer (PrCA) is the most frequently diagnosed and 
the second most common cause of cancer death among men (72, 73). During the last 15 
years, PrCA mortality rates in the US decreased from 38.6 to 24.6 per 100,000, most 
likely due to widespread population-based screening and improved treatment. Despite 
this, the absolute number of incident PrCA is expected to increase substantially as baby-
boomers age (260). In the United States, PrCA incidence and mortality rates vary by race 
and are the highest among African Americans who tend to be diagnosed at a younger age 
and with more aggressive disease than their European-American counterparts (72, 73). 
According to age-adjusted estimates for 2013, PrCA incidence in African Americans is 
70% and mortality is 2.4 times higher than in European Americans (72, 73). PrCA 
incidence and mortality in Hispanics/Latino and Asian-Americans are lower than in 
African- and European Americans (73). 
 Few modifiable PrCA risk factors have been established. Thus, further 
characterization of PrCA risk factors is important for bolstering prevention efforts. 
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 Currently, only increasing age, African ancestry, and a family history of the PrCA 
are considered well-established PrCA risk factors (73). Evidence suggests that persistent 
inflammation within the prostate due to infections, physical trauma, urine reflux, 
hormonal changes, diabetes, dietary exposures or other environmental factors may play a 
role in development of PrCA (136, 138, 261). Increased levels of the inflammatory 
markers, C-reactive protein (CRP) in circulation and transcripts of interleukin (IL)-6 gene 
in prostate tissue, have been observed among men with PrCA compared to those with 
benign prostatic hyperplasia (262, 263). A biological pathway of innate immunity and 
inflammation has been associated with risk of advanced PrCA (264). There is evidence 
that diet may influence PrCA risk via modulation of inflammation. For instance, 
heterocyclic amines, strong dietary mutagens produced in high quantities when cooking 
meat, have been associated with prostatic inflammation in animal models, and with 
increased PrCA risk in epidemiologic studies (261, 265, 266). In contrast, 
phytochemicals contained in cruciferous vegetables (e.g., kale, cauliflower and Brussels 
sprouts) exert anti-oxidant, pro-apoptotic, anti-proliferative and anti-metastatic effects in 
PrCA cells in vitro, and in animal models (158). It has been reported that some 
racial/ethnic minorities are more likely to have diets with low fruit and vegetable 
consumption and sedentary lifestyles as compared to non-Hispanic Whites (149-151). 
Such lifestyle patterns have been associated with high levels of systemic inflammation, as 
expressed by increased levels of CRP (149-151).  
Few epidemiologic studies have investigated interrelationships between diet, 
inflammation and PrCA (82, 181, 267). Investigators at the University of South 
Carolina’s Cancer Prevention and Control Program, created the Dietary Inflammatory 
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Index (DII)
TM
, which calculates the overall inflammatory potential of an individual’s diet 
(81). The major advantage of the DII over other dietary indices is that it measures the 
inflammatory potential of the individual’s diet based on reported intakes. DII calculation 
is based on previous research that entailed reading and scoring nearly 2,000 articles 
focusing specifically on inflammation (160). Additionally, individuals’ DII scores are 
standardized against a range of actual food intakes observed in 11 different populations 
around the world, which facilitates comparability between populations (160). In previous 
studies, the DII predicted increased levels of several inflammatory biomarkers including: 
CRP (83, 177), IL-6 (169, 170, 179), tumor necrosis factor alpha (170) and homocysteine 
(169). A higher, pro-inflammatory DII has been associated with increased risk of 
colorectal (174, 180, 268-270), pancreatic (176), and esophageal (165, 271) cancer, 
asthma (179), and cardiovascular disease (272). 
To date, three investigations examined the relationship between the DII and PrCA 
risk; two case-control (82, 181) and one prospective study (267). Men in the highest 
(most pro-inflammatory) quartile of the DII had significantly higher risk of PrCA than 
those in the first quartile. 
   The current study characterized the relationship between dietary inflammation 
potential and PrCA risk in a prospective cohort study of California men of varying racial 
and ethnic composition. The hypotheses of this study was that men with higher (i.e., pro-
inflammatory) DII scores had elevated PrCA risk and a higher risk of more aggressive 
PrCA relative to those with anti-inflammatory diets. It was further hypothesized that 
these associations would be stronger among African Americans compared with other 
races. 
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Methods 
Study population 
The California Men’s Health Study (CMHS) is a large multiethnic cohort of U.S. 
male members of Kaiser Permanente (KP), a health insurance provider that covers a large 
number of residents of Northern and Southern California. In 2002-2003 the CMHS 
recruited 84,170 men 45-69 years of age; 40% of whom were from minority populations, 
including Chinese, Hispanic and African Americans. Information about the CMHS 
recruitment and data collection procedures are described in detail elsewhere (206). 
Briefly, comprehensive information on participants' demographics, health status, family 
history of PrCA, medication and supplementation use, and potential PrCA risk factors 
such as diet, physical activity and sleep were collected upon enrollment via two mailed 
questionnaires (206). All participants provided informed consent and this study was 
approved by the Institutional Review boards of Kaiser Permanente Northern California 
and the University of Southern Carolina. 
 The study population was comprised of CMHS participants (Northern California 
region only) who had active KP membership for at least one year prior to the enrollment 
into the CMHS. Individuals were excluded if they: had any cancer except non-melanoma 
skin cancer (n=1,363) at enrollment, were missing information on race/ethnicity (n=346), 
or had implausible total daily energy intake (<500 kcal or >6000 kcal, n=958). 
Participants who developed PrCA during follow-up but were missing information on 
PrCA stage (SEER) also were excluded (n=65).  
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PrCA ascertainment 
The ascertainment of incident PrCA cases was performed via linkage of CMHS 
members to the Kaiser Permanente Northern California Cancer Registry. California state 
law requires reporting of all incident cancer cases, and the KPNCCR ascertains and 
reports all cases according to the standards established by the National Cancer Institute’s 
Surveillance, Epidemiology, and End Result Program (SEER). 
 In this study, PrCA was categorized into three groups using the updated (2010) 
version of the standard PrCA staging system endorsed by the American Joint Committee 
on Cancer (AJCC)/International Union Against Cancer (UICC) (212). The high-risk 
PrCA group included men with clinically localized high-risk PrCA and advanced, very 
high-risk PrCA (≥T3a or PSA>20 ng/ml, or a Gleason score of 8-10, or those who died 
from PrCA). The clinically localized, intermediate-risk group consisted of men with T2b-
T2c, or T1-T2a and PSA10-20, or T1-T2a and a Gleason score of 7. All other men with 
PrCA were in the clinically localized, low-risk PrCA group. 
 
Dietary assessment 
Information about usual diet during the previous year was obtained at baseline 
from a self-administered semi-quantitative food frequency questionnaire (FFQ) using a 
version of the Women's Health Initiative FFQ that was modified for use in men and 
validated in several studies (207-209). The nutrient contents of an individual's diet were 
calculated using the Nutrition Data Systems for Research software (NDSR) (Nutrition 
Coordinating Center, University of Minnesota, Minneapolis, MN, USA). The FFQ 
 105 
 
provided information on 27 individual food parameters needed to compute DII scores 
(carbohydrate, protein, total fat, alcohol, fiber, cholesterol, saturated fat, MUFA, PUFA, 
omega-3, omega-6, trans-fat, Niacin, Thiamin, Riboflavin, B12, B6, Iron, Magnesium, 
Zinc, Selenium, vitamin-A, vitamin-C, vitamin-D, vitamin-E, folic acid, and beta 
carotene). An individual DII score was computed for each study participant who 
completed the FFQ, as described previously (80, 81). 
Briefly, for each food parameter in the DII calculation, its "global" mean and 
standard deviation were obtained using a "world" database compiled from 11 countries 
around the world (USA, Mexico, England, Denmark, India, Australia, New Zealand, 
Bahrain, Scotland, South Korea and Japan) (82). For each participant, this global mean 
was then subtracted from the amount of consumed nutrient and divided by the global 
standard deviation, yielding a food-specific z-score. The z-scores were then converted 
into percentile scores in order to minimize the effect of the right skew characteristic of 
dietary data.  In order to center the values around zero, these values were doubled and 1 
was subtracted from each value. These centered percentile scores were multiplied by an 
inflammatory effect score previously derived for each food parameter based on an 
extensive literature review and evidence ranking of 1,943 relevant peer-reviewed 
publications (80, 81). The percentile-scores for all food parameters were summed to 
produce a DII score for each study participant which was further adjusted for energy (e-
DII). Intakes for the 27 food parameters were divided by total estimated energy intake 
and multiplied by 1,000. The same technique was applied to the world standard 
database. More negative e-DII scores are associated with anti-inflammatory potential, 
whereas more positive scores are indicative of more pro-inflammatory potential (160).  
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Confounder assessment 
Information on all potential confounders was collected at baseline via 
questionnaire and medical record review. Physical activity was assessed using questions 
adopted from the Coronary Artery Risk Development in Young Adults (CARDIA) 
Physical Activity History (210). Analysis of frequency, duration and intensity of 
recreational, household and occupational activities yielded a total physical activity 
estimate in MET-hours per week (206). The following variables were tested as potential 
confounders for inclusion in statistical models: race (White, Black, Asian, Hispanic, 
Other), age at baseline (5-year intervals for the overall PrCA risk estimates and 45-55, 
56-65, 65-70 years for subgroup analyses), body mass index (BMI) calculated from self-
reported weight in kilograms divided by square height in meters (< 25, 25-29.9, ≥30 
kg/m
2
), education (high school equivalent or less; vocational or technical school;  some 
college, associate or bachelor degree; graduate/professional school), smoking status 
(current or former smokers vs. non-smoker), income (<$40,000, $40,000-$59,000, $60-
$80,000, $80-100,000, >$100,000), regular use of non-steroidal anti inflammatory 
medicines (NSAID) (Yes/No), regular multivitamin use (Yes/No), sleep duration (≤6, 7, 
≥8 hrs), total physical activity (0-359, 360-1102, 1103-2201, > 2202 MET-min/week), 
history of diabetes of any type (Yes/No; recorded diagnosis in the Northern California 
KP Diabetes Registry), family history of PrCA in a first-degree relative (Yes/No), and 
benign prostatic hyperplasia (BPH). 
Statistical analysis 
The follow-up time was censored at: diagnosis of incident PrCA, death, gap in KP 
membership exceeding 90 days, or the end of the study (December 31, 2014), whichever 
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came first. The e-DII was categorized into quartiles based on the distribution in all 
participants in the analytic sample (Q1: -6.19 to -3.36; -3.37 to -2.03; -2.04 to -0.55; -0.56 
to 4.89). To address potential confounding, variables with >10% missing values were 
recoded using indicator variables which had missing values as a separate category. A 
manual backwards selection procedure was used to identify covariates for inclusion in 
multivariable models. Variables were retained in the final statistical models if their 
exclusion resulted in a change in the effect estimate for e-DII by ≥10%. Statistically 
significant covariates (α<0.05) also were retained in the final statistical models. The 
proportional hazards assumption was tested using graphical (Kaplan-Meyer survival 
plots) and regression approaches (cumulative Martingale residuals). Effect modification 
was tested using two approaches: Likelihood Ratio Test (LRT) for significance of the 
interaction term added to the final model, and stratification of the analysis based on 
differing levels of the effect modifier.  
 In the analysis of the relationships between e-DII and the risk of total PrCA 
(PrCA of any stage), the proportional hazards assumption for the e-DII (quartiles) was 
not met; thus, the parametric accelerated failure time model was used with a log-logistic 
distribution (273). Since the proportional odds assumption was not met, only the 
acceleration factor, with 95% confidence interval (CI) was presented. 
 Cox proportional hazards models were used to assess the relationships between 
the e-DII and either high- or intermediate-risk PrCA. The proportional hazards 
assumption was violated for sleep and age; therefore, these variables were placed in the 
STRATA statement in the PHREG procedure in SAS
®
. For linear trend tests, the median 
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of each e-DII quartile was included in statistical models as a continuous variable with 
adjustment for the same confounders that were included in the previous analyses.  
 Sensitivity analyses were conducted to explore the possible effects of missing 
data on the results. Men diagnosed with PrCA during the first 3 years of follow-up were 
excluded in order to assess the possibility of reverse causality. In separate analyses, all 
participants with missing sleep duration were excluded, and analyses were then repeated 
after removal of the sleep duration variable from the statistical models. 
 All statistical analyses were performed using SAS
®
 9.4 (Cary, North Carolina) 
with significance levels set at α=0.05. 
 
Results  
The analytical sample consisted from 40,161 men with mean follow-up of 9.7 
years (SD=3.83). From 2002-2003 until December 31, 2014, a total of 2,707 CMHS 
participants were diagnosed with incident PrCA.   
 Participants' characteristics at baseline by quartile of e-DII are presented in Table 
6.1. Men in lower quartiles of e-DII were older than those in the upper quartiles. The 
proportion of Whites slightly decreased across quartiles of e-DII, while proportion of 
Blacks and Hispanics increased. Compared to the first (anti-inflammatory) quartile of e-
DII, men in the fourth (pro-inflammatory) quartile were more obese, and had lower 
educational attainment and income. The proportion of single men increased with quartile 
of e-DII, as physical activity and sleep duration decreased. The proportion of smokers 
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and regular nonsteroidal anti-inflammatory drug (NSAID) users increased with quartiles 
of e-DII, while the proportion of regular multivitamin users decreased.  
 There was no statistically significant difference in time to development of 
incident total PrCA between quartiles of e-DII after adjustment for the effects of age, 
race, BPH, family history of PrCA, diabetes, and smoking status (Table 2). Men in the 
highest quartile of e-DII developed incident PrCA 7% faster than those in the lowest 
quartile (acceleration factor (AF)=1.07; 95%CI: 0.95-1.20). Exclusion of men who were 
diagnosed during the first 3 years of follow-up did not alter the relationship between 
quartiles of e-DII and incident PrCA (Table 2). In separate sensitivity analyses, exclusion 
of those with missing sleep duration, or adjustment for this variable, did not change the 
results (Table 6.2). Race modified the relationship between the e-DII and overall PrCA 
risk (LRT p=0.0001). In the race-stratified analyses, White men in the fourth quartile of 
e-DII had a shorter time (16%) to PrCA diagnosis (AF=1.16;95%CI:1.01-1.34). Among 
Black men in the third quartile of e-DII, the time to development of PrCA was longer 
(35%) (AR=0.65; 95%CI:0.44-0.96). 
 Compared to the first quartile of e-DII, HRs for high-risk PrCA increased by 27% 
and 36%, respectively, in the second and third quartiles (hazard ratio (HR)Q2vs.Q1=1.27; 
95%CI:0.98-1.66, and HRQ3 vs. Q1 =1.36; 95%CI: 1.04-1.76), although there was no 
association between the highest and the lowest e-DII quartiles (HR=0.99;95%CI:0.74-
1.32) (Table 6.3). Relationships between e-DII and high-risk PrCA were modified by 
race (LRT p=0.0002). In race-stratified analyses, high-risk PrCA among Blacks increased 
across e-DII quartiles and was elevated by nearly four-fold among those in the third e-DII 
quartile (HRQ3 vs. Q1=3.77; 95%CI:1.29-11.06). Among participants in the multi-
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ethnic/other category, there was a 23% increase in high-risk PrCA per unit e-DII 
(HR=1.23;95%:1.03-1.48, Table 6.3). No relationship was observed between e-DII and 
the risk of intermediate-risk PrCA (Table 6.3) or low-risk PrCA (data not shown). 
  
Discussion   
In this study, the e-DII was not significantly associated with time-to-development 
of PrCA when all cases were considered simultaneously. Estimates of the acceleration 
factor suggested that it took slightly less time (7%) for men in the most pro-inflammatory 
quartile of e-DII to develop incident PrCA compared to those in the lowest e-DII quartile, 
but the effect was not statistically significant. Assessment of potential reverse causality 
via exclusion of men who developed PrCA during the first 3 years of follow-up did not 
change the results. However, a statistically significant 16% decrease in time to total PrCA 
development was found among White men with the most pro-inflammatory diets.  When 
only high-risk PrCA was examined, there was an increased risk with increasing e-DII, 
although it was the highest in the third rather than the fourth quartile. Thus, interpretation 
of the results is complicated by an apparent lack of monotonic dose-response across 
quartiles of e-DII, and by a lack of association when using e-DII as a continuous variable. 
Furthermore, the inflammatory potential of the diet was not associated with intermediate-
risk PrCA. 
 To date, three studies have examined the relationship between DII scores and 
PrCA. Two case-control studies explored these relationships among Italian and Jamaican 
men (82, 181). In the Jamaican study, 229 incident PrCA cases and 250 PrCA-free 
controls were recruited from the same urology clinics, two large hospitals and private 
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practices between 2006 and 2007 (181). Jamaican men in the highest quartile of the DII 
had 2.4 times increased risk of total PrCA relative to men in the "healthiest" first quartile. 
Consistent with that result, a prospective study in France found that men in the highest 
quartile of the DII had PrCA risks 2.1 times higher than those with anti-inflammatory 
diets (267). Of note, the test for PrCA trend across quartiles of DII was not statistically 
significant. In a large case-control study conducted in Southern Italy, PrCA risk among 
men in the fourth DII quartile was 33% higher than in those in the first quartile (82). In 
the current study, no statistically significant differences in time to development of total 
PrCA were detected between the lowest and the highest quartiles of e-DII. However, in a 
race-stratified analyses, White men in the highest quartile of e-DII had a shorter time (by 
16%) to development of PrCA, which is closer to the risk estimates reported for the 
above-mentioned case-control study among Italian men (82). 
 The lack of statistically significant association between e-DII and total PrCA prior 
to stratification by race may be attributed to several factors. It is plausible that the 
relationship between dietary inflammation potential and PrCA risk may vary by disease 
aggressiveness and race. In the Jamaican study, more than 50% of PrCA cases were high-
grade (Gleason score ≥7), and all participants were of African descent (181, 274). In this 
study, the high-risk PrCA cases represented only 18% of the total number of cases and 
Black men represented only 6% of the study population.  In race-stratified analyses, the 
relationship between e-DII and high-risk PrCA was the strongest and statistically 
significant only among Blacks and those in the Multiethnic/Other group (this latter group 
included men of races/ethnicities other than Black or White, and could have included 
those of mixed race with some African admixture). The risk estimates for e-DII and high-
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risk PrCA among Blacks were similar in magnitude to overall PrCA risk in the Jamaican 
study (181). Also, DII scores in this study were generally lower than what we see in most 
studies examining the role of DII in health. 
 It is not clear why increased incidence of high-risk PrCA was observed in the 
third, but not in the highest (i.e., most pro-inflammatory), quartile of the e-DII. In 
ancillary analyses, change of cut-off points (e.g. tertiles or quintiles) did not meaningfully 
alter the results. In secondary analyses with DII and total energy intake as a separate 
variable, the risk of high-risk PrCA did not differ between second, third and forth 
quartiles of DII (HR=1.11;95%CI:0.76-1.63). After exclusion of cases diagnosed during 
first 3 years of follow up, the risk of high-risk PrCA was the highest in fourth quartile but 
was not statistically significant (HR=1.25;95%CI:0.81-1.91). 
 In the study among Italian men, the risk of total PrCA in the fourth quartile of e-
DII was practically the same as in the third quartile (ORQuartile4v.1 =1.33, 95% CI: 1.01-
1.76 vs. ORQuartile3v.1=1.32, 95% CI:1.03-1.69, respectively) and there was no statistically 
significant trend in the other two studies (181, 267). These observations may suggest the 
possibility of a non-linear relationship between diet and PrCA, and a possible threshold 
effect. The study among French men investigated dose-response relationships between 
the DII and prostate cancer using restricted cubic splines (267). Men with DII ≥ -1.0 had 
2.3-fold increased PrCA risk relative to those with DII < -1.0 (HR: 2.31; 95%CI: 1.35-
3.95; P =0.002) (267). Previously, increased PrCA risk among men in the Jamaican, 
Italian and French studies were observed for DII quartiles that were ≥ -1.0 (82, 181, 267). 
In this study, the incidence of high-risk PrCA was significantly increased only in the third 
quartile that included e-DII values of ≥ -1.0 (Q3: -2.0313 to ≤ -0.5517). The absence of 
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increased PrCA risk among those in the highest e-DII quartile also may be related to 
confounding by unknown factor, measurement error, or may suggest an overall lack of 
association. 
 Differences in dietary intakes and food parameters available for the DII 
calculations and use of the e-DII instead of the DII to calculate risk, have contributed to 
the differences in the risk estimates between this study and others published to date. For 
instance, the first and second quartiles of e-DII in this study were considerably more 
negative than those in the previous PrCA studies (82, 181, 267). The range of actual DII 
in this study was clearly larger (-6.28 to 4.69) than in other PrCA studies: Jamaican study 
(-3.14 to 2.77) and the French study (-5.0 to 5.3) (82, 181, 267). Compared to other large 
cohorts, such as National Institutes of Health–American Associations of Retired Persons 
Diet and Health Study individuals (NIH-AARP), that explored the relationships between 
the DII and a risk of colorectal cancer, quartiles in this study were more negative, 
indicating an overall healthier diet in this study population (174).  
 The strengths of this study include a robust sample size among a diverse cohort 
with prospectively collected data, extended follow-up (up to 12 years), rigorous case 
ascertainment, and ample information on potential confounders. Because the diet was 
assessed prior to the development of the outcome, differential recall was not an issue. The 
sensitivity analyses indicated that, after the exclusion of cases diagnosed during the first 3 
years of follow-up, the results did not change; thus, it is unlikely that reverse causation 
played a significant role. About forty percent of the study population was represented by 
different racial and ethnic groups (Asian, Black, Hispanic and Filipinos). The FFQ was 
modified for use among men and to include foods commonly eaten by previously 
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mentioned ethnic groups; it was also translated into Spanish and Chinese. Thus, any 
significant misclassification of the exposure is unlikely.  
 One limitation of this study is that the information about diet was assessed only at 
baseline with a single FFQ.  Thus, it is possible that temporal changes in inflammatory 
effect of diet on tumor development could not be captured. Previous research indicates 
that dietary patterns in adulthood are fairly stable over time (275-278). Moreover, 
previous large prospective studies that used diet assessment only at baseline found that 
higher DII scores were associated with statistically significant increased risks for chronic 
disease, including cancer, and increased mortality (171, 174, 175, 270). 
 Another study limitation was that the sample sizes and statistical power may have 
been limited for assessment of the relationship between the e-DII and PrCA risk among 
sub-strata of race or PrCA aggressiveness.  
 In summary, the results of this study suggest that a pro-inflammatory diet was 
associated with 16% increase in total PrCA risk among middle-age White men. The 
inflammatory potential of diet was associated with increases in high-risk PrCA incidence. 
However, the patterns of risk observed across quartiles complicate the interpretation, 
suggesting either a complex dose-response pattern (non-linear relationship with possible 
threshold effect), or a lack of association. The relationship between the inflammatory 
potential of a diet and PrCA may vary by race; Blacks and those of non-White (or mixed) 
races may be more susceptible. The relationship between dietary inflammatory potential 
and risk of advanced /aggressive disease merits further investigation, particularly among 
those of racial or ethnic minorities.
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Table 6.1 Participants' characteristics (n, %) by quartiles of Energy-Density Dietary 
Inflammatory Index at baseline, California Men's Health Study 2002-2014 
 
Characteristic Q1: -6.1940 to 
≤-3.3597 
(the 
healthiest) 
n= 10042 
Q2: -3.3597 to 
≤-2.0313 
n= 10040 
Q3: -2.0313 to 
≤-0.5517 
n= 10040 
Q4: -0.5517 to 
4.8927 
(the least 
healthy) 
n=10039 
Age at baseline     
   44-50 1649 (16.4) 1884 (18.8) 2122 (21.1) 2447 (24.4) 
   51-55 2006 (20.0) 2173 (21.6) 2236 (22.3) 2363 (24.5) 
   56-60 2223 (22.1) 2132 (21.2) 2126 (21.2) 2136 (21.3) 
   61- 65 2312 (23.1) 2050 (20.4) 1936 (19.3) 1731 (17.2) 
   66-70 1852 (18.4) 1801 (18.0) 1620 (16.1) 1362 (13.6) 
Race     
   White 6989 (69.6) 6555 (65.3) 6380 (63.6) 6212 (61.9) 
   Black 429 (4.3) 483 (4.8) 606 (6.0) 801 (8.0) 
   Asian 973 (9.7) 1128 (11.2) 923 (9.2) 852 (8.5) 
   Hispanic  793 (7.9) 973 (9.7) 1148 (11.4) 1121 (11.2) 
   Multiethnic/Other 858 (8.5) 901 (9.0) 983 (9.8) 1053 (10.5) 
Body mass index , kg/m
2
     
   Normal, < 25 3388 (33.7) 2876 (28.7) 2488 (24.8) 2191 (21.8) 
   Overweight, 25 to <30 4572 (45.5) 4694 (46.7) 4750 (47.3) 4442 (44.3) 
   Obese,  ≥30 1946 (19.4) 2329 (23.2) 2660 (26.5) 3210 (32.0) 
Education     
     High school, 
equivalent or less 
1510 (15.0) 1934 (12.3) 2349 (23.4) 2822 (28.1) 
     Vocational/tech 
school 
2451 (24.4) 2766 (27.6) 2977 (29.7) 3393 (33.8) 
     Some college, 
associate or bachelor 
degree 
2267 (22.6) 2304 (22.9) 2304 (22.9) 2019 (20.1) 
     Graduate/professional 
school 
3776 (37.6) 2996 (29.8) 2377 (23.7) 1753 (14.5) 
   Missing 38 (0.4) 40 (0.4) 33 (0.3) 52 (0.5) 
Income, $     
   <40,000 1421 (14.1) 1630 (16.2) 1850 (18.4) 2112 (21.0) 
   40-59,000 1565 (15.6) 1772 (17.7) 1864 (18.6) 2020 (20.1) 
   60-80,000 1649 (16.4) 1784 (17.8) 1861 (18.5) 1865 (18.6) 
   80-100,000 1382 (13.8) 1433 (14.3) 1352 (13.5) 1370 (13.7) 
   >100,000 3616 (36.0) 3026 (30.1) 2745 (27.3) 2296 (22.9) 
   Missing 409 (4.1) 395 (3.9) 368 (3.7) 376 (3.7) 
Marital status     
   Married/living with a 
partner 
8463 (84.3) 8322 (82.9) 8234 (82.0) 7871 (78.4) 
   Single 1539 (15.3) 1699 (16.9) 1776 (17.7) 2129 (21.2) 
   Missing 40 (0.4) 19 (0.2) 30 (0.3) 39 (0.4) 
Total physical activity, 
MET-min/week 
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   0-359 1401 (13.9) 2125 (21.2) 2744 (27.3) 3749 (37.3) 
   360-1102 2229 (22.2) 2504 (24.9) 2649 (26.4) 2635 (26.2) 
   1103-2201 2743 (27.3) 2638 (26.3) 2488 (24.8) 2144 (21.4) 
   >2202 3653 (36.4) 2753 (27.4) 2137 (21.3) 1484 (14.8) 
   Missing 16 (0.2) 20 (0.2) 22 (0.2) 27 (0.3) 
Sleep duration, hr/day     
   ≤6 2115 (21.1) 2209 (22.0) 2235 (22.3) 2271 (22.6) 
   7 2959 (29.5) 2733 (27.2) 2574 (25.6) 2278 (22.7) 
   ≥8 2284 (22.7) 2085 (20.8) 2055 (20.5) 1873 (18.7) 
   Missing 2684 (26.7) 3013 (30.0) 3176 (31.6) 3617 (36.3) 
NSAID regular
1 
use     
   No 7032 (70.0) 6851 (68.2) 6646 (66.2) 6556 (65.3) 
   Yes 1268 (12.6) 1330 (13.3) 1478 (14.7) 1607 (16.0) 
   Missing 1742 (17.4) 1859 (18.5) 1916 (19.1) 1876 (18.7) 
Multivitamin regular
1 
use     
   No 4392 (43.7) 5022 (50.0) 5430 (54.1) 6034 (60.1) 
   Yes 5650 (56.3) 5018 (50.0) 4610 (45.9) 4005 (39.9) 
Smoking status     
   Non-smoker 4626 (46.1) 4471 (44.5) 4150 (41.3) 3692 (36.8) 
   Former smoker 4666 (46.5) 4544 (45.3) 4601 (45.8) 4430 (44.1) 
   Current smoker 511 (5.1) 782 (7.8) 1061 (10.6) 1624 (16.2) 
   Missing 239 (2.4) 243 (2.4) 228 (2.3) 293 (2.9) 
Diabetes     
   No 8894 (88.6) 8805 (87.7) 8753 (87.2) 8883 (88.5) 
   Yes 1148 (11.4) 1235 (12.3) 1287 (12.8) 1156 (11.5) 
Benign prostatic 
hyperplasia 
    
   No 7459 (74.3) 7548 (75.2) 7691 (76.6) 7899 (78.7) 
   Yes 2201 (21.9) 2075 (20.7) 1897 (18.9) 1705 (17.0) 
   Missing 382 (3.8) 417 (4.2) 452 (4.5) 435 (4.3) 
Family history of prostate 
cancer
2 
    
   No 8792 (87.6) 8811 (87.8) 8737 (87.0) 8799 (87.6) 
   Yes 1250 (12.4) 1229 (12.2) 1303 (13.0) 1240 (12.4) 
1 
Use 3-4 times per week. 
2
 Father or brother had prostate cancer. 
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Table 6.2 Relationships between quartiles of Energy-Density DII and incidence of Prostate Cancer of any stage  
 
  Q1: -6.1940 to 
≤-3.3597 
 
Q2:- 3.3598 to 
 ≤-2.0313 
 
Q3: -2.0314 to  
≤-0.5517 
 
Q4: -0.5518 to 
4.8927 
 
e-DII continuous, 
AF (95%CI) 
Sleep duration is not 
included in confounder 
selection 
N with PrCA 640 621 621 522 2,404 
AF (95%CI)
1 
1.00 (Ref.) 0.98 (0.88-1.09) 0.95 (0.85-1.06) 1.05 (0.94-1.18) 1.01 (0.98-1.03) 
Sleep duration modeled as 
a dummy variable 
N with PrCA 636 609 616 514 2,375 
AF (95%CI)
2 
1.00 (Ref.) 0.998 (0.90-1.11) 0.96 (0.86-1.06) 1.07 (0.95-1.20) 1.01 (0.99-1.03) 
Men with missing sleep 
duration removed 
N with PrCA
2 
461 428 449 345 1,683 
AF (95%CI)
2
 1.00 (Ref.) 0.995 (0.90-1.11) 0.92 (0.83-1.02) 1.04 (0.93-1.16) 1.00 (0.98-1.02) 
Men diagnosed with 
prostate cancer during first 
3 y. of follow up removed 
N with PrCA
2 
456 441 483 372 1,752 
AF (95%CI)
2
 1.00 (Ref.) 0.99 (0.92-1.07) 0.92 (0.85-0.99) 1.03 (0.95-1.11) 1.00 (0.98-1.01) 
Stratified by Race  
   White N with PrCA 481 423 418 315 1,637 
AF (95%CI)
2
 1.00 (Ref.) 1.02 (0.90-1.16) 0.96 (0.84-1.09) 1.16 (1.01-1.34) 1.02 (1.00-1.05) 
   Black N with PrCA 35 44 73 74 226 
AF (95%CI)
2
 1.00 (Ref.) 0.89 (0.58-1.36) 0.65 (0.44-0.96) 0.75 (0.50-1.11) 0.95 (0.89-1.02) 
   Asian  N with PrCA 41 52 38 30 161 
AF (95%CI)
2
 1.00 (Ref.) 0.92 (0.60-1.40) 0.95 (0.60-1.51) 0.99 (0.61-1.62) 1.03 (0.94-1.14) 
   Hispanic N with PrCA 45 48 45 45 183 
AF (95%CI)
2
 1.00 (Ref.) 1.09 (0.75-1.59) 1.36 (0.93-1.99) 1.22 (0.83-1.80) 1.04 (0.97-1.13) 
   Multiethnic/Other N with PrCA 34 42 42 50 168 
AF (95%CI)
2
 1.00 (Ref.) 0.79 (0.51-1.22) 0.80 (0.52-1.23) 0.68 (0.44-1.04) 0.92 (0.85-1.00) 
Detailed legend: Accelerated failure time models with log-logistic distribution were used to estimate parameters. 
AF: acceleration factor, CI: confidence interval, PrCA: Prostate Cancer. 
1 
Adjusted for age (in 5-year intervals), race, BPH, prostate cancer family history, diabetes, and smoking status. Only significant confounders were 
kept in the model. 
2 
Adjusted for age (in 5-year intervals), race, sleep (categorical), BPH, BMI (categorical), prostate cancer family history, diabetes, and smoking 
status. Physical activity was not a significant confounder. 
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Table 6.3 Relationships between Energy-Density DII and High- and Intermediate-high risk Prostate Cancer  
 
 Q1: -6.1940 
to  
≤-3.3597 
(healthiest) 
Q2:- 3.3598 to 
≤-2.0313 
Q3: -2.0314 to  
≤-0.5517 
Q4: -0.5518 to 
≤4.8927 
(least healthy) 
p-value  
for tend  
e-DII 
continuous,  
HR (95%CI) 
High-risk prostate cancer   
N with prostate cancer 100 123 126 88  437 
Age adjusted, HR (95%CI) 1.00 (Ref.) 1.28 (0.98-1.67) 1.39 (1.07-1.80) 1.04 (0.78-1.38) 0.97 1.03 (0.98-1.08) 
HR (95%CI)
1 
1.00 (Ref.) 1.27 (0.98-1.66) 1.36 (1.04-1.76) 0.99 (0.74-1.32) 0.74 1.02 (0.96-1.07) 
Men with missing sleep duration excluded   
N with prostate cancer 78 87 99 57  321 
HR (95%CI)
1
 1.00 (Ref.) 1.19 (0.88-1.62) 1.44 (1.07-1.94) 0.91 (0.65-1.28) 0.91 1.02 (0.96-1.08) 
Cases diagnosed during first 3 years removed   
N with prostate cancer 83 94 103 67  347 
HR (95%CI)
1
 1.00 (Ref.) 1.19 (0.88-1.59) 1.35 (1.01-1.81) 0.93 (0.67-1.28) 0.99 1.02 (0.96-1.08) 
Stratified by race
1 
      
   White with prostate cancer (n) 73 86 69 46  274 
   HR (95%CI)
1
 1.00 (Ref.) 1.29 (0.95-1.76) 1.12 (0.81-1.56) 0.80 (0.55-1.16) NA 0.97 (0.91-1.04) 
   Black with prostate cancer (n) 4 11 20 15  50 
   HR (95%CI)
1
 1.00 (Ref.) 2.43 (0.77-7.64) 3.77 (1.29-11.06) 2.29 (0.76-6.94) NA 1.10 (0.95-1.28) 
   Asian with prostate cancer (n) 10 11 13 6  40 
   HR (95%CI)
1
 1.00 (Ref.) 0.97 (0.41-2.30) 1.51 (0.66-3.46) 0.81 (0.30-2.24) NA 1.03 (0.87-1.24) 
   Hispanic with prostate cancer (n) 9 9 13 11  42 
   HR (95%CI)
1
 1.00 (Ref.) 0.91 (0.36-2.28) 1.16 (0.49-2.72) 1.11 (0.46-2.70) NA 1.04 (0.88-1.23) 
  Multiethnic/Other with prostate 
cancer (n) 
4 6 9 11  30 
   HR (95%CI)
1
 1.00 (Ref.) 1.68 (0.47-5.97) 2.97 (0.94-9.34) 2.94 (0.92-9.43) NA 1.23 (1.03-1.48) 
Intermediate-risk prostate cancer   
N with prostate cancer 237 242 239 201  919 
Age adjusted, HR (95%CI) 1.00 (Ref.) 1.06 (0.88-1.26) 1.08 (0.90-1.30) 0.96 (0.79-1.16) 0.70 0.99 (0.96-1.03) 
HR (95%CI)
2
 1.00 (Ref.) 1.05 (0.88-1.26) 1.06 (0.88-1.26) 0.91 (0.76-1.10) 0.36 0.98 (0.95-1.02) 
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Men with missing sleep duration excluded   
N with prostate cancer 172 168 185 131  656 
HR (95%CI)
2
 1.00 (Ref.) 1.05 (0.85-1.30) 1.20 (0.98-1.48) 0.93 (0.74-1.17) 0.84 1.00 (0.96-1.04) 
Cases diagnosed during first 3 years removed   
N with prostate cancer 180 174 195 144  693 
HR (95%CI)
2
 1.00 (Ref.) 1.01 (0.82-1.24) 1.15 (0.94-1.41) 0.89 (0.71-1.11) 0.53 0.99 (0.95-1.03) 
Detailed legend: Cox proportional hazards models were used to calculate parameters. 
1Adjusted for race and BPH; sleep duration (categorical) and age (≤55, 55-65, >65 y.) are in strata statement. Physical activity was not a 
significant confounder. 
2 Adjusted for race, BPH, family history of prostate cancer; sleep duration (categorical) and age (≤55, 55-65, >65 y.) are in strata statement. 
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CHAPTER 7 
Summary 
 
 This study showed that disrupted sleep and social jetlag in adults 21-35 years of 
age remained stable within two years. By the end of the study, chronotype became on 
average, 23 minutes earlier, most likely due to the phase advance among participants with 
evening chronotypes. Whether the observations in the present study correspond to more chronic 
sleep disruption that extends beyond two years remains to be determined. The demographic 
characteristics identified in this study that may contribute to persistent sleep disruption include: 
male sex, being a student, non-White race, low income, and evening chronotype. The further 
identification of susceptible subgroups of young adults with persistent sleep disruption may 
provide a health benefit to those individuals in terms of chronic disease prevention, given the 
persistent character of insomnia and other sleep disorders and their reported association with 
chronic diseases such as depression (37, 220, 239), obesity (213, 240, 241), diabetes (62, 120), 
hypertension (63, 118, 242), CVD (65) and cancer (28). 
 Chronotype and SJL were not associated with any anthropometric indexes of 
metabolic disorder. The relationships between disrupted sleep (SOL, SE, TST) and 
central obesity or elevated SBP were only modest. Despite being a fairly strong predictor 
for all sleep measures except SOL, chronotype seemed to modify rather than confound 
the relationships between disrupted sleep and obesity or high blood pressure. Those with 
poor sleep and morning chronotype were more likely to have excess body fat and central
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obesity. Evening types seemed to be more resilient to detrimental effects of sleep 
disruption than morning types and only had increased chance of having high SBP if they 
slept <6 hours. The discovery of the effect-modifying role of chronotype is novel 
compared to the previous studies that either inferred that chronotype, SJL and sleep 
confound each other's relationships with metabolic disorder (12, 49, 58) or that SJL 
mediates the relationships between chronotype and obesity (56). Due to the lack of 
association between chronotype or SJL with anthropometric measures, we were unable 
totest the latter hypothesis. This study's findings suggest that the relationships between 
sleep, chronotype, SJL and anthropometric indices are more complex than it was 
previously hypothesized and deserve further investigation in the future studies.  
 A pro-inflammatory diet was associated with 16% increase in total PrCA risk 
among middle-age White men while among all race combined the results were only 
suggestive. The inflammatory potential of diet was associated with increases in high-risk 
PrCA incidence. However, the patterns of risk observed across quartiles of e-DII 
complicate the interpretation, suggesting either a complex dose-response pattern (non-
linear relationship with possible threshold effect), or a lack of association. The 
relationship between the inflammatory potential of a diet and PrCA may vary by race; 
Blacks and those of non-White (or mixed) races may be more susceptible. The 
relationship between dietary inflammatory potential and risk of advanced /aggressive 
disease merits further investigation, particularly among those of racial or ethnic 
minorities. 
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APPENDIX A 
Chronotype estimation 
 
 Time (in minutes) from midnight to the sleep onset the next day and from the 
following midnight to the wake up time on the following day was calculated using the 
SWA data. During calculation of chronotype, minutes were converted into hours. Since 
the information on work schedule was not collected in this study, it was assumed that free 
days occurred only on weekends. The first step in calculation of chronotype was 
calculation of the mid-point of sleep on free days (MSF) using the following formulas:  
a. If a study participant went to bed before midnight (the bed time on the weekend 
(SOwkend) ≤ 1440 minutes), then 
 MSF= (WTwkend -((1440- SOwkend+WTwkend)/2))/60 (hours), 
 where WTwkend - wake time on the weekend; 
b. If a study participant went to bed after midnight (SOwkend >1440 minutes), then  
 MSF=( WTwkend -(( WTwkend -(SOwkend -1440))/2))/60 (hours) 
The MSF was corrected for make-up sleep on free days (weekends in this study) 
(MSFsc)[8]. The “oversleep” is an excessive time spent asleep on a weekend to 
compensate for sleep deprivation during the working week. The MSFsc was calculated 
using the formula: 
 MSFsc = MSF - (SDwkend - SD)/2, 
where SDwkend – sleep duration on free days (weekend);
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SD – average sleep duration across the week (includes sleep duration on all available 
week and weekend nights).  
 The MSF is adjusted for make-up sleep only in study participants who sleep 
longer on free days (weekend) than on work days. In persons who sleep longer on work 
days, chronotype is defined as MSF:  
 MSFsc = MSF 
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APPENDIX B: 
Chronotype, Social Jetlag, Mood and Stress 
 
 In adjusted analyses, chronotype was not associated with mood and stress. Later 
chronotypes were associated with reduced risk of having bad sleep assessed with PSQI 
(Table B.1). Per 1 hour increase in lateness of chronotype, odds of bad sleep decreased 
0.8 times (95%CI: 0.74-0.97). 
 Absolute SJL was not associated with TMD score and any of its six factors (Table 
B.2). Per 1 hour increase in absolute SJL risk of high perceived stress decreased 0.8 times 
(95%CI: 0.68-0.99). Stratification by latent chronotype group showed that among those 
with intermediate chronotypes, Per 1 hour increase in SJL, odds of high stress decreased 
0.7 times (95%CI: 0.57-0.94, pinteraction=0.44).
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Table B.1 Relationships between Chronotype, Mood, Stress, and Sleep 
Quality 
 
Variable 
 
Estimate SE p-value 
TMD score (cont.)    
   crude 0.03734 0.03488 0.29 
   adjusted
1 
0.007626 0.03528 0.83 
Depression    
   crude 0.02625 0.03647 0.47 
   adjusted
2 
-0.02261 0.03855 0.56 
Tension-Anxiety    
   crude 0.04439 0.02123 0.04 
   Adjusted
3 
0.01998 0.02140 0.35 
Fatigue    
   crude 0.02463 0.02163 0.26 
   Adjusted
4 
0.01687 0.02217 0.45 
Confusion-
bewilderment 
   
   crude 0.03226 0.01760 0.07 
   Adjusted
5 
0.009604 0.01813 0.60 
Anger-Hostility    
   crude 0.02940 0.02826 0.30 
   Adjusted
6 
0.003888 0.02857 0.89 
Vigor    
   crude -0.2096 -0.2096 0.19 
   Adjusted
7 
-0.2250 0.1557 0.15 
PSS (cont.)    
   crude 0.07438 0.1343 0.58 
   Adjusted
8 
-0.04034
 
0.1335 0.76 
 OR 95%CI p-value 
PSS (>12 vs. ≤12) 
   crude 1.04 0.93-1.17 0.51 
   adjusted
9 
1.01 0.88-1.13 0.98 
PSQI (>5 vs. ≤5) 
   crude 0.86 0.75-0.98 0.02 
   Adjusted
10 
0.84 0.74-0.97 0.01 
Detailed legend: Linear models with repeated measures and unstructured 
correlation matrix (proc GLIMMIX). POMs, depression, tension modeled 
using lognormal distribution, vigor and PSS score - normal distribution for 
continuous variable). Dichotomous PSS score and PSQI were modeled with 
binary distribution). 
1 
Adjusted for time, employment status, income, marital status, e-DII 
(continuous), sleep duration on work days, social desirability score, 
bulimia score, physical activity (continuous, MET-hrs), nap (yes/no)and 
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perceived body image. 
2 
Adjusted for time, age, sex, alcohol, income, marital status, season, sleep 
duration on work days, race, bulimia score, social desirability score and 
perceived body image. 
3 
Adjusted for  time, age, e-DII (cont.), employment status, social desirability 
score, thinness score. 
4 
Adjusted for time, race, season, alcohol, e-DII (cont.),sleep duration on 
work days, social desirability score, perceived body image and having 
children. 
5 
Adjusted for time, income, race, marital status, e-DII (cont.), social 
desirability score, bulimia score. 
6 
Adjusted for time, season, income, sleep duration on work days,  
desirability score, thinness score, ideal body image and current diet.  
7 
Adjusted for time, sex, having children, physical activity (continuous, hrs), 
e-DII continuous), social desirability score, smoking status. 
8 
Adjusted for time, age, sex, total sleep hours week day, physical activity 
hours, e-DII, income, season, social desirability score, bulimia score. 
9 
Adjusted for time, sex, race, total number of hours slept on week night, e-
DII (cont.), social desirability score, bulimia score. 
10 
Adjusted for time, sleep duration on work days, social desirability score, 
bulimia score. 
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Table B.2 Relationships between Absolute Social Jetlag and Mood, 
Stress, and Poor Sleep 
 
Variable Estimate SE p-value 
TMD score (cont.)    
   crude -0.08584 0.05492 0.12 
   adjusted
1 
-0.07980 0.05370 0.14 
Depression    
   crude -0.05808 0.05894 0.33 
   adjusted
2 
-0.02329 0.05671 0.68 
Tension-Anxiety    
   crude -0.02087 0.03014 0.49 
   Adjusted
3 
-0.01880 0.02931 0.52 
Fatigue    
   crude 0.004596 0.03160 0.88 
   Adjusted
4 
-0.02227 0.03103 0.47 
Confusion-
bewilderment 
   
   crude -0.03416 0.02523 0.18 
   Adjusted
5 
-0.04562 0.02455 0.06 
Anger-Hostility    
   crude -0.00995 0.04115 0.81 
   Adjusted
6 
-0.02826 0.04033 0.48 
Vigor    
   crude -0.09702 0.2236 0.66 
   Adjusted
7 
0.01722 0.2153 0.94 
PSS (cont.)    
   crude -0.4022 0.1835 0.03 
   Adjusted
8 
-0.4906
 
0.1792 0.01 
 OR 95%CI  
PSS (>12 vs. ≤12) 
   crude 0.87 0.73-1.05 0.14 
   adjusted
9 
0.82 0.68-0.99 0.04 
  Stratified by latent chronotype group  (pinteraction=0.44)
10 
   Early 1.05  0.68-1.60 0.83 
   Intermediate 0.73 0.57-0.94 0.02 
   Late 0.81 0.42-1.54 0.51 
PSQI (>5 vs. ≤5) 
   crude 0.91 0.75-1.11 0.37 
   Adjusted
11 
0.92 0.75-1.12 0.40 
Detailed legend: Linear models with repeated measures and unstructured 
correlation matrix (proc GLIMMIX). TMD score, depression, tension 
modeled using lognormal distribution, vigor and PSS - normal distribution.  
1 
Adjusted for time, employment, sleep duration on work days, social 
desirability score, bulimia score. 
2 
Adjusted for time, sex, race, income, 
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marital status, season, sleep duration on work days, alcohol, caffeine 
(tertiles), bulimia score and perceived body image. 
3 
Adjusted for
  
time, 
income, e-DII (cont.), employment, social desirability score and thinness 
score. 
4 
Adjusted for time,  race, e-DII, sleep duration on work days, social 
desirability score, perceived body image, having  children. 
5 
Adjusted for 
time, marital status, total sleep duration on work days, social desirability 
score, bulimia score. 
6 
Adjusted for time, season, current diet, social 
desirability score, thinness score, ideal body image, sleep duration on work 
days. 
7 
Adjusted for time, sex, physical activity (continuous, hrs),social 
desirability score, having children, smoking status. 
8 
Adjusted for time, sex, 
total sleep duration on work days (cont., hrs), e-DII (cont.), income, season, 
social desirability score, bulimia score. 
9 
Adjusted for time, sex, race, e-DII 
(cont.), total sleep duration on work days, social desirability score, bulimia 
score. 
10 
Adjusted for time, sex, race, e-DII (cont.), total sleep duration on 
work days, social desirability score, bulimia score. 
11 
Adjusted for time, 
marital status, social desirability score and thinness score. 
 
